BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, Ochsenkühn T, Orchard T, Rogler G, Louis E, Kupcinskas L, Mantzaris G, Travis S, Stange E; for the European Crohn's and Colitis Organisation (ECCO). The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. Journal of Crohn's and Colitis 2010;4:7-27. [DOI: 10.1016/j.crohns.2009.12.003] [Cited by in Crossref: 762] [Cited by in F6Publishing: 685] [Article Influence: 63.5] [Reference Citation Analysis]
Number Citing Articles
1 Halliday J, Djordjevic J, Lust M, Culver E, Braden B, Travis S, Chapman R. A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease. Journal of Crohn's and Colitis 2012;6:174-81. [DOI: 10.1016/j.crohns.2011.07.015] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
2 Jusué V, Chaparro M, Gisbert JP. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease. Dig Liver Dis 2018;50:353-9. [PMID: 29396129 DOI: 10.1016/j.dld.2017.12.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
3 Bolwell JG, Wild D. Indications, Contraindications, and Considerations for Video Capsule Endoscopy. Gastrointest Endosc Clin N Am 2021;31:267-76. [PMID: 33743925 DOI: 10.1016/j.giec.2020.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li L, Liu JN, Zhou Y. Recurrence of Crohn's disease in a patient after surgery for gastric cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(19): 3163-3165 [DOI: 10.11569/wcjd.v23.i19.3163] [Reference Citation Analysis]
5 Brůhová Michalčíková R, Dryahina K, Španěl P. SIFT-MS quantification of several breath biomarkers of inflammatory bowel disease, IBD: A detailed study of the ion chemistry. International Journal of Mass Spectrometry 2016;396:35-41. [DOI: 10.1016/j.ijms.2015.12.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Navarro E. El papel de enfermería en una unidad monográfica de enfermedad inflamatoria intestinal, una visión de 360°. Enfermedad Inflamatoria Intestinal al Día 2017;16:21-9. [DOI: 10.1016/j.eii.2016.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
7 Hart AL, Ng SC. Crohn’s disease. Medicine 2011;39:229-36. [DOI: 10.1016/j.mpmed.2011.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
8 Argüelles-Arias F, Rodríguez-Oballe J, Duarte-Chang C, Castro-Laria L, García-Montes JM, Caunedo-Álvarez A, Herrerías-Gutiérrez JM. Capsule endoscopy in the small bowel Crohn's disease. Gastroenterol Res Pract 2014;2014:529136. [PMID: 24741374 DOI: 10.1155/2014/529136] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kumar S, Hakim A, Alexakis C, Chhaya V, Tzias D, Pilcher J, Vlahos J, Pollok R. Small intestinal contrast ultrasonography for the detection of small bowel complications in Crohn's disease: correlation with intraoperative findings and magnetic resonance enterography. J Gastroenterol Hepatol. 2015;30:86-91. [PMID: 25168482 DOI: 10.1111/jgh.12724] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
10 Sohn IW, Kim ST, Kim B, Lee HJ, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH. Efficacy of Adalimumab in Korean Patients with Crohn's Disease. Gut Liver 2016;10:255-61. [PMID: 26470766 DOI: 10.5009/gnl15165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
11 Glass J, Alcalá HE, Tobin M. The Value of Obtaining Colonic Mucosal Biopsies of Grossly Normal Tissue in Pediatric Patients. J Pediatr Gastroenterol Nutr 2021;72:677-82. [PMID: 33399330 DOI: 10.1097/MPG.0000000000003038] [Reference Citation Analysis]
12 Barreiro-De Acosta M, Domènech E, Martín Arranz MD, García Sánchez V, Gutiérrez Casbas A, Chaparro M, Alcain G, Iborra M, Taxonera C, Rodriguez-Lago I, Menchén L, Khorrami S, Romero C, Cea-Calvo L, Juliá B. Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn's disease patients: the Practicrohn study. Expert Rev Gastroenterol Hepatol 2019;13:807-13. [PMID: 31203691 DOI: 10.1080/17474124.2019.1626717] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Hisabe T, Hirai F, Matsui T, Watanabe M. Evaluation of diagnostic criteria for Crohn's disease in Japan. J Gastroenterol 2014;49:93-9. [PMID: 23546557 DOI: 10.1007/s00535-013-0798-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
14 Calabrese E, Zorzi F, Zuzzi S, Ooka S, Onali S, Petruzziello C, Lasinio GJ, Biancone L, Rossi C, Pallone F. Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn’s disease. J Crohns Colitis. 2012;6:852-860. [PMID: 22398077 DOI: 10.1016/j.crohns.2012.01.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
15 Prideaux L, De Cruz P, Ng SC, Kamm MA. Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 2012;18:1340-1355. [PMID: 22069240 DOI: 10.1002/ibd.21903] [Cited by in Crossref: 111] [Cited by in F6Publishing: 94] [Article Influence: 10.1] [Reference Citation Analysis]
16 Nazarian A, Bishay K, Gholami R, Scaffidi MA, Khan R, Cohen-Lyons D, Griller N, Satchwell JB, Baker JP, Grover SC, Irvine EJ. Factors Associated with Poor Quality of Life in a Canadian Cohort of Patients with Inflammatory Bowel Disease: A Cross-sectional Study. J Can Assoc Gastroenterol 2021;4:91-6. [PMID: 33855267 DOI: 10.1093/jcag/gwaa014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn's disease. Dis Mon. 2018;64:20-57. [PMID: 28826742 DOI: 10.1016/j.disamonth.2017.07.001] [Cited by in Crossref: 108] [Cited by in F6Publishing: 88] [Article Influence: 21.6] [Reference Citation Analysis]
18 Greco A, Caviglia GP, Brignolo P, Ribaldone DG, Reggiani S, Sguazzini C, Smedile A, Pellicano R, Resegotti A, Astegiano M, Bresso F. Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response. Scand J Gastroenterol 2015;50:1376-81. [PMID: 25990116 DOI: 10.3109/00365521.2015.1050691] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
19 Li E, Zhang Y, Tian X, Wang X, Gathungu G, Wolber A, Shiekh SS, Sartor RB, Davidson NO, Ciorba MA, Zhu W, Nelson LM, Robertson CE, Frank DN. Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome. PLoS One 2019;14:e0213108. [PMID: 30818349 DOI: 10.1371/journal.pone.0213108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
20 Lo Re G, Cappello M, Tudisca C, Galia M, Randazzo C, Craxì A, Cammà C, Giovagnoni A, Midiri M. CT enterography as a powerful tool for the evaluation of inflammatory activity in Crohn's disease: relationship of CT findings with CDAI and acute-phase reactants. Radiol Med 2014;119:658-66. [PMID: 24408044 DOI: 10.1007/s11547-013-0377-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
21 Haisma SM, Verkade HJ, Scheenstra R, van der Doef HPJ, Bodewes FAJA, van Rheenen PF. Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:466-73. [PMID: 31365486 DOI: 10.1097/MPG.0000000000002458] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Daperno M, Castiglione F, de Ridder L, Dotan I, Färkkilä M, Florholmen J, Fraser G, Fries W, Hebuterne X, Lakatos PL. Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease. J Crohns Colitis. 2011;5:484-498. [PMID: 21939926 DOI: 10.1016/j.crohns.2011.07.003] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 6.5] [Reference Citation Analysis]
23 Beigmohammadi F, Mahmoudi M, Karami J, Ahmadzadeh N, Ebrahimi-Daryani N, Rezaei N. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases. J Immunol Res 2020;2020:4873648. [PMID: 33015197 DOI: 10.1155/2020/4873648] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 De Franco A, Marzo M, Felice C, Pugliese D, Veronica AD, Bonomo L, Armuzzi A, Guidi L. Ileal Crohn's disease: CEUS determination of activity. Abdom Imaging 2012;37:359-68. [PMID: 22223202 DOI: 10.1007/s00261-011-9831-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
25 Strik AS, Bots SJA, D’haens G, Löwenberg M. Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease. Expert Review of Clinical Pharmacology 2015;9:429-39. [DOI: 10.1586/17512433.2016.1133288] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
26 Zhang W, Zhu W, Ren J, Zuo L, Wu X, Li J. Skeletal muscle percentage: A protective factor for postoperative morbidity in Crohn's disease patients with severe malnutrition. J Gastrointest Surg. 2015;19:715-721. [PMID: 25666099 DOI: 10.1007/s11605-015-2763-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
27 Ward MG, Thwaites PA, Beswick L, Hogg J, Rosella G, Van Langenberg D, Reynolds J, Gibson PR, Sparrow MP. Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease. Aliment Pharmacol Ther 2017;45:1135-45. [PMID: 28239869 DOI: 10.1111/apt.13992] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
28 Yacoub JH, Oto A. New Magnetic Resonance Imaging Modalities for Crohn Disease. Magnetic Resonance Imaging Clinics of North America 2014;22:35-50. [DOI: 10.1016/j.mric.2013.07.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
29 Huang ZC, Yang QF, Tang J, Li M, Chao K, Gao X. Thiopurines are superior to mesalamine for preventing postoperative recurrence in patients with Crohn's disease and two or more risk factors. J Dig Dis 2021;22:590-6. [PMID: 34453408 DOI: 10.1111/1751-2980.13047] [Reference Citation Analysis]
30 Jeon SR, Kim JO, Byeon JS, Yang DH, Ko BM, Goong HJ, Jang HJ, Park SJ, Kim ER, Hong SN, Im JP, Kim SE, Koo JS, Eun CS, Chang DK; Korean Association for the Study of Intestinal Diseases (KASID). Enteroscopy in Crohn's Disease: Are There Any Changes in Role or Outcomes Over Time? A KASID Multicenter Study. Gut Liver 2021;15:375-82. [PMID: 32616680 DOI: 10.5009/gnl20023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Con D, De Cruz P. Mobile Phone Apps for Inflammatory Bowel Disease Self-Management: A Systematic Assessment of Content and Tools. JMIR Mhealth Uhealth. 2016;4:e13. [PMID: 26831935 DOI: 10.2196/mhealth.4874] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 7.2] [Reference Citation Analysis]
32 Yu H, Shen YQ, Tan FQ, Zhou ZL, Li Z, Hu DY, Morelli JN. Quantitative diffusion-weighted magnetic resonance enterography in ileal Crohn's disease: A systematic analysis of intra and interobserver reproducibility. World J Gastroenterol 2019; 25(27): 3619-3633 [PMID: 31367161 DOI: 10.3748/wjg.v25.i27.3619] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Mainenti PP, Castiglione F, Rispo A, Laccetti E, Guarino S, Romeo V, Testa A, Pace L, Maurea S. MR-enterography in Crohn's disease: what MRE mural parameters are associated to one-year therapeutic management outcome? Br J Radiol 2021;94:20200844. [PMID: 33186053 DOI: 10.1259/bjr.20200844] [Reference Citation Analysis]
34 Zappa M, Stefanescu C, Cazals-Hatem D, Bretagnol F, Deschamps L, Attar A, Larroque B, Tréton X, Panis Y, Vilgrain V, Bouhnik Y. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis 2011;17:984-93. [PMID: 20722053 DOI: 10.1002/ibd.21414] [Cited by in Crossref: 170] [Cited by in F6Publishing: 149] [Article Influence: 14.2] [Reference Citation Analysis]
35 Fiorino G, Bonifacio C, Padrenostro M, Sposta FM, Spinelli A, Malesci A, Balzarini L, Peyrin-Biroulet L, Danese S. Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn's disease. Dig Dis Sci 2013;58:3246-55. [PMID: 23903867 DOI: 10.1007/s10620-013-2781-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
36 Copova I, Hradsky O, Zarubova K, Gonsorcikova L, Potuznikova K, Lerchova T, Nevoral J, Bronsky J. Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease. Eur J Pediatr 2018;177:1685-93. [DOI: 10.1007/s00431-018-3228-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Monteiro S, Boal Carvalho P, Dias de Castro F, Magalhães J, Machado F, Moreira MJ, Rosa B, Cotter J. Capsule Endoscopy: Diagnostic Accuracy of Lewis Score in Patients with Suspected Crohn's Disease. Inflamm Bowel Dis 2015;21:2241-6. [PMID: 26197449 DOI: 10.1097/MIB.0000000000000517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
38 Zhou J, Li Y, Gong J, Zhu W. Frequency and risk factors of surgical recurrence of Crohn's disease after primary bowel resection. Turk J Gastroenterol. 2018;29:655-663. [PMID: 30381273 DOI: 10.5152/tjg.2018.17774] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Glapa-Nowak A, Szczepanik M, Iwańczak B, Kwiecień J, Szaflarska-Popławska AB, Grzybowska-Chlebowczyk U, Osiecki M, Dziekiewicz M, Stawarski A, Kierkuś J, Banasiewicz T, Banaszkiewicz A, Walkowiak J. Apolipoprotein E variants correlate with the clinical presentation of paediatric inflammatory bowel disease: A cross-sectional study. World J Gastroenterol 2021; 27(14): 1483-1496 [PMID: 33911469 DOI: 10.3748/wjg.v27.i14.1483] [Reference Citation Analysis]
40 Yousuf H, Aleem U, Egan R, Maheshwari P, Mohamad J, Mcnamara D. Elevated Faecal Calprotectin Levels are a Reliable Non-Invasive Screening Tool for Small Bowel Crohn’s Disease in Patients Undergoing Capsule Endoscopy. Dig Dis 2018;36:202-8. [DOI: 10.1159/000485375] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
41 Yoon K, Chang KT, Lee HJ. MRI for Crohn’s Disease: Present and Future. Biomed Res Int. 2015;2015:786802. [PMID: 26413543 DOI: 10.1155/2015/786802] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
42 Annese V, Daperno M, Rutter MD, Amiot A, Bossuyt P, East J, Ferrante M, Götz M, Katsanos KH, Kießlich R, Ordás I, Repici A, Rosa B, Sebastian S, Kucharzik T, Eliakim R. European evidence based consensus for endoscopy in inflammatory bowel disease. Journal of Crohn's and Colitis 2013;7:982-1018. [DOI: 10.1016/j.crohns.2013.09.016] [Cited by in Crossref: 486] [Cited by in F6Publishing: 410] [Article Influence: 54.0] [Reference Citation Analysis]
43 Brouquet A, Maggiori L, Zerbib P, Lefevre JH, Denost Q, Germain A, Cotte E, Beyer-Berjot L, Munoz-Bongrand N, Desfourneaux V, Rahili A, Duffas JP, Pautrat K, Denet C, Bridoux V, Meurette G, Faucheron JL, Loriau J, Guillon F, Vicaut E, Benoist S, Panis Y;  GETAID chirurgie group. Anti-TNF Therapy Is Associated With an Increased Risk of Postoperative Morbidity After Surgery for Ileocolonic Crohn Disease: Results of a Prospective Nationwide Cohort. Ann Surg. 2018;267:221-228. [PMID: 29300710 DOI: 10.1097/sla.0000000000002017] [Cited by in Crossref: 73] [Cited by in F6Publishing: 12] [Article Influence: 24.3] [Reference Citation Analysis]
44 Kwak MS, Kim DH, Park SJ, Kim TI, Hong SP, Kim WH, Cheon JH. Efficacy of early immunomodulator therapy on the outcomes of Crohn's disease. BMC Gastroenterol. 2014;14:85. [PMID: 24886458 DOI: 10.1186/1471-230x-14-85] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
45 Sasaki T, Kunisaki R, Kinoshita H, Kimura H, Kodera T, Nozawa A, Hanzawa A, Shibata N, Yonezawa H, Miyajima E. Doppler ultrasound findings correlate with tissue vascularity and inflammation in surgical pathology specimens from patients with small intestinal Crohn’s disease. BMC Res Notes. 2014;7:363. [PMID: 24927748 DOI: 10.1186/1756-0500-7-363] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
46 Armuzzi A, Felice C, Lubrano E, Cantini F, Castiglione F, Gionchetti P, Orlando A, Salvarani C, Scarpa R, Marchesoni A, Vecchi M, Olivieri I. Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts. Digestive and Liver Disease 2017;49:1298-305. [DOI: 10.1016/j.dld.2017.06.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
47 Biancone L, Onali S, Petruzziello C, Calabrese E, Pallone F. Cancer and immunomodulators in inflammatory bowel diseases. Inflamm Bowel Dis. 2015;21:674-698. [PMID: 25545375 DOI: 10.1097/mib.0000000000000243] [Cited by in Crossref: 35] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
48 Skamnelos A, Lazaridis N, Vlachou E, Koukias N, Apostolopoulos P, Murino A, Christodoulou D, Despott EJ. The role of small-bowel endoscopy in inflammatory bowel disease: an updated review on the state-of-the-art in 2021. Ann Gastroenterol 2021;34:599-611. [PMID: 34475730 DOI: 10.20524/aog.2021.0652] [Reference Citation Analysis]
49 Cernoch PS, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group. Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study. Dig Dis Sci 2020;65:2654-63. [PMID: 31797187 DOI: 10.1007/s10620-019-05978-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
50 Lui RNS, Ng SC. The Same Intestinal Inflammatory Disease despite Different Genetic Risk Factors in the East and West? Inflamm Intest Dis 2016;1:78-84. [PMID: 29922661 DOI: 10.1159/000446625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
51 Iannicelli E, Martini I, Fantini C, Papi C, Gigante P, Carbonetti F, Di Pietropaolo M, David V. Magnetic resonance enterography in Crohn's disease: new simple proposal to assess disease activity. Clin Imaging. 2016;40:492-497. [PMID: 27133693 DOI: 10.1016/j.clinimag.2015.11.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
52 Portela F, Dias CC, Caldeira P, Cravo M, Deus J, Gonçalves R, Lago P, Morna H, Peixe P, Ramos J, Sousa H, Tavares L, Vasconcelos H, Magro F, Ministro P. The who-when-why triangle of complementary and alternative medicine use among Portuguese IBD patients. Digestive and Liver Disease 2017;49:388-96. [DOI: 10.1016/j.dld.2016.12.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
53 Tielbeek JA, Ziech ML, Li Z, Lavini C, Bipat S, Bemelman WA, Roelofs JJ, Ponsioen CY, Vos FM, Stoker J. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn's disease assessment with histopathology of surgical specimens. Eur Radiol. 2014;24:619-629. [PMID: 24037299 DOI: 10.1007/s00330-013-3015-7] [Cited by in Crossref: 134] [Cited by in F6Publishing: 123] [Article Influence: 14.9] [Reference Citation Analysis]
54 Cerrillo E, Beltrán B, Pous S, Echarri A, Gallego JC, Iborra M, Pamies J, Nos P. Fecal Calprotectin in Ileal Crohnʼs Disease: Relationship with Magnetic Resonance Enterography and a Pathology Score. Inflammatory Bowel Diseases 2015;21:1572-9. [DOI: 10.1097/mib.0000000000000404] [Cited by in Crossref: 41] [Cited by in F6Publishing: 19] [Article Influence: 5.9] [Reference Citation Analysis]
55 Verdejo C, Hervías D, Roncero Ó, Arias Á, Bouhmidi A, Lorente R, Salueña I, Lucendo AJ. Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease. Eur J Gastroenterol Hepatol 2018;30:1521-7. [PMID: 30303822 DOI: 10.1097/MEG.0000000000001284] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
56 Szymanska E, Dadalski M, Szymanska S, Grajkowska W, Pronicki M, Kierkus J. The impact of induction therapy with three doses of infliximab on deep histological healing in paediatric patients with active Crohn's disease. Prz Gastroenterol 2016;11:176-80. [PMID: 27713779 DOI: 10.5114/pg.2016.57753] [Reference Citation Analysis]
57 Cotter J, Dias de Castro F, Moreira MJ, Rosa B. Tailoring Crohn's disease treatment: the impact of small bowel capsule endoscopy. J Crohns Colitis. 2014;8:1610-1615. [PMID: 24631311 DOI: 10.1016/j.crohns.2014.02.018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
58 Qiu Y, Mao R, Chen B, He Y, Zeng Z, Xue L, Song X, Li Z, Chen M. Fecal Calprotectin for Evaluating Postoperative Recurrence of Crohnʼs Disease: A Meta-analysis of Prospective Studies. Inflammatory Bowel Diseases 2015;21:315-22. [DOI: 10.1097/mib.0000000000000262] [Cited by in Crossref: 41] [Cited by in F6Publishing: 10] [Article Influence: 5.9] [Reference Citation Analysis]
59 Schreiber-Dietrich D, Chiorean L, Cui XW, Braden B, Kucharzik T, Jüngert J, Kosiak W, Stenzel M, Dietrich CF. Particularities of Crohn's disease in pediatric patients: current status and perspectives regarding imaging modalities. Expert Rev Gastroenterol Hepatol 2015;9:1313-25. [PMID: 26377445 DOI: 10.1586/17474124.2015.1083420] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
60 Strong S, Steele SR, Boutrous M, Bordineau L, Chun J, Stewart DB, Vogel J, Rafferty JF; Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. Clinical Practice Guideline for the Surgical Management of Crohn's Disease. Dis Colon Rectum 2015;58:1021-36. [PMID: 26445174 DOI: 10.1097/DCR.0000000000000450] [Cited by in Crossref: 65] [Cited by in F6Publishing: 19] [Article Influence: 10.8] [Reference Citation Analysis]
61 Pollok RCG, Saxena S, Alexakis C, Chhaya V. Letter to Editor Regarding Narula et al, IBD 2017, Budenoside Use Is a Key Quality Marker in the Management of IBD: . Inflammatory Bowel Diseases 2017;23:E41. [DOI: 10.1097/mib.0000000000001184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
62 de Bie CI, Buderus S, Sandhu BK, de Ridder L, Paerregaard A, Veres G, Dias JA, Escher JC, EUROKIDS Porto IBD Working Group of ESPGHAN. Diagnostic workup of paediatric patients with inflammatory bowel disease in Europe: results of a 5-year audit of the EUROKIDS registry. J Pediatr Gastroenterol Nutr. 2012;54:374-380. [PMID: 21857248 DOI: 10.1097/mpg.0b013e318231d984] [Cited by in Crossref: 71] [Cited by in F6Publishing: 20] [Article Influence: 7.1] [Reference Citation Analysis]
63 De Cassan C, Fiorino G, Danese S. Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects? Dig Dis. 2012;30:368-375. [PMID: 22796798 DOI: 10.1159/000338128] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
64 Freitas TH, Hyphantis TN, Andreoulakis E, Quevedo J, Miranda HL, Alves GS, Souza MH, Braga LL, Pargament KI, Soczynska JK, Mcintyre RS, Carvalho AF. Religious coping and its influence on psychological distress, medication adherence, and quality of life in inflammatory bowel disease. Braz J Psychiatry 2015;37:219-27. [DOI: 10.1590/1516-4446-2014-1507] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
65 Mantzaris GJ. When can we cure Crohn's? Best Practice & Research Clinical Gastroenterology 2014;28:519-29. [DOI: 10.1016/j.bpg.2014.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
66 Thomsen SB, Ungaro RC, Allin KH, Elmahdi R, Poulsen G, Andersson M, Colombel JF, Jess T. Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study. Aliment Pharmacol Ther 2022. [PMID: 35080036 DOI: 10.1111/apt.16777] [Reference Citation Analysis]
67 Fatemi A, Jazi HH, Emami MH, Kazemizadeh A, Tavakkoli H, Smiley A. Relationship between articular and nonarticular manifestations in inflammatory bowel diseases. J Res Med Sci 2016;21:48. [PMID: 27904594 DOI: 10.4103/1735-1995.183989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
68 Pesce Lamas Constantino C, Souza Rodrigues R, Araujo Oliveira Neto J, Marchiori E, Eiras Araujo AL, Perez Rde M, Braz Parente D. Computed tomography and magnetic resonance enterography findings in Crohn's disease: what does the clinician need to know from the radiologist? Can Assoc Radiol J 2014;65:42-51. [PMID: 23706867 DOI: 10.1016/j.carj.2012.11.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
69 Ciccocioppo R, Racca F, Scudeller L, Piralla A, Formagnana P, Pozzi L, Betti E, Vanoli A, Riboni R, Kruzliak P, Baldanti F, Corazza GR. Differential cellular localization of Epstein-Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease. Immunol Res 2016;64:191-203. [PMID: 26659090 DOI: 10.1007/s12026-015-8737-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
70 Olivera P, Danese S, Peyrin-biroulet L. JAK inhibition in inflammatory bowel disease. Expert Review of Clinical Immunology 2017;13:693-703. [DOI: 10.1080/1744666x.2017.1291342] [Cited by in Crossref: 46] [Cited by in F6Publishing: 20] [Article Influence: 9.2] [Reference Citation Analysis]
71 Costa Pereira C, Durães C, Coelho R, Grácio D, Silva M, Peixoto A, Lago P, Pereira M, Catarino T, Pinho S, Teixeira JP, Macedo G, Annese V, Magro F. Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease. PLoS One 2017;12:e0169102. [PMID: 28052094 DOI: 10.1371/journal.pone.0169102] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
72 Schaefer M, Laurent V, Grandmougin A, Vuitton L, Bourreille A, Luc A, Clerc-Urmes I, Orry X, Frampas E, De Billy M, Pouillon L, Le Berre C, Gay C, Meyer J, Baumann C, Peyrin-Biroulet L. A Magnetic Resonance Imaging Index to Predict Crohn's Disease Postoperative Recurrence: The MONITOR Index. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00699-6. [PMID: 34216820 DOI: 10.1016/j.cgh.2021.06.035] [Reference Citation Analysis]
73 Yamamoto T, Shimoyama T. Monitoring and detection of disease recurrence after resection for Crohn’s disease: the role of non-invasive fecal biomarkers. Expert Review of Gastroenterology & Hepatology 2017;11:899-909. [DOI: 10.1080/17474124.2017.1356226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
74 Yadav DP, Madhusudhan KS, Kedia S, Sharma R, Pratap Mouli V, Bopanna S, Dhingra R, Pradhan R, Goyal S, Sreenivas V, Vikram NK, Makharia G, Ahuja V. Development and validation of visceral fat quantification as a surrogate marker for differentiation of Crohn's disease and intestinal tuberculosis. J Gastroenterol Hepatol. 2017;32:420-426. [PMID: 27532624 DOI: 10.1111/jgh.13535] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
75 Tontini GE, Vecchi M, Neurath MF, Neumann H. Advanced endoscopic imaging techniques in Crohn’s disease. J Crohns Colitis. 2014;8:261-269. [PMID: 24080247 DOI: 10.1016/j.crohns.2013.09.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
76 Yung D, Douglas S, Hobson AR, Giannakou A, Plevris JN, Koulaouzidis A. Morpho-functional evaluation of small bowel using wireless motility capsule and video capsule endoscopy in patients with known or suspected Crohn's disease: pilot study. Endosc Int Open 2016;4:E480-6. [PMID: 27092333 DOI: 10.1055/s-0042-100718] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
77 Pariente B, Peyrin-Biroulet L, Cohen L, Zagdanski AM, Colombel JF. Gastroenterology review and perspective: the role of cross-sectional imaging in evaluating bowel damage in Crohn disease. AJR Am J Roentgenol. 2011;197:42-49. [PMID: 21701009 DOI: 10.2214/ajr.11.6632] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
78 Picchianti-Diamanti A, Lorenzetti R, Chimenti MS, Luchetti MM, Conigliaro P, Canofari C, Benfaremo D, Bruzzese V, Laganà B, Perricone R; SIGR. Enteropathic spondyloarthritis: Results from a large nationwide database analysis. Autoimmun Rev 2020;19:102457. [PMID: 31838160 DOI: 10.1016/j.autrev.2019.102457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
79 Hu D, Ren J, Wang G, Gu G, Li G, Liu S, Wu X, Chen J, Wu Q, Ren H, Hong Z, Li J. Value of Red Cell Distribution Width for Assessing Disease Activity in Crohn's Disease. The American Journal of the Medical Sciences 2015;349:42-5. [DOI: 10.1097/maj.0000000000000334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
80 Monasta L, Pierobon C, Princivalle A, Martelossi S, Marcuzzi A, Pasini F, Perbellini L. Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry. PLoS One 2017;12:e0184118. [PMID: 28859138 DOI: 10.1371/journal.pone.0184118] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
81 Nunes T, Etchevers MJ, Sandi MJ, Pinó Donnay S, Grandjean T, Pellisé M, Panés J, Ricart E, Iovanna JL, Dagorn JC, Chamaillard M, Sans M. Pancreatitis-associated protein does not predict disease relapse in inflammatory bowel disease patients. PLoS One 2014;9:e84957. [PMID: 24416322 DOI: 10.1371/journal.pone.0084957] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
82 Eugene C. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease. Clinics and Research in Hepatology and Gastroenterology 2011;35:257-9. [DOI: 10.1016/j.clinre.2011.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
83 Kim DH, Park SJ, Park JJ, Yun YH, Hong SP, Kim TI, Kim WH, Cheon JH. Effect of follow-up endoscopy on the outcomes of patients with inflammatory bowel disease. Dig Dis Sci. 2014;59:2514-2522. [PMID: 24838498 DOI: 10.1007/s10620-014-3197-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
84 Vieira-Silva S, Sabino J, Valles-Colomer M, Falony G, Kathagen G, Caenepeel C, Cleynen I, van der Merwe S, Vermeire S, Raes J. Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses. Nat Microbiol. 2019;4:1826-1831. [PMID: 31209308 DOI: 10.1038/s41564-019-0483-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 15.7] [Reference Citation Analysis]
85 Kierkus J, Szymanska E, Oracz G, Wiernicka A, Dadalski M. Profile of infliximab in the treatment of pediatric Crohn's disease. Pediatric Health Med Ther 2015;6:79-85. [PMID: 29388577 DOI: 10.2147/PHMT.S64943] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 Wan J, Wang X, Zhang Y, Xue X, Li Y, Liu Z, Han S, Chen M, Nie Y, Shi Y, Liang J, Wu K. 5-Aminosalicylic Acid Prevents Disease Behavior Progression and Intestinal Resection in Colonic and Ileocolonic Crohn's Disease Patients: A Retrospective Study. Can J Gastroenterol Hepatol 2021;2021:1412663. [PMID: 34422708 DOI: 10.1155/2021/1412663] [Reference Citation Analysis]
87 Reenaers C, Louis E, Belaiche J, Seidel L, Keshav S, Travis S. Does co-treatment with immunosuppressors improve outcome in patients with Crohn’s disease treated with adalimumab? Aliment Pharmacol Ther. 2012;36:1040-1048. [PMID: 23061650 DOI: 10.1111/apt.12076] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
88 Rimola J, Rodríguez S, Cabanas ML, Ayuso C, Panés J, Cuatrecasas M. MRI of Crohn’s disease: from imaging to pathology. Abdom Imaging 2012;37:387-96. [DOI: 10.1007/s00261-011-9797-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
89 Maldonado-Arriaga B, Sandoval-Jiménez S, Rodríguez-Silverio J, Lizeth Alcaráz-Estrada S, Cortés-Espinosa T, Pérez-Cabeza de Vaca R, Licona-Cassani C, Gámez-Valdez JS, Shaw J, Mondragón-Terán P, Hernández-Cortez C, Suárez-Cuenca JA, Castro-Escarpulli G. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis. Microbiologyopen 2021;10:e1181. [PMID: 33970546 DOI: 10.1002/mbo3.1181] [Reference Citation Analysis]
90 Grover Z, Biron R, Carman N, Lewindon P. Predictors of response to Infliximab in children with luminal Crohn's disease. J Crohns Colitis. 2014;8:739-746. [PMID: 24445015 DOI: 10.1016/j.crohns.2013.12.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
91 Ciccocioppo R, Cangemi GC, Kruzliak P, Gallia A, Betti E, Badulli C, Martinetti M, Cervio M, Pecci A, Bozzi V, Dionigi P, Visai L, Gurrado A, Alvisi C, Picone C, Monti M, Bernardo ME, Gobbi P, Corazza GR. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact. Stem Cell Res Ther 2015;6:137. [PMID: 26206376 DOI: 10.1186/s13287-015-0122-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
92 Langer SL, Romano JM, Mancl L, Levy RL. Parental Catastrophizing Partially Mediates the Association between Parent-Reported Child Pain Behavior and Parental Protective Responses. Pain Res Treat 2014;2014:751097. [PMID: 24579047 DOI: 10.1155/2014/751097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
93 Armuzzi A, Gionchetti P, Daperno M, Danese S, Orlando A, Lia Scribano M, Vecchi M, Rizzello F; GIVI (Gruppo Italiano su Vedolizumab nelle IBD) Group. Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease. Dig Liver Dis. 2016;48:360-370. [PMID: 26821929 DOI: 10.1016/j.dld.2015.12.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
94 Saito H, Hirayama A, Umemura T, Joshita S, Mukawa K, Suga T, Tanaka E, Ota M. Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population. PLoS One 2018;13:e0195778. [PMID: 29649328 DOI: 10.1371/journal.pone.0195778] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
95 Cao Y, Su Q, Zhang B, Shen F, Li S. Efficacy of stem cells therapy for Crohn's fistula: a meta-analysis and systematic review. Stem Cell Res Ther 2021;12:32. [PMID: 33413661 DOI: 10.1186/s13287-020-02095-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
96 Kameli N, Becker HEF, Welbers T, Jonkers DMAE, Penders J, Savelkoul P, Stassen FR. Metagenomic Profiling of Fecal-Derived Bacterial Membrane Vesicles in Crohn's Disease Patients. Cells 2021;10:2795. [PMID: 34685776 DOI: 10.3390/cells10102795] [Reference Citation Analysis]
97 Chiorean L, Schreiber-Dietrich D, Braden B, Cui XW, Buchhorn R, Chang JM, Dietrich CF. Ultrasonographic imaging of inflammatory bowel disease in pediatric patients. World J Gastroenterol 2015; 21(17): 5231-5241 [PMID: 25954096 DOI: 10.3748/wjg.v21.i17.5231] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
98 Nardone OM, Calabrese G, Testa A, Caiazzo A, Fierro G, Rispo A, Castiglione F. The Impact of Intestinal Ultrasound on the Management of Inflammatory Bowel Disease: From Established Facts Toward New Horizons. Front Med 2022;9:898092. [DOI: 10.3389/fmed.2022.898092] [Reference Citation Analysis]
99 Bazin T, Micoulaud Franchi J, Terras N, Taillard J, Laharie D, Zerbib F, Philip P. Altered sleep quality is associated with Crohn’s disease activity: an actimetry study. Sleep Breath 2020;24:971-7. [DOI: 10.1007/s11325-019-01934-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 O'Neill SB, Mc Laughlin PD, Crush L, O'Connor OJ, Mc Williams SR, Craig O, Mc Garrigle AM, O'Neill F, Bye J, Ryan MF, Shanahan F, Maher MM. A prospective feasibility study of sub-millisievert abdominopelvic CT using iterative reconstruction in Crohn's disease. Eur Radiol 2013;23:2503-12. [PMID: 23740025 DOI: 10.1007/s00330-013-2858-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
101 Eugene C. The second European evidence-based consensus on the diagnosis and management of Crohn's disease (part 3). Clin Res Hepatol Gastroenterol. 2011;35:516-517. [PMID: 21816700 DOI: 10.1016/j.clinre.2011.06.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Chen GB, Lee SH, Montgomery GW, Wray NR, Visscher PM, Gearry RB, Lawrance IC, Andrews JM, Bampton P, Mahy G, Bell S, Walsh A, Connor S, Sparrow M, Bowdler LM, Simms LA, Krishnaprasad K, Radford-Smith GL, Moser G; International IBD Genetics Consortium. Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method. BMC Med Genet 2017;18:94. [PMID: 28851283 DOI: 10.1186/s12881-017-0451-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
103 Díaz-Jiménez D, De la Fuente M, Dubois-Camacho K, Landskron G, Fuentes J, Pérez T, González MJ, Simian D, Hermoso MA, Quera R. Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution. BMC Gastroenterol 2016;16:103. [PMID: 27565556 DOI: 10.1186/s12876-016-0520-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
104 Triantafyllou K, Gkolfakis P, Viazis N, Tsibouris P, Tsigaridas A, Apostolopoulos P, Anastasiou J, Hounda E, Skianis I, Katopodi K. A 13-year time trend analysis of 3724 small bowel video capsule endoscopies and a forecast model during the financial crisis in Greece. Eur J Gastroenterol Hepatol. 2017;29:185-191. [PMID: 27775952 DOI: 10.1097/meg.0000000000000771] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
105 Kim SY, An S, Park DK, Kwon KA, Kim KO, Chung JW, Kim JH, Kim YJ. Efficacy of iron supplementation in patients with inflammatory bowel disease treated with anti-tumor necrosis factor-alpha agents. Therap Adv Gastroenterol 2020;13:1756284820961302. [PMID: 33029199 DOI: 10.1177/1756284820961302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Tew GA, Carpenter R, Seed M, Anderson S, Langmead L, Fairhurst C, Bottoms L. Feasibility of high-intensity interval training and moderate-intensity continuous training in adults with inactive or mildly active Crohn's disease: study protocol for a randomised controlled trial. Pilot Feasibility Stud 2017;3:17. [PMID: 28373911 DOI: 10.1186/s40814-017-0133-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
107 Shi X, Yang W, Wang N, Zhu J. Circulating JNK pathway-associated phosphatase level correlates with decreased risk, activity, inflammation level and reduced clinical response to tumor necrosis factor-α inhibitor in Crohn disease patients. Medicine (Baltimore) 2019;98:e16622. [PMID: 31415355 DOI: 10.1097/MD.0000000000016622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
108 Korolkova OY, Myers JN, Pellom ST, Wang L, M'Koma AE. Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides. Clin Med Insights Gastroenterol. 2015;8:29-44. [PMID: 26078592 DOI: 10.4137/cgast.s20612] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
109 Fornaro R, Caratto E, Caratto M, Fornaro F, Caristo G, Frascio M, Sticchi C. Post-operative recurrence in Crohn's disease. Critical analysis of potential risk factors. An update. The Surgeon 2015;13:330-47. [DOI: 10.1016/j.surge.2015.04.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
110 Mak LY, Ng SC, Wong IOL, Li MKK, Lo FH, Wong MTL, Leung CM, Tsang SWC, Chan KH, Sze SF, Shan EHS, Lam BCY, Hui AJ, Hung IFN, Leung WK. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis. J Gastroenterol Hepatol 2018;33:141-9. [PMID: 28475813 DOI: 10.1111/jgh.13817] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
111 Iaculli E, Agostini M, Biancone L, Fiorani C, Di Vizia A, Montagnese F, Sibio S, Manzelli A, Tesauro M, Rufini A, Sica GS. C-reactive protein levels in the perioperative period as a predictive marker of endoscopic recurrence after ileo-colonic resection for Crohn's disease. Cell Death Discov. 2016;2:16032. [PMID: 27551522 DOI: 10.1038/cddiscovery.2016.32] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
112 Damoiseaux J, Csernok E, Rasmussen N, Cohen Tervaert JW, Bossuyt X. Antineutrophil cytoplasmic antibodies: reporting and diagnostic strategies. Ann Rheum Dis 2017;76:e39. [PMID: 28274911 DOI: 10.1136/annrheumdis-2017-211171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
113 Gouldthorpe O, Catto-Smith AG, Alex G, Simpson D. Loss of response to long-term infliximab therapy in children with Crohn's disease. Pharmaceuticals (Basel) 2013;6:1322-34. [PMID: 24275852 DOI: 10.3390/ph6101322] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
114 Sub Lee H, Jae Lee K. Immunoglobulin G4-related immune responses to common food antigens in patients with ulcerative colitis and Crohn's disease. Turk J Gastroenterol 2019;30:408–414. [PMID: 31060995 DOI: 10.5152/tjg.2019.18466] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 González-Lama Y, Suárez C, González-Partida I, Calvo M, Matallana V, de la Revilla J, Magaz M, Bernardo C, Agudo B, Ibarrola P, Relea L, Arévalo J, Vera MI, Abreu L. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study. J Crohns Colitis 2016;10:55-60. [PMID: 26520164 DOI: 10.1093/ecco-jcc/jjv187] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
116 García-López S, Bocos JM, Gisbert JP, Bajador E, Chaparro M, Castaño C, García-Erce JA, Gomollón F. High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of life. Blood Transfus 2016;14:199-205. [PMID: 27177405 DOI: 10.2450/2016.0246-15] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
117 Craig O, O’Neill S, O’Neill F, McLaughlin P, McGarrigle A, McWilliams S, O’Connor O, Desmond A, Walsh EK, Ryan M. Diagnostic accuracy of computed tomography using lower doses of radiation for patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2012;10:886-892. [PMID: 22469992 DOI: 10.1016/j.cgh.2012.03.014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
118 Huh J, Kim KJ, Park SH, Park SH, Yang SK, Ye BD, Park SH, Han K, Kim AY. Diffusion-Weighted MR Enterography to Monitor Bowel Inflammation after Medical Therapy in Crohn's Disease: A Prospective Longitudinal Study. Korean J Radiol. 2017;18:162-172. [PMID: 28096726 DOI: 10.3348/kjr.2017.18.1.162] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
119 Molendijk I, Nuij VJ, van der Meulen-de Jong AE, van der Woude CJ. Disappointing durable remission rates in complex Crohn's disease fistula. Inflamm Bowel Dis. 2014;20:2022-2028. [PMID: 25159455 DOI: 10.1097/mib.0000000000000148] [Cited by in Crossref: 71] [Cited by in F6Publishing: 27] [Article Influence: 10.1] [Reference Citation Analysis]
120 Shah A, Talley NJ, Koloski N, Macdonald GA, Kendall BJ, Shanahan ER, Walker MM, Keely S, Jones MP, Morrison M, Holtmann GJ. Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease. Aliment Pharmacol Ther 2020;52:155-67. [PMID: 32412673 DOI: 10.1111/apt.15786] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
121 Frede N, Glocker EO, Wanders J, Engelhardt KR, Kreisel W, Ruemmele FM, Grimbacher B. Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease. BMC Immunol 2014;15:10. [PMID: 24581234 DOI: 10.1186/1471-2172-15-10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
122 Lakatos PL, Lovasz BD, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics PA, Vegh Z, Mandel M, Horvath A, Szathmari M, Kiss LS, Lakatos L. The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe. J Crohns Colitis 2013;7:385-91. [PMID: 22766526 DOI: 10.1016/j.crohns.2012.06.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
123 Atkinson NSS, Bryant RV, Dong Y, Maaser C, Kucharzik T, Maconi G, Asthana AK, Blaivas M, Goudie A, Gilja OH, Nuernberg D, Schreiber-Dietrich D, Dietrich CF. How to perform gastrointestinal ultrasound: Anatomy and normal findings. World J Gastroenterol 2017; 23(38): 6931-6941 [PMID: 29097866 DOI: 10.3748/wjg.v23.i38.6931] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 21] [Article Influence: 5.4] [Reference Citation Analysis]
124 Burisch J, Vardi H, Pedersen N, Brinar M, Cukovic-cavka S, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Bailey Y, Oʼmorain C, Schwartz D, Lupinacci G, De Padova A, Jonaitis L, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Pineda JR, Almer S, Halfvarson J, Tsai H, Sebastian S, Friger M, Greenberg D, Lakatos PL, Langholz E, Odes S, Munkholm P. Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort: An ECCO-EpiCom Study. Inflammatory Bowel Diseases 2015;21:121-31. [DOI: 10.1097/mib.0000000000000250] [Cited by in Crossref: 39] [Cited by in F6Publishing: 14] [Article Influence: 5.6] [Reference Citation Analysis]
125 Berrill JW, Gallacher J, Hood K, Green JT, Matthews SB, Campbell AK, Smith A. An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease. Neurogastroenterol Motil. 2013;25:918-e704. [PMID: 23981191 DOI: 10.1111/nmo.12219] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
126 Roque Ramos L, DiMaio CJ, Sachar DB, Atreja A, Colombel JF, Torres J. Autoimmune pancreatitis and inflammatory bowel disease: Case series and review of literature. Dig Liver Dis. 2016;48:893-898. [PMID: 27260331 DOI: 10.1016/j.dld.2016.05.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
127 Habot-Wilner Z, Tiosano L, Sanchez JM, Shulman S, Barequet D, Rahat O, Amarilyo G, Amer R. Demographic and Clinical Features of Pediatric Uveitis in Israel. Ocul Immunol Inflamm 2020;28:43-53. [PMID: 30332547 DOI: 10.1080/09273948.2018.1535079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
128 Billioud V, Gibot S, Massin F, Oussalah A, Chevaux J, Williet N, Bronowicki J, Bigard M, Guéant J, Peyrin-biroulet L. Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn's disease. Digestive and Liver Disease 2012;44:466-70. [DOI: 10.1016/j.dld.2012.01.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
129 Orlando A, Renna S, Mocciaro F, Cappello M, Di Mitri R, Randazzo C, Cottone M. Adalimumab in steroid-dependent Crohn’s disease patients: prognostic factors for clinical benefit. Inflamm Bowel Dis. 2012;18:826-831. [PMID: 21837774 DOI: 10.1002/ibd.21835] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
130 Deepak P, Park SH, Ehman EC, Hansel SL, Fidler JL, Bruining DH, Fletcher JG. Crohn’s disease diagnosis, treatment approach, and management paradigm: what the radiologist needs to know. Abdom Radiol 2017;42:1068-86. [DOI: 10.1007/s00261-017-1068-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
131 Takenaka K, Ohtsuka K, Kitazume Y, Nagahori M, Fujii T, Saito E, Fujioka T, Matsuoka K, Naganuma M, Watanabe M. Correlation of the Endoscopic and Magnetic Resonance Scoring Systems in the Deep Small Intestine in Crohn’s Disease. Inflamm Bowel Dis. 2015;21:1832-1838. [PMID: 26020602 DOI: 10.1097/mib.0000000000000449] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
132 Chen X, Yang K, Xu Y, Li K. Top-100 highest-cited original articles in inflammatory bowel disease: A bibliometric analysis. Medicine (Baltimore) 2019;98:e15718. [PMID: 31096525 DOI: 10.1097/MD.0000000000015718] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
133 Rukmangadachar LA, Makharia GK, Mishra A, Das P, Hariprasad G, Srinivasan A, Gupta SD, Ahuja V, Acharya SK. Proteome analysis of the macroscopically affected colonic mucosa of Crohn's disease and intestinal tuberculosis. Sci Rep 2016;6:23162. [PMID: 26988818 DOI: 10.1038/srep23162] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
134 Takenaka K, Ohtsuka K, Kitazume Y, Matsuoka K, Fujii T, Nagahori M, Kimura M, Fujioka T, Araki A, Watanabe M. Magnetic resonance evaluation for small bowel strictures in Crohn’s disease: comparison with balloon enteroscopy. J Gastroenterol 2017;52:879-88. [DOI: 10.1007/s00535-016-1284-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
135 Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ. Crohn's disease complicated by strictures: a systematic review. Gut. 2013;62:1072-1084. [PMID: 23626373 DOI: 10.1136/gutjnl-2012-304353] [Cited by in Crossref: 243] [Cited by in F6Publishing: 217] [Article Influence: 27.0] [Reference Citation Analysis]
136 Greener T, Klang E, Yablecovitch D, Lahat A, Neuman S, Levhar N, Avidan B, Yanai H, Dotan I, Chowers Y, Weiss B, Saibil F, Amitai MM, Ben-Horin S, Kopylov U, Eliakim R; Israeli IBD Research Nucleus (IIRN). The Impact of Magnetic Resonance Enterography and Capsule Endoscopy on the Re-classification of Disease in Patients with Known Crohn's Disease: A Prospective Israeli IBD Research Nucleus (IIRN) Study. J Crohns Colitis. 2016;10:525-531. [PMID: 26748404 DOI: 10.1093/ecco-jcc/jjw006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
137 Brückner M, Heidemann J, Nowacki TM, Cordes F, Stypmann J, Lenz P, Gohar F, Lügering A, Bettenworth D. Detection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasound. World J Gastroenterol 2017; 23(16): 2899-2911 [PMID: 28522908 DOI: 10.3748/wjg.v23.i16.2899] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
138 Chao K, Wang X, Cao Q, Qian J, Wu K, Zhu X, Yang H, Liang J, Lin L, Huang Z, Zhang Y, Huang Y, Sun Y, Xue X, Huang M, Hu P, Lan P, Gao X. Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis. Inflamm Bowel Dis. 2017;23:1592-1599. [PMID: 28570428 DOI: 10.1097/mib.0000000000001148] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
139 Bathe AL, Mavropoulou E, Mechie NC, Petzold G, Ellenrieder V, Kunsch S, Amanzada A. Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn's disease and ulcerative colitis. PLoS One 2019;14:e0223893. [PMID: 31647834 DOI: 10.1371/journal.pone.0223893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
140 Papay P, Hackner K, Vogelsang H, Novacek G, Primas C, Reinisch W, Eser A, Mikulits A, Mayr WR, Körmöczi GF. High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease. Am J Med 2012;125:717.e1-8. [PMID: 22560809 DOI: 10.1016/j.amjmed.2011.11.028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
141 Onali S, Calabrese E, Petruzziello C, Lolli E, Ascolani M, Ruffa A, Sica G, Rossi A, Chiaramonte C, Pallone F, Biancone L. Post-operative recurrence of Crohn's disease: A prospective study at 5 years. Digestive and Liver Disease 2016;48:489-94. [DOI: 10.1016/j.dld.2016.01.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
142 Bruno ME, Rogier EW, Arsenescu RI, Flomenhoft DR, Kurkjian CJ, Ellis GI, Kaetzel CS. Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis. Dig Dis Sci. 2015;60:2976-2984. [PMID: 25956706 DOI: 10.1007/s10620-015-3700-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
143 Kedia S, Sharma R, Sreenivas V, Madhusudhan KS, Sharma V, Bopanna S, Pratap Mouli V, Dhingra R, Yadav DP, Makharia G, Ahuja V. Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysis. Intest Res. 2017;15:149-159. [PMID: 28522943 DOI: 10.5217/ir.2017.15.2.149] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
144 Salkic NN, Adler G, Zawada I, Alibegovic E, Karakiewicz B, Kozlowska-Wiechowska A, Wasilewicz M, Sulzyc-Bielicka V, Bielicki D. NOD2/CARD15 mutations in Polish and Bosnian populations with and without Crohn's disease: prevalence and genotype-phenotype analysis. Bosn J Basic Med Sci 2015;15:67-72. [PMID: 26042516 DOI: 10.17305/bjbms.2015.348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
145 Macaluso FS, Maida M, Renna S, Orlando E, Affronti M, Sapienza C, Dimarco M, Orlando R, Rizzuto G, Cottone M, Orlando A. Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants. Digestive and Liver Disease 2017;49:157-62. [DOI: 10.1016/j.dld.2016.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
146 Dias CC, Rodrigues PP, Coelho R, Santos PM, Fernandes S, Lago P, Caetano C, Rodrigues Â, Portela F, Oliveira A, Ministro P, Cancela E, Vieira AI, Barosa R, Cotter J, Carvalho P, Cremers I, Trabulo D, Caldeira P, Antunes A, Rosa I, Moleiro J, Peixe P, Herculano R, Gonçalves R, Gonçalves B, Sousa HT, Contente L, Morna H, Lopes S, Magro F; on behalf GEDII. Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions. J Crohns Colitis 2017;11:445-53. [PMID: 27683799 DOI: 10.1093/ecco-jcc/jjw171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
147 Branchi F, Caprioli F, Orlando S, Conte D, Fraquelli M. Non-invasive evaluation of intestinal disorders: The role of elastographic techniques. World J Gastroenterol 2017; 23(16): 2832-2840 [PMID: 28522902 DOI: 10.3748/wjg.v23.i16.2832] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
148 Siegel CA, Whitman CB, Spiegel BMR, Feagan B, Sands B, Loftus EV Jr, Panaccione R, D'Haens G, Bernstein CN, Gearry R, Ng SC, Mantzaris GJ, Sartor B, Silverberg MS, Riddell R, Koutroubakis IE, O'Morain C, Lakatos PL, McGovern DPB, Halfvarson J, Reinisch W, Rogler G, Kruis W, Tysk C, Schreiber S, Danese S, Sandborn W, Griffiths A, Moum B, Gasche C, Pallone F, Travis S, Panes J, Colombel JF, Hanauer S, Peyrin-Biroulet L. Development of an index to define overall disease severity in IBD. Gut. 2018;67:244-254. [PMID: 27780886 DOI: 10.1136/gutjnl-2016-312648] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 10.7] [Reference Citation Analysis]
149 Choi CH, Song ID, Kim YH, Koo JS, Kim YS, Kim JS, Kim N, Kim ES, Kim JH, Kim JW, Kim TO, Kim HS, Kim HJ, Park YS, Park DI, Park SJ, Song HJ, Shin SJ, Yang SK, Ye BD, Lee KM, Lee BI, Lee SY, Lee CK, Im JP, Jang BI, Jeon TJ, Cho YK, Chang SK, Jeon SR, Jung SA, Jeen YT, Cha JM, Han DS, Kim WH; IBD Study Group of the Korean Association for the Study of the Intestinal Diseases. Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study. Yonsei Med J. 2016;57:1376-1385. [PMID: 27593865 DOI: 10.3349/ymj.2016.57.6.1376] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
150 Yang DH, Keum B, Jeen YT. Capsule Endoscopy for Crohn's Disease: Current Status of Diagnosis and Management. Gastroenterol Res Pract 2016;2016:8236367. [PMID: 26819612 DOI: 10.1155/2016/8236367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
151 Del Hoyo J, Nos P, Faubel R, Muñoz D, Domínguez D, Bastida G, Valdivieso B, Correcher M, Aguas M. A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Randomized Controlled Trial. J Med Internet Res 2018;20:e11602. [PMID: 30482739 DOI: 10.2196/11602] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
152 Park SK, Ye BD, Kim KO, Park CH, Lee WS, Jang BI, Jeen YT, Choi MG, Kim HJ; Korean Gut Image Study Group. Guidelines for video capsule endoscopy: emphasis on Crohn's disease. Clin Endosc 2015;48:128-35. [PMID: 25844340 DOI: 10.5946/ce.2015.48.2.128] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
153 Benitez JM, Meuwis MA, Reenaers C, Van Kemseke C, Meunier P, Louis E. Role of endoscopy, cross-sectional imaging and biomarkers in Crohn’s disease monitoring. Gut. 2013;62:1806-1816. [PMID: 24203056 DOI: 10.1136/gutjnl-2012-303957] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 8.8] [Reference Citation Analysis]
154 Lindsay JO, Allez M, Clark M, Labopin M, Ricart E, Rogler G, Rovira M, Satsangi J, Farge D, Hawkey CJ; ASTIC trial group; European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party; European Crohn's and Colitis Organisation. Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial. Lancet Gastroenterol Hepatol. 2017;2:399-406. [PMID: 28497755 DOI: 10.1016/s2468-1253(17)30056-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 22] [Article Influence: 8.4] [Reference Citation Analysis]
155 Lee J, Allen R, Ashley S, Becker S, Cummins P, Gbadamosi A, Gooding O, Huston J, Le Couteur J, O'Sullivan D, Wilson S, Lomer MC; Gastroenterology Specialist Group of the British Dietetic Association. British Dietetic Association evidence-based guidelines for the dietary management of Crohn's disease in adults. J Hum Nutr Diet 2014;27:207-18. [PMID: 24313460 DOI: 10.1111/jhn.12176] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
156 Kim JH, Moon W. Optimal Diagnostic Approaches for Patients with Suspected Small Bowel Disease. Clin Endosc. 2016;49:364-369. [PMID: 27334413 DOI: 10.5946/ce.2016.074] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
157 D'haens G, Feagan B, Colombel J, Sandborn WJ, Reinisch W, Rutgeerts P, Carbonnel F, Mary J, Danese S, Fedorak RN, Hanauer S, Lémann M. Challenges to the Design, Execution, and Analysis of Randomized Controlled Trials for Inflammatory Bowel Disease. Gastroenterology 2012;143:1461-9. [DOI: 10.1053/j.gastro.2012.09.031] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
158 Gruber L, Kisling S, Lichti P, Martin FP, May S, Klingenspor M, Lichtenegger M, Rychlik M, Haller D. High fat diet accelerates pathogenesis of murine Crohn's disease-like ileitis independently of obesity. PLoS One 2013;8:e71661. [PMID: 23977107 DOI: 10.1371/journal.pone.0071661] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 7.6] [Reference Citation Analysis]
159 Talabur Horje CS, Meijer J, Rovers L, van Lochem EG, Groenen MJ, Wahab PJ. Prevalence of Upper Gastrointestinal Lesions at Primary Diagnosis in Adults with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:E33-4. [PMID: 27542141 DOI: 10.1097/MIB.0000000000000888] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
160 Horjus Talabur Horje CS, Meijer J, Rovers L, van Lochem EG, Groenen MJ, Wahab PJ. Prevalence of Upper Gastrointestinal Lesions at Primary Diagnosis in Adults with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:1896-1901. [PMID: 27057685 DOI: 10.1097/mib.0000000000000786] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 8.3] [Reference Citation Analysis]
161 Ministro P, Dias CC, Portela F, Fernandes S, Bernardo S, Pires F, Lago P, Rosa I, Trindade E, Alves C, Correia L, Magro F. Age at Diagnosis Is Determinant for the Outcome of Inflammatory Bowel Disease: Is It a Myth? Clin Transl Gastroenterol 2021;12:e00309. [PMID: 33587489 DOI: 10.14309/ctg.0000000000000309] [Reference Citation Analysis]
162 Xia H, Li S, He Y, Ren Q, Qin S. Long non-coding RNA ANRIL serves as a potential marker of disease risk, inflammation, and disease activity of pediatric inflammatory bowel disease. Clinics and Research in Hepatology and Gastroenterology 2022. [DOI: 10.1016/j.clinre.2022.101895] [Reference Citation Analysis]
163 Calabrese E, Zorzi F, Onali S, Stasi E, Fiori R, Prencipe S, Bella A, Petruzziello C, Condino G, Lolli E, Simonetti G, Biancone L, Pallone F. Accuracy of small-intestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with Crohn's disease. Clin Gastroenterol Hepatol. 2013;11:950-955. [PMID: 23375998 DOI: 10.1016/j.cgh.2013.01.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
164 Reinisch S, Schweiger K, Pablik E, Collet-Fenetrier B, Peyrin-Biroulet L, Alfaro I, Panés J, Moayyedi P, Reinisch W. An index with improved diagnostic accuracy for the diagnosis of Crohn's disease derived from the Lennard-Jones criteria. Aliment Pharmacol Ther 2016;44:601-11. [PMID: 27466047 DOI: 10.1111/apt.13727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
165 Palkovits J, Novacek G, Kollars M, Hron G, Osterode W, Quehenberger P, Kyrle PA, Vogelsang H, Reinisch W, Papay P. Tissue factor exposing microparticles in inflammatory bowel disease. J Crohns Colitis. 2013;7:222-229. [PMID: 22705067 DOI: 10.1016/j.crohns.2012.05.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
166 Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, van Assche G. [Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis (Spanish version)]. Rev Gastroenterol Mex 2014;79:263-89. [PMID: 25487134 DOI: 10.1016/j.rgmx.2014.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
167 Jesuratnam-Nielsen K, Løgager VB, Rezanavaz-Gheshlagh B, Munkholm P, Thomsen HS. Plain magnetic resonance imaging as an alternative in evaluating inflammation and bowel damage in inflammatory bowel disease--a prospective comparison with conventional magnetic resonance follow-through. Scand J Gastroenterol 2015;50:519-27. [PMID: 25592192 DOI: 10.3109/00365521.2014.1003398] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
168 Portela F, Lago P. Fulminant colitis. Best Practice & Research Clinical Gastroenterology 2013;27:771-82. [DOI: 10.1016/j.bpg.2013.08.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
169 Shannahan SE, Erlich JM, Peppercorn MA. Insights into the treatment of inflammatory bowel disease in pregnancy. Therap Adv Gastroenterol 2019;12:1756284819852231. [PMID: 31191713 DOI: 10.1177/1756284819852231] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
170 Lech G, Korcz W, Kowalczyk E, Chaber A, Słodkowski M. The risk of small bowel adenocarcinoma in patients with Crohn's disease. Prz Gastroenterol 2020;15:309-13. [PMID: 33777270 DOI: 10.5114/pg.2020.101559] [Reference Citation Analysis]
171 Baran B, Karaca C. Practical medical management of Crohn's disease. ISRN Gastroenterol 2013;2013:208073. [PMID: 24307950 DOI: 10.1155/2013/208073] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
172 Smolinska A, Tedjo DI, Blanchet L, Bodelier A, Pierik MJ, Masclee AAM, Dallinga J, Savelkoul PHM, Jonkers DMAE, Penders J, van Schooten FJ. Volatile metabolites in breath strongly correlate with gut microbiome in CD patients. Anal Chim Acta 2018;1025:1-11. [PMID: 29801597 DOI: 10.1016/j.aca.2018.03.046] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
173 Nowak JK, Glapa-Nowak A, Banaszkiewicz A, Iwańczak B, Kwiecień J, Szaflarska-Popławska A, Grzybowska-Chlebowczyk U, Osiecki M, Kierkuś J, Hołubiec M, Chanaj-Kaczmarek J, Radzikowski A, Walkowiak J. HLA-DQA1*05 Associates with Extensive Ulcerative Colitis at Diagnosis: An Observational Study in Children. Genes (Basel) 2021;12:1934. [PMID: 34946883 DOI: 10.3390/genes12121934] [Reference Citation Analysis]
174 Vuyyuru SK, Kante B, Kumar P, Sahu P, Kedia S, Ranjan MK, Sharma R, Panwar R, Makharia G, Ahuja V. Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn's disease. Sci Rep 2021;11:11704. [PMID: 34083575 DOI: 10.1038/s41598-021-90660-2] [Reference Citation Analysis]
175 Papp M, Sipeki N, Tornai T, Altorjay I, Norman GL, Shums Z, Roggenbuck D, Fechner K, Stöcker W, Antal-Szalmas P, Veres G, Lakatos PL. Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1]. J Crohns Colitis 2015;9:659-68. [PMID: 25968583 DOI: 10.1093/ecco-jcc/jjv087] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
176 Fiorino G, Bonifacio C, Peyrin-Biroulet L, Minuti F, Repici A, Spinelli A, Fries W, Balzarini L, Montorsi M, Malesci A. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn’s disease. Inflamm Bowel Dis. 2011;17:1073-1080. [PMID: 21484958 DOI: 10.1002/ibd.21533] [Cited by in Crossref: 152] [Cited by in F6Publishing: 133] [Article Influence: 12.7] [Reference Citation Analysis]
177 Mosquera-klinger GA, Camargo Trillos J, Gómez Ramirez LA, Bustamante Duque M, Carvajal Gutierrez JJ. Experiencia con videocápsula endoscópica en el estudio y diagnóstico de enfermedades del intestino delgado en un hospital de alta complejidad en Medellín, Colombia. Rev Colomb Gastroenterol 2018;33:386. [DOI: 10.22516/25007440.223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
178 Calvet X, Panés J, Alfaro N, Hinojosa J, Sicilia B, Gallego M, Pérez I, Lázaro y de Mercado P, Gomollón F, Aldeguera X. Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units. J Crohns Colitis. 2014;8:240-251. [PMID: 24295646 DOI: 10.1016/j.crohns.2013.10.010] [Cited by in Crossref: 63] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
179 Fiorino G, Morin M, Bonovas S, Bonifacio C, Spinelli A, Germain A, Laurent V, Zallot C, Peyrin-Biroulet L, Danese S. Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome. J Crohns Colitis. 2017;11:274-280. [PMID: 27799269 DOI: 10.1093/ecco-jcc/jjw185] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
180 Maggiori L, Brouquet A, Zerbib P, Lefevre JH, Denost Q, Germain A, Cotte E, Beyer-berjot L, Munoz-bongrand N, Desfourneaux V, Rahili A, Duffas J, Pautrat K, Denet C, Bridoux V, Meurette G, Faucheron J, Loriau J, Souche R, Vicaut E, Panis Y, Benoist S. Penetrating Crohn Disease Is Not Associated With a Higher Risk of Recurrence After Surgery: A Prospective Nationwide Cohort Conducted by the Getaid Chirurgie Group. Annals of Surgery 2019;270:827-34. [DOI: 10.1097/sla.0000000000003531] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
181 Ciccocioppo R, Racca F, Paolucci S, Campanini G, Pozzi L, Betti E, Riboni R, Vanoli A, Baldanti F, Corazza GR. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: Need for mucosal viral load measurement. World J Gastroenterol 2015; 21(6): 1915-1926 [PMID: 25684960 DOI: 10.3748/wjg.v21.i6.1915] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
182 Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association. Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing). J Dig Dis 2021;22:298-317. [PMID: 33905603 DOI: 10.1111/1751-2980.12994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Castiglione F, Testa A, Rea M, De Palma GD, Diaferia M, Musto D, Sasso F, Caporaso N, Rispo A. Transmural healing evaluated by bowel sonography in patients with Crohn’s disease on maintenance treatment with biologics. Inflamm Bowel Dis. 2013;19:1928-1934. [PMID: 23835441 DOI: 10.1097/mib.0b013e31829053ce] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
184 Musquer N, Coquenlorge S, Bourreille A, Aubert P, Matysiak-budnik T, des Varannes SB, Lauwers G, Neunlist M, Coron E. Probe-based confocal laser endomicroscopy: A new method for quantitative analysis of pit structure in healthy and Crohn's disease patients. Digestive and Liver Disease 2013;45:487-92. [DOI: 10.1016/j.dld.2013.01.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
185 Banerjee R, Pal P. Endoscopic Evaluation and Therapeutic Considerations of Small Bowel Crohn’s Disease. Gastroenterology Insights 2021;12:238-58. [DOI: 10.3390/gastroent12020021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Zhang W, Zhu W, Li Y, Zuo L, Wang H, Li N, Li J. The respective role of medical and surgical therapy for enterovesical fistula in Crohn's disease. J Clin Gastroenterol 2014;48:708-11. [PMID: 24457944 DOI: 10.1097/MCG.0000000000000040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
187 Bálint A, Rutka M, Végh Z, Kürti Z, Gecse KB, Banai J, Bene L, Gasztonyi B, Kristóf T, Lakatos L, Miheller P, Palatka K, Patai Á, Salamon Á, Szamosi T, Szepes Z, Tóth GT, Vincze Á, Bor R, Milassin Á, Fábián A, Nagy F, Kolar M, Bortlik M, Duricova D, Hruba V, Lukas M, Mitrova K, Malickova K, Lukas M, Lakatos PL, Molnár T, Farkas K. Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort. Expert Opinion on Drug Safety 2017;16:885-90. [DOI: 10.1080/14740338.2017.1323330] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
188 Huang Z, Liu X, Yang F, Wang G, Ge N, Wang S, Guo J, Sun S. Diagnostic efficacy of double-balloon enteroscopy in patients with suspected isolated small bowel Crohn's disease. BMC Gastroenterol 2020;20:42. [PMID: 32101148 DOI: 10.1186/s12876-020-01188-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
189 Vuyyuru SK, Desai D, Kedia S, Dhoble P, Sahu P, Kante B, Agarwal S, Bopanna S, Dhingra R, Venigalla PM, Sharma R, Gupta SD, Makharia G, Sahni P, Ahuja V. Long-term outcomes of anti-tumor necrosis factor therapy and surgery in nonperianal fistulizing Crohn's disease. JGH Open 2021;5:420-7. [PMID: 33860091 DOI: 10.1002/jgh3.12370] [Reference Citation Analysis]
190 Xu S, Zhou F, Tao J, Song L, Ng SC, Wang X, Chen L, Yi F, Ran Z, Zhou R. Exome sequencing identifies DLG1 as a novel gene for potential susceptibility to Crohn’s disease in a Chinese family study. PLoS One. 2014;9:e99807. [PMID: 24937328 DOI: 10.1371/journal.pone.0099807] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
191 Caccaro R, D'Incà R, Pathak S, Sturniolo GC. Clinical utility of calprotectin and lactoferrin in patients with inflammatory bowel disease: is there something new from the literature? Expert Rev Clin Immunol 2012;8:579-85. [PMID: 22992152 DOI: 10.1586/eci.12.50] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
192 Ward MG, Warner B, Unsworth N, Chuah SW, Brownclarke C, Shieh S, Parkes M, Sanderson JD, Arkir Z, Reynolds J, Gibson PR, Irving PM. Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors. Aliment Pharmacol Ther 2017;46:150-61. [PMID: 28481014 DOI: 10.1111/apt.14124] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
193 Weng YJ, Gan HY, Li X, Huang Y, Li ZC, Deng HM, Chen SZ, Zhou Y, Wang LS, Han YP, Tan YF, Song YJ, Du ZM, Liu YY, Wang Y, Qin N, Bai Y, Yang RF, Bi YJ, Zhi FC. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease. J Dig Dis 2019;20:447-59. [DOI: 10.1111/1751-2980.12795] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 11.7] [Reference Citation Analysis]
194 Herraiz Hidalgo L, Alvarez Moreno E, Carrascoso Arranz J, Cano Alonso R, Martínez de Vega Fernández V. Entero-resonancia magnética: revisión de la técnica para el estudio de la enfermedad de Crohn. Radiología 2011;53:421-33. [DOI: 10.1016/j.rx.2011.03.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
195 Maconi G, Bolzoni E, Giussani A, Friedman AB, Duca P. Accuracy and cost of diagnostic strategies for patients with suspected Crohn's disease. J Crohns Colitis. 2014;8:1684-1692. [PMID: 25179579 DOI: 10.1016/j.crohns.2014.08.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
196 Grimstad T, Norheim KB, Isaksen K, Leitao K, Hetta AK, Carlsen A, Karlsen LN, Skoie IM, Gøransson L, Harboe E, Aabakken L, Omdal R. Fatigue in Newly Diagnosed Inflammatory Bowel Disease. J Crohns Colitis 2015;9:725-30. [PMID: 25994356 DOI: 10.1093/ecco-jcc/jjv091] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
197 Sturm A, Maaser C, Mendall M, Karagiannis D, Karatzas P, Ipenburg N, Sebastian S, Rizzello F, Limdi J, Katsanos K, Schmidt C, Jeuring S, Colombo F, Gionchetti P. European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly. J Crohns Colitis 2017;11:263-73. [PMID: 27797918 DOI: 10.1093/ecco-jcc/jjw188] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
198 Eugene C. The second European evidence-based consensus on the diagnosis and management of Crohn's disease (part 4). Clin Res Hepatol Gastroenterol 2011;35:518-20. [PMID: 21813353 DOI: 10.1016/j.clinre.2011.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
199 Gabryel M, Skrzypczak-Zielinska M, Kucharski MA, Slomski R, Dobrowolska A. The impact of genetic factors on response to glucocorticoids therapy in IBD. Scand J Gastroenterol 2016;51:654-65. [PMID: 26776488 DOI: 10.3109/00365521.2015.1132336] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
200 Egea Valenzuela J, Carrilero Zaragoza G, Iglesias Jorquera E, Tomás Pujante P, Alberca de las Parras F, Carballo Álvarez F. Análisis histórico de la experiencia en cápsula endoscópica de intestino delgado en un hospital terciario español. Gastroenterología y Hepatología 2017;40:70-9. [DOI: 10.1016/j.gastrohep.2016.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
201 Tetangco EP, Stein AC. Medical Treatment of Intestinal Crohn's disease. Seminars in Colon and Rectal Surgery 2022. [DOI: 10.1016/j.scrs.2022.100862] [Reference Citation Analysis]
202 Patel KV, Darakhshan AA, Griffin N, Williams AB, Sanderson JD, Irving PM. Patient optimization for surgery relating to Crohn's disease. Nat Rev Gastroenterol Hepatol 2016;13:707-19. [DOI: 10.1038/nrgastro.2016.158] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
203 Langner C, Magro F, Driessen A, Ensari A, Mantzaris GJ, Villanacci V, Becheanu G, Borralho Nunes P, Cathomas G, Fries W, Jouret-Mourin A, Mescoli C, de Petris G, Rubio CA, Shepherd NA, Vieth M, Eliakim R, Geboes K; European Society of Pathology; European Crohn's and Colitis Foundation. The histopathological approach to inflammatory bowel disease: a practice guide. Virchows Arch. 2014;464:511-527. [PMID: 24487791 DOI: 10.1007/s00428-014-1543-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
204 Rosa B, Pinho R, de Ferro SM, Almeida N, Cotter J, Saraiva MM. Endoscopic Scores for Evaluation of Crohn's Disease Activity at Small Bowel Capsule Endoscopy: General Principles and Current Applications. GE Port J Gastroenterol 2016;23:36-41. [PMID: 28868428 DOI: 10.1016/j.jpge.2015.08.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
205 Takenaka K, Ohtsuka K, Kitazume Y, Nagahori M, Fujii T, Saito E, Naganuma M, Araki A, Watanabe M. Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn's disease. Gastroenterology 2014;147:334-342.e3. [PMID: 24732015 DOI: 10.1053/j.gastro.2014.04.008] [Cited by in Crossref: 74] [Cited by in F6Publishing: 58] [Article Influence: 9.3] [Reference Citation Analysis]
206 Canavese G, Bassotti G, Astegiano M, Castellano I, Cassoni P, Sapino A, Villanacci V. Inflammatory bowel disease: A proposal to facilitate the achievement of an unequivocal diagnosis. World J Gastroenterol 2013; 19(3): 426-428 [DOI: 10.3748/wjg.v19.i3.426] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
207 Zidar N, Boštjančič E, Jerala M, Kojc N, Drobne D, Štabuc B, Glavač D. Down-regulation of microRNAs of the miR-200 family and up-regulation of Snail and Slug in inflammatory bowel diseases - hallmark of epithelial-mesenchymal transition. J Cell Mol Med 2016;20:1813-20. [PMID: 27113480 DOI: 10.1111/jcmm.12869] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
208 Guo G, Shi F, Zhu J, Shao Y, Gong W, Zhou G, Wu H, She J, Shi W. Piperine, a functional food alkaloid, exhibits inhibitory potential against TNBS-induced colitis via the inhibition of IκB-α/NF-κB and induces tight junction protein (claudin-1, occludin, and ZO-1) signaling pathway in experimental mice. Hum Exp Toxicol 2020;39:477-91. [PMID: 31835924 DOI: 10.1177/0960327119892042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
209 Mocci G, Migaleddu V, Cabras F, Sirigu D, Scanu D, Virgilio G, Marzo M. SICUS and CEUS imaging in Crohn's disease: an update. J Ultrasound 2017;20:1-9. [PMID: 28298939 DOI: 10.1007/s40477-016-0230-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
210 Chhaya V, Saxena S, Cecil E, Subramanian V, Curcin V, Majeed A, Pollok RC. Steroid dependency and trends in prescribing for inflammatory bowel disease - a 20-year national population-based study. Aliment Pharmacol Ther 2016;44:482-94. [DOI: 10.1111/apt.13700] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
211 Pellino G, Sciaudone G, Candilio G, Campitiello F, Selvaggi F, Canonico S. Effects of a new pocket device for negative pressure wound therapy on surgical wounds of patients affected with Crohn’s disease: a pilot trial. Surg Innov. 2014;21:204-212. [PMID: 23883481 DOI: 10.1177/1553350613496906] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
212 Paparo F, Revelli M, Puppo C, Bacigalupo L, Garello I, Garlaschi A, Biscaldi E, Rollandi L, Binda GA, Rollandi GA. Crohn's disease recurrence in patients with ileocolic anastomosis: value of computed tomography enterography with water enema. Eur J Radiol 2013;82:e434-40. [PMID: 23727378 DOI: 10.1016/j.ejrad.2013.04.033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
213 Derwa Y, Williams CJM, Sood R, Mumtaz S, Bholah MH, Selinger CP, Hamlin PJ, Ford AC, Gracie DJ. Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin. Therap Adv Gastroenterol. 2018;11:1756283X17744739. [PMID: 29383026 DOI: 10.1177/1756283x17744739] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
214 Slonim-Nevo V, Sarid O, Friger M, Schwartz D, Chernin E, Shahar I, Sergienko R, Vardi H, Rosenthal A, Mushkalo A, Dizengof V, Ben-Yakov G, Abu-Freha N, Munteanu D, Gaspar N, Eidelman L, Segal A, Fich A, Greenberg D, Odes S; Israeli IBD Research Nucleus (IIRN). Effect of psychosocial stressors on patients with Crohn's disease: threatening life experiences and family relations. Eur J Gastroenterol Hepatol. 2016;28:1073-1081. [PMID: 27203602 DOI: 10.1097/meg.0000000000000666] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
215 Paroni M, Magarotto A, Tartari S, Nizzoli G, Larghi P, Ercoli G, Gianelli U, Pagani M, Elli L, Abrignani S, Conte D, Geginat J, Caprioli F. Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune Enteropathy. Clin Transl Gastroenterol 2016;7:e182. [PMID: 27415620 DOI: 10.1038/ctg.2016.41] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
216 Wang Z, Wang Z, Wang J, Diao Y, Qian X, Zhu N. T-bet-Expressing B Cells Are Positively Associated with Crohn's Disease Activity and Support Th1 Inflammation. DNA Cell Biol 2016;35:628-35. [PMID: 27348235 DOI: 10.1089/dna.2016.3304] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
217 González-Lama Y, Bermejo F, López-Sanromán A, García-Sánchez V, Esteve M, Cabriada JL, McNicholl AG, Pajares R, Casellas F, Merino O, Carpio D, Vera MI, Muñoz C, Calvo M, Benito LM, Bujanda L, García-Fernández FJ, Ricart E, Ginard D, Velasco M, Carneros JA, Manceñido N, Calvo M, Algaba A, Froilan C, Cara C, Maté J, Abreu L, Gisbert JP; "Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)". Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients. Aliment Pharmacol Ther 2011;34:544-54. [PMID: 21722149 DOI: 10.1111/j.1365-2036.2011.04756.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
218 Chavarría C, Casanova MJ, Chaparro M, Barreiro-de Acosta M, Ezquiaga E, Bujanda L, Rivero M, Argüelles-Arias F, Martín-Arranz MD, Martínez-Montiel MP, Valls M, Ferreiro-Iglesias R, Llaó J, Moraleja-Yudego I, Casellas F, Antolín-Melero B, Cortés X, Plaza R, Pineda JR, Navarro-Llavat M, García-López S, Robledo-Andrés P, Marín-Jiménez I, García-Sánchez V, Merino O, Algaba A, Arribas-López MR, Banales JM, Castro B, Castro-Laria L, Honrubia R, Almela P, Gisbert JP. Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre Study. J Crohns Colitis 2019;13:996-1002. [PMID: 30721954 DOI: 10.1093/ecco-jcc/jjz024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
219 Bilal M, Singh S, Lee H, Khosa K, Khehra R, Clarke K. Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists. Ann Gastroenterol 2017;30:192-6. [PMID: 28243040 DOI: 10.20524/aog.2016.0114] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
220 Peyrin-biroulet L, Panés J, Sandborn WJ, Vermeire S, Danese S, Feagan BG, Colombel J, Hanauer SB, Rycroft B. Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. Clinical Gastroenterology and Hepatology 2016;14:348-354.e17. [DOI: 10.1016/j.cgh.2015.06.001] [Cited by in Crossref: 186] [Cited by in F6Publishing: 169] [Article Influence: 31.0] [Reference Citation Analysis]
221 Yang L, Ge Z, Gao Y, Li X, Dai J, Zhang Y, Xue H, Zhao Y. Assessment of capsule endoscopy scoring index, clinical disease activity, and C-reactive protein in small bowel Crohn's disease: Small bowel Crohn's disease. J Gastroenterol Hepatol 2013;28:829-33. [DOI: 10.1111/jgh.12146] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
222 Settesoldi A, Coppola M, Rogai F, Annese V. Ustekinumab: moving the target from psoriasis to Crohn's disease. Expert Rev Gastroenterol Hepatol 2014;8:5-13. [PMID: 24410468 DOI: 10.1586/17474124.2014.850414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
223 Ciccocioppo R, Vanoli A, Klersy C, Imbesi V, Boccaccio V, Manca R, Betti E, Cangemi GC, Strada E, Besio R, Rossi A, Falcone C, Ardizzone S, Fociani P, Danelli P, Corazza GR. Role of the advanced glycation end products receptor in Crohn’s disease inflammation. World J Gastroenterol 2013; 19(45): 8269-8281 [PMID: 24363518 DOI: 10.3748/wjg.v19.i45.8269] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
224 Carrasco A, Fernández-bañares F, Pedrosa E, Salas A, Loras C, Rosinach M, Aceituno M, Andújar X, Forné M, Zabana Y, Esteve M. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases. ECCOJC 2016;10:1042-54. [DOI: 10.1093/ecco-jcc/jjw066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
225 Cottone M, Renna S, Orlando A, Mocciaro F. Medical management of Crohn's disease. Expert Opin Pharmacother. 2011;12:2505-2525. [PMID: 21988215 DOI: 10.1517/14656566.2011.609556] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
226 Aguilera-Castro L, Ferre-Aracil C, Garcia-Garcia-de-Paredes A, Rodriguez-de-Santiago E, Lopez-Sanroman A. Management of complex perianal Crohn's disease. Ann Gastroenterol. 2017;30:33-44. [PMID: 28042236 DOI: 10.20524/aog.2016.0099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
227 Brouquet A, Rangheard AS, Ifergan J, Lazure T, Carbonnel F, Penna C, Benoist S. The accuracy of preoperative imaging in measuring the length of the ileocolic segment affected by Crohn's disease: a prospective cohort study. Colorectal Dis 2017;19:437-45. [PMID: 27607894 DOI: 10.1111/codi.13502] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
228 Peyrin-biroulet L, Bouhnik Y, Roblin X, Bonnaud G, Hagège H, Hébuterne X. French national consensus clinical guidelines for the management of Crohn’s disease. Digestive and Liver Disease 2017;49:368-77. [DOI: 10.1016/j.dld.2016.12.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
229 Radhamma A, Halligan S, Bloom S, McCartney S, Taylor SA. MRI enterography: what is the clinical impact of unsuspected extra-enteric findings? Br J Radiol 2012;85:e766-9. [PMID: 22553300 DOI: 10.1259/bjr/33344438] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
230 Kampa KC, Morsoletto DBG, Loures MR, Pissaia A, Nones RB, Ivantes CAP. IMPORTANCE OF MEASURING LEVELS OF INFLIXIMAB IN PATIENTS TREATING INFLAMMATORY BOWEL DISEASE IN A BRAZILIAN COHORT. Arq Gastroenterol 2017;54:333-7. [PMID: 28954041 DOI: 10.1590/S0004-2803.201700000-41] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
231 Chatu S, Subramanian V, Saxena S, Pollok RC. The role of thiopurines in reducing the need for surgical resection in Crohn’s disease: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:23-34; quiz 35. [PMID: 24322839 DOI: 10.1038/ajg.2013.402] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 7.6] [Reference Citation Analysis]
232 Saeed M, Hullur H, Salem A, Ali A, Sahib Y, Ashfaq M. Improved Biochemical Parameters in Patients Who Undergo Early Resection in Isolated Ileocaecal Crohn's Disease. Surg Res Pract 2017;2017:4396573. [PMID: 28776001 DOI: 10.1155/2017/4396573] [Reference Citation Analysis]
233 Aggarwal D, Limdi JK. Anti-TNF therapy is associated with a reduction in radiation exposure in patients with Crohn's disease. Eur J Gastroenterol Hepatol 2015;27:13-9. [PMID: 25341058 DOI: 10.1097/MEG.0000000000000222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
234 Di Girolamo M, Sartini A, Critelli R, Bertani A, Merighi A, Villa E. Efficacy of a Novel Granulocyte Monocyte Apheresis Adsorber Device in the Treatment of Inflammatory Bowel Diseases: A Pilot Study. Ther Apher Dial 2016;20:668-76. [PMID: 27921374 DOI: 10.1111/1744-9987.12453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
235 Wehkamp J, Götz M, Herrlinger K, Steurer W, Stange EF. Inflammatory Bowel Disease. Dtsch Arztebl Int 2016;113:72-82. [PMID: 26900160 DOI: 10.3238/arztebl.2016.0072] [Cited by in Crossref: 20] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
236 Verdier J, Begue B, Cerf-Bensussan N, Ruemmele FM. Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases. Inflamm Bowel Dis 2012;18:1260-6. [PMID: 21994045 DOI: 10.1002/ibd.21905] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
237 Despalatović BR, Bratanić A, Radić M, Jurišić Z, Tonkić A. Epidemiological trends of inflammatory bowel disease (IBD) in Split-Dalmatia County, Croatia from 2006 to 2014. Eur J Intern Med 2017;46:e17-9. [PMID: 28882418 DOI: 10.1016/j.ejim.2017.08.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
238 Breynaert C, Dresselaers T, Perrier C, Arijs I, Cremer J, Van Lommel L, Van Steen K, Ferrante M, Schuit F, Vermeire S, Rutgeerts P, Himmelreich U, Ceuppens JL, Geboes K, Van Assche G. Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease. PLoS One 2013;8:e68876. [PMID: 23894361 DOI: 10.1371/journal.pone.0068876] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
239 Seeger WA, Thieringer J, Esters P, Allmendinger B, Stein J, Schulze H, Dignass A. Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's disease. United European Gastroenterol J 2020;8:804-13. [PMID: 32580666 DOI: 10.1177/2050640620936383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
240 De Voogd FA, Gearry RB, Mulder CJ, Day AS. Osteoprotegerin: A novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma. J Gastroenterol Hepatol 2016;31:1386-92. [PMID: 26896745 DOI: 10.1111/jgh.13324] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
241 Mao R, Xiao YL, Gao X, Chen BL, He Y, Yang L, Hu PJ, Chen MH. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies. Inflamm Bowel Dis. 2012;18:1894-1899. [PMID: 22238138 DOI: 10.1002/ibd.22861] [Cited by in Crossref: 177] [Cited by in F6Publishing: 168] [Article Influence: 17.7] [Reference Citation Analysis]
242 Cucchiara S, D'Arcangelo G, Isoldi S, Aloi M, Stronati L. Mucosal healing in Crohn's disease: new insights. Expert Rev Gastroenterol Hepatol. 2020;14:335-345. [PMID: 32315209 DOI: 10.1080/17474124.2020.1759416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
243 Simon M, Cosnes J, Gornet JM, Seksik P, Stefanescu C, Blain A, Pariente B, Nancey S, Vuitton L, Nachury M, D’haens G, Filippi J, Chevret S, Laharie D; GETAID group. Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn’s Disease: A Prospective Cohort-Study in High-Risk Patients. ECCOJC 2016;11:47-52. [DOI: 10.1093/ecco-jcc/jjw123] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
244 Zhou Y, Xu ZZ, He Y, Yang Y, Liu L, Lin Q, Nie Y, Li M, Zhi F, Liu S, Amir A, González A, Tripathi A, Chen M, Wu GD, Knight R, Zhou H, Chen Y. Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction. mSystems 2018;3:e00188-17. [PMID: 29404425 DOI: 10.1128/mSystems.00188-17] [Cited by in Crossref: 85] [Cited by in F6Publishing: 52] [Article Influence: 21.3] [Reference Citation Analysis]
245 Gersemann M, Becker S, Nuding S, Antoni L, Ott G, Fritz P, Oue N, Yasui W, Wehkamp J, Stange EF. Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD. J Crohns Colitis. 2012;6:425-434. [PMID: 22398066 DOI: 10.1016/j.crohns.2011.09.013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
246 Russo I, Luciani A, De Cicco P, Troncone E, Ciacci C. Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery. PLoS One. 2012;7:e32841. [PMID: 22412931 DOI: 10.1371/journal.pone.0032841] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 6.9] [Reference Citation Analysis]
247 Zorzi F, Zuzzi S, Onali S, Calabrese E, Condino G, Petruzziello C, Ascolani M, Pallone F, Biancone L. Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study. Aliment Pharmacol Ther. 2012;35:1397-1407. [PMID: 22519466 DOI: 10.1111/j.1365-2036.2012.05100.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
248 Kamat N, Kedia S, Ghoshal UC, Nehra A, Makharia G, Sood A, Midha V, Gupta V, Choudhuri G, Ahuja V. Effectiveness and safety of adalimumab biosimilar in inflammatory bowel disease: A multicenter study. Indian J Gastroenterol. 2019;38:44-54. [PMID: 30645725 DOI: 10.1007/s12664-018-0922-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
249 Fernandes SR, Rodrigues RV, Bernardo S, Cortez-pinto J, Rosa I, da Silva JP, Gonçalves AR, Valente A, Baldaia C, Santos PM, Correia L, Venâncio J, Campos P, Pereira AD, Velosa J. Transmural Healing Is Associated with Improved Long-term Outcomes of Patients with Crohnʼs Disease: . Inflammatory Bowel Diseases 2017;23:1403-9. [DOI: 10.1097/mib.0000000000001143] [Cited by in Crossref: 73] [Cited by in F6Publishing: 17] [Article Influence: 14.6] [Reference Citation Analysis]
250 Kopylov U, Yung DE, Engel T, Avni T, Battat R, Ben-Horin S, Plevris JN, Eliakim R, Koulaouzidis A. Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016;28:1137-1144. [PMID: 27415156 DOI: 10.1097/meg.0000000000000692] [Cited by in Crossref: 51] [Cited by in F6Publishing: 23] [Article Influence: 10.2] [Reference Citation Analysis]
251 Okabayashi S, Kobayashi T, Sujino T, Ozaki R, Umeda S, Toyonaga T, Saito E, Nakano M, Tablante MC, Morinaga S, Hibi T. Steroid-refractory extensive enteritis complicated by ulcerative colitis successfully treated with adalimumab. Intest Res 2017;15:535-9. [PMID: 29142523 DOI: 10.5217/ir.2017.15.4.535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
252 Taxonera C, Ponferrada Á, Riestra S, Bermejo F, Saro C, Martín-arranz MD, Cabriada JL, Barreiro-de Acosta M, de Castro ML, López-serrano P, Barrio J, Suarez C, Iglesias E, Argüelles-arias F, Ferrer I, Marín-jiménez I, Hernández-camba A, Bastida G, Van Domselaar M, Martínez-montiel P, Olivares D, Rivero M, Fernandez-salazar L, Nantes Ó, Merino O, Alba C, Gisbert JP, del Mar Martín-rodriguez M, Botella B, Carpio D, Ceballos D, Verdejo C, Morales I, Legido J, Peñate M, Chaparro M, Algaba A, de Francisco R; CONVERT study group from GETECCU. Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2018;12:1270-9. [DOI: 10.1093/ecco-jcc/jjy104] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
253 Hong Z, Ren J, Li Y, Wang G, Gu G, Wu X, Ren H, Li J. Delayed Diagnosis is Associated with Early and Emergency Need for First Crohn's Disease-Related Intestinal Surgery. Med Sci Monit 2017;23:4841-6. [PMID: 28991890 DOI: 10.12659/msm.904238] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
254 Serrano-montalbán B, Arias Á, Friginal-ruiz AB, Lucendo AJ. The Use of the Fracture Risk Assessment (FRAX®) Tool in Predicting Risk of Fractures in Patients With Inflammatory Bowel Disease: A Systematic Review. Journal of Clinical Densitometry 2017;20:180-7. [DOI: 10.1016/j.jocd.2016.08.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
255 Di Nardo G, Aloi M, Oliva S, Civitelli F, Casciani E, Cucchiara S. Investigation of small bowel in pediatric Crohnʼs disease: . Inflammatory Bowel Diseases 2012;18:1760-76. [DOI: 10.1002/ibd.22885] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
256 Fiorino G, Bonifacio C, Malesci A, Balzarini L, Danese S. MRI in Crohn’s disease--current and future clinical applications. Nat Rev Gastroenterol Hepatol. 2012;9:23-31. [PMID: 22105109 DOI: 10.1038/nrgastro.2011.214] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
257 Kalaria R, Desai D, Abraham P, Joshi A, Gupta T, Shah S. Temporal Change in Phenotypic Behaviour in Patients with Crohn's Disease: Do Indian Patients Behave Differently from Western and Other Asian Patients? J Crohns Colitis. 2016;10:255-261. [PMID: 26519461 DOI: 10.1093/ecco-jcc/jjv202] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
258 Petruo VA, Zeißig S, Schmelz R, Hampe J, Beste C. Specific neurophysiological mechanisms underlie cognitive inflexibility in inflammatory bowel disease. Sci Rep 2017;7:13943. [PMID: 29066846 DOI: 10.1038/s41598-017-14345-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
259 Aguas M, Del Hoyo J, Faubel R, Muñoz D, Domínguez D, Bastida G, Navarro B, Barrios A, Valdivieso B, Correcher M, Nos P. A Web-Based Telemanagement System for Patients With Complex Inflammatory Bowel Disease: Protocol for a Randomized Controlled Clinical Trial. JMIR Res Protoc 2018;7:e190. [PMID: 30578197 DOI: 10.2196/resprot.9639] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
260 Kelleci UA, Calhan T, Sahin A, Aydin-ozemir Z, Kahraman R, Ozdil K, Sokmen HM, Yalcin AD. Electroencephalography Findings in Crohn’s Disease. Clin EEG Neurosci 2019;50:129-33. [DOI: 10.1177/1550059418767589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
261 Lobatón T, Ferrante M, Rutgeerts P, Ballet V, Van Assche G, Vermeire S. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther 2015;42:441-51. [PMID: 26104047 DOI: 10.1111/apt.13294] [Cited by in Crossref: 90] [Cited by in F6Publishing: 79] [Article Influence: 12.9] [Reference Citation Analysis]
262 Liefferinckx C, Franchimont D. Viewpoint: Toward the Genetic Architecture of Disease Severity in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2018;24:1428-39. [PMID: 29788122 DOI: 10.1093/ibd/izy109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
263 Kirov S, Sasson A, Zhang C, Chasalow S, Dongre A, Steen H, Stensballe A, Andersen V, Birkelund S, Bennike TB. Degradation of the extracellular matrix is part of the pathology of ulcerative colitis. Mol Omics 2019;15:67-76. [PMID: 30702115 DOI: 10.1039/c8mo00239h] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
264 Vogel H, Halpert D, Horoupian DS. Hypoplasia of posterior spinal roots and dorsal spinal tracts with arthrogryposis multiplex congenita. Acta Neuropathol. 1990;79:692-696. [PMID: 2360413 DOI: 10.1136/gutjnl-2013-304636] [Cited by in Crossref: 221] [Cited by in F6Publishing: 196] [Article Influence: 6.9] [Reference Citation Analysis]
265 Schill G, Iesalnieks I, Haimerl M, Müller-Wille R, Dendl LM, Wiggermann P, Schleder S, Rennert J, Ott C, Agha A, Stroszczynski C, Schreyer AG. Assessment of disease behavior in patients with Crohn's disease by MR enterography. Inflamm Bowel Dis 2013;19:983-90. [PMID: 23474779 DOI: 10.1097/MIB.0b013e31828029dd] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
266 Enns RA, Hookey L, Armstrong D, Bernstein CN, Heitman SJ, Teshima C, Leontiadis GI, Tse F, Sadowski D. Clinical Practice Guidelines for the Use of Video Capsule Endoscopy. Gastroenterology. 2017;152:497-514. [PMID: 28063287 DOI: 10.1053/j.gastro.2016.12.032] [Cited by in Crossref: 168] [Cited by in F6Publishing: 132] [Article Influence: 33.6] [Reference Citation Analysis]
267 Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, Kato J, Kobayashi K, Kobayashi K, Koganei K, Kunisaki R, Motoya S, Nagahori M, Nakase H, Omata F, Saruta M, Watanabe T, Tanaka T, Kanai T, Noguchi Y, Takahashi KI, Watanabe K, Hibi T, Suzuki Y, Watanabe M, Sugano K, Shimosegawa T. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol. 2018;53:305-353. [PMID: 29429045 DOI: 10.1007/s00535-018-1439-1] [Cited by in Crossref: 184] [Cited by in F6Publishing: 166] [Article Influence: 46.0] [Reference Citation Analysis]
268 Amara J, Saliba Y, Hajal J, Smayra V, Bakhos JJ, Sayegh R, Fares N. Circadian Rhythm Disruption Aggravates DSS-Induced Colitis in Mice with Fecal Calprotectin as a Marker of Colitis Severity. Dig Dis Sci 2019;64:3122-33. [PMID: 31115725 DOI: 10.1007/s10620-019-05675-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
269 Chatu S, Subramanian V, Pollok RC. Meta-analysis: diagnostic medical radiation exposure in inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35:529-539. [PMID: 22239831 DOI: 10.1111/j.1365-2036.2011.04975.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
270 Malik F, Scherl E, Weber U, Carrino JA, Epsten M, Wichuk S, Pedersen SJ, Paschke J, Schwartzman S, Kroeber G, Maksymowych WP, Longman R, Mandl LA. Utility of magnetic resonance imaging in Crohn's associated sacroiliitis: A cross-sectional study. Int J Rheum Dis 2021;24:582-90. [PMID: 33528900 DOI: 10.1111/1756-185X.14081] [Reference Citation Analysis]
271 Van Assche G, Herrmann KA, Louis E, Everett SM, Colombel JF, Rahier JF, Vanbeckevoort D, Meunier P, Tolan D, Ernst O. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn’s disease. J Crohns Colitis. 2013;7:950-957. [PMID: 23411006 DOI: 10.1016/j.crohns.2013.01.011] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 7.9] [Reference Citation Analysis]
272 Sahin S, Gulec D, Günay S, Cekic C. Evaluation of the Clinical Effects and Frequency of MEFV Gene Mutation in Patients with Inflammatory Bowel Disease. Gastroenterol Res Pract 2021;2021:5538150. [PMID: 34819953 DOI: 10.1155/2021/5538150] [Reference Citation Analysis]
273 Yang QF, Chen BL, Zhang QS, Zhu ZH, Hu B, He Y, Gao X, Wang YM, Hu PJ, Chen MH. Contribution of MDR1 gene polymorphisms on IBD predisposition and response to glucocorticoids in IBD in a Chinese population. J Dig Dis. 2015;16:22-30. [PMID: 25346426 DOI: 10.1111/1751-2980.12205] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
274 Matusiewicz M, Neubauer K, Lewandowska P, Gamian A, Krzystek-Korpacka M. Reduced Transferrin Levels in Active Inflammatory Bowel Disease. Biomed Res Int 2017;2017:9541370. [PMID: 29226154 DOI: 10.1155/2017/9541370] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
275 Kamat N, Rajan Mallayasamy S, Sharma PSVN, Kamath A, Pai CG. Video assisted patient education improves compliance with follow up and depression scores in Inflammatory Bowel Diseases. Postgrad Med 2018;130:355-60. [PMID: 29460659 DOI: 10.1080/00325481.2018.1442978] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
276 Ye BD, Yang S, Shin SJ, Lee KM, Jang BI, Cheon JH, Choi CH, Kim Y, Lee H; IBD Study Group of the Korean Association for the Study of the Intestinal Diseases. Guidelines for the Management of Crohn's Disease. Intest Res 2012;10:26. [DOI: 10.5217/ir.2012.10.1.26] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
277 Duijvestein M, Battat R, Vande Casteele N, D’haens GR, Sandborn WJ, Khanna R, Jairath V, Feagan BG. Novel Therapies and Treatment Strategies for Patients with Inflammatory Bowel Disease. Curr Treat Options Gastro 2018;16:129-46. [DOI: 10.1007/s11938-018-0175-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 9.8] [Reference Citation Analysis]
278 Prager M, Büttner J, Grunert P, Ellinghaus D, Büning C. A Promoter Variant Within the Aryl Hydrocarbon Receptor Gene Is Associated with an Epithelial Barrier Defect in Smokers with Crohn's Disease. Inflamm Bowel Dis 2016;22:2356-68. [PMID: 27598741 DOI: 10.1097/MIB.0000000000000910] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
279 Hafeez R, Punwani S, Boulos P, Bloom S, McCartney S, Halligan S, Taylor SA. Diagnostic and therapeutic impact of MR enterography in Crohn's disease. Clin Radiol. 2011;66:1148-1158. [PMID: 21943719 DOI: 10.1016/j.crad.2010.12.018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
280 Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, Van Assche G. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6:965-990. [PMID: 23040452 DOI: 10.1016/j.crohns.2012.09.003] [Cited by in Crossref: 539] [Cited by in F6Publishing: 479] [Article Influence: 53.9] [Reference Citation Analysis]
281 Gawron I, Chmura L, Adamek D, Skotniczny K, Pityński K, Ludwin A. Laparoscopic Intervention in Acute Crohn's Disease Involving an Ovary. J Minim Invasive Gynecol 2017;24:1040-5. [PMID: 28559086 DOI: 10.1016/j.jmig.2017.04.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
282 Dubron C, Avni F, Boutry N, Turck D, Duhamel A, Amzallag-Bellenger E. Prospective evaluation of free-breathing diffusion-weighted imaging for the detection of inflammatory bowel disease with MR enterography in childhood population. Br J Radiol 2016;89:20150840. [PMID: 26838954 DOI: 10.1259/bjr.20150840] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
283 Farkas K, Chan H, Rutka M, Szepes Z, Nagy F, Tiszlavicz L, Nyári T, Tang W, Wong G, Tang R, Lo A, Cheung C, Wong S, Lui R, Molnár T, Ng SC. Gastroduodenal Involvement in Asymptomatic Crohn’s Disease Patients in Two Areas of Emerging Disease: Asia and Eastern Europe. ECCOJC 2016;10:1401-6. [DOI: 10.1093/ecco-jcc/jjw113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
284 Peters V, Tigchelaar-Feenstra EF, Imhann F, Dekens JAM, Swertz MA, Franke LH, Wijmenga C, Weersma RK, Alizadeh BZ, Dijkstra G, Campmans-Kuijpers MJE. Habitual dietary intake of IBD patients differs from population controls: a case-control study. Eur J Nutr 2021;60:345-56. [PMID: 32333097 DOI: 10.1007/s00394-020-02250-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
285 Pernat Drobež C, Repnik K, Gorenjak M, Ferkolj I, Weersma RK, Potočnik U. DNA polymorphisms predict time to progression from uncomplicated to complicated Crohn's disease. Eur J Gastroenterol Hepatol 2018;30:447-55. [PMID: 29293112 DOI: 10.1097/MEG.0000000000001055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
286 Rieder F, Kurada S, Grove D, Cikach F, Lopez R, Patel N, Singh A, Alkhouri N, Shen B, Brzezinski A, Baker M, Fiocchi C, Dweik RA. A Distinct Colon-Derived Breath Metabolome is Associated with Inflammatory Bowel Disease, but not its Complications. Clin Transl Gastroenterol 2016;7:e201. [PMID: 27831543 DOI: 10.1038/ctg.2016.57] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
287 Jensen MD, Kjeldsen J, Nathan T. Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon. Scand J Gastroenterol. 2011;46:694-700. [PMID: 21456899 DOI: 10.3109/00365521.2011.560680] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
288 Armuzzi A, Fiorino G, Variola A, Manetti N, Fries W, Orlando A, Maconi G, Bossa F, Cappello M, Biancone L, Cantoro L, Costa F, D’incà R, Lionetti P, Principi M, Castiglione F, Annunziata ML, Di Sabatino A, Di Girolamo M, Terpin MM, Cortelezzi CC, Saibeni S, Amato A, Ardizzone S, Guidi L, Danese S, Massella A, Ventra A, Rizzuto G, Massari A, Perri F, Annese V, Saettone S, Tari R, Petruzzellis C, Meucci G, Imperiali G, Guglielmi FW, Mazzuoli S, Caserta L, Caterina Parodi M, Colli A, Ronchetti A, Pugliese D, Geccherle A, Rogai F, Milani S, Renna S, Cassinotti A, Andriulli A, Martino G, Scrivo B, Troncone E, Kohn A, Bertani L, Lorenzon G, Ghione S, Nardone O, Vecchi M, Bertani A, Bosani MA, Bezzio C, Salerno R; PROSIT Investigators. The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy. Inflammatory Bowel Diseases 2019;25:568-79. [DOI: 10.1093/ibd/izy264] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
289 Zissimopoulos A, Vradelis S, Konialis M, Chadolias D, Bampali A, Constantinidis T, Efremidou E, Kouklakis G. Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study. Scand J Gastroenterol. 2014;49:942-949. [PMID: 24897131 DOI: 10.3109/00365521.2014.920910] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
290 Nguyen VQ, Jiang D, Hoffman SN, Guntaka S, Mays JL, Wang A, Gomes J, Sorrentino D. Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort. Inflamm Bowel Dis. 2017;23:1825-1831. [PMID: 28885229 DOI: 10.1097/mib.0000000000001257] [Cited by in Crossref: 38] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
291 Friedman AB, Brown SJ, Bampton P, Barclay ML, Chung A, Macrae FA, McKenzie J, Reynolds J, Gibson PR, Hanauer SB, Sparrow MP. Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study). Aliment Pharmacol Ther. 2018;47:1092-1102. [PMID: 29468701 DOI: 10.1111/apt.14571] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
292 Taxonera C, Ponferrada Á, Bermejo F, Riestra S, Saro C, Martín-Arranz MD, Cabriada JL, Barreiro-de Acosta M, de Castro ML, López-Serrano P, Barrio J, Suarez C, Iglesias E, Argüelles-Arias F, Ferrer I, Marín-Jiménez I, Hernández-Camba A, Bastida G, Van Domselaar M, Martínez-Montiel P, Olivares D, Alba C, Gisbert JP; SEGURTB study group from GETECCU. Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease. J Crohns Colitis 2017;11:792-800. [PMID: 28333182 DOI: 10.1093/ecco-jcc/jjx022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
293 Boal Carvalho P, Cotter J. Contrast-Enhanced Cross Sectional Imaging and Capsule Endoscopy: New Perspectives for a Whole Picture of the Small Bowel. GE Port J Gastroenterol 2016;23:28-35. [PMID: 28868427 DOI: 10.1016/j.jpge.2015.07.007] [Reference Citation Analysis]
294 Rahier J, Pariente B, Colombel J. Skipping Crohn's Disease: When Ileocolonoscopy Is Not Enough. Clinical Gastroenterology and Hepatology 2012;10:1260-1. [DOI: 10.1016/j.cgh.2012.06.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
295 Murphy KP, Crush L, Twomey M, McLaughlin PD, Mildenberger IC, Moore N, Bye J, O'Connor OJ, McSweeney SE, Shanahan F, Maher MM. Model-Based Iterative Reconstruction in CT Enterography. AJR Am J Roentgenol 2015;205:1173-81. [PMID: 26587922 DOI: 10.2214/AJR.14.13321] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
296 Borecki K, Zawada I, Salkić NN, Karakiewicz B, Adler G. Relationship between the IL23R SNPs and Crohn's Disease Susceptibility and Phenotype in the Polish and Bosnian Populations: A Case-Control Study. Int J Environ Res Public Health 2019;16:E1551. [PMID: 31052515 DOI: 10.3390/ijerph16091551] [Reference Citation Analysis]
297 Golik M, Kurek M, Poteralska A, Bieniek E, Marynka A, Pabich G, Liebert A, Kłopocka M, Rydzewska G. Working Group Guidelines on the nursing roles in caring for patients with Crohn's disease and ulcerative colitis in Poland. Prz Gastroenterol 2014;9:179-93. [PMID: 25276248 DOI: 10.5114/pg.2014.45098] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
298 Arora U, Kedia S, Garg P, Bopanna S, Jain S, Yadav DP, Goyal S, Gupta V, Sahni P, Pal S, Dash NR, Madhusudhan KS, Sharma R, Makharia G, Ahuja V. Colonic Crohn's Disease Is Associated with Less Aggressive Disease Course Than Ileal or Ileocolonic Disease. Dig Dis Sci. 2018;63:1592-1599. [PMID: 29611078 DOI: 10.1007/s10620-018-5041-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
299 Baars JE, Nuij VJ, Oldenburg B, Kuipers EJ, van der Woude CJ. Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation. Inflamm Bowel Dis. 2012;18:1634-1640. [PMID: 22069022 DOI: 10.1002/ibd.21925] [Cited by in Crossref: 131] [Cited by in F6Publishing: 123] [Article Influence: 11.9] [Reference Citation Analysis]
300 Maddu KK, Mittal P, Shuaib W, Tewari A, Ibraheem O, Khosa F. Colorectal emergencies and related complications: a comprehensive imaging review--imaging of colitis and complications. AJR Am J Roentgenol 2014;203:1205-16. [PMID: 25415697 DOI: 10.2214/AJR.13.12250] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
301 Kedia S, Madhusudhan KS, Sharma R, Bopanna S, Yadav DP, Goyal S, Jain S, Das P, Dattagupta S, Makharia G, Ahuja V. Combination of increased visceral fat and long segment involvement: Development and validation of an updated imaging marker for differentiating Crohn's disease from intestinal tuberculosis. J Gastroenterol Hepatol. 2018;33:1234-1241. [PMID: 29205485 DOI: 10.1111/jgh.14065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
302 Eugène C. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease. Clinics and Research in Hepatology and Gastroenterology 2011;35:340-3. [DOI: 10.1016/j.clinre.2011.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
303 Ghaly S, Costello S, Beswick L, Pudipeddi A, Agarwal A, Sechi A, Antoniades S, Headon B, Connor S, Lawrance IC, Sparrow M, Walsh AJ, Andrews JM; AIBDA. Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response: Biologic dose tailoring in Crohn disease. Intern Med J 2015;45:170-7. [DOI: 10.1111/imj.12621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
304 Bouchard S, Ibrahim M, Gossum AV. Video capsule endoscopy: Perspectives of a revolutionary technique. World J Gastroenterol 2014; 20(46): 17330-17344 [PMID: 25516644 DOI: 10.3748/wjg.v20.i46.17330] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
305 De Cruz P, Kamm MA, Prideaux L, Allen PB, Desmond PV. Postoperative recurrent luminal Crohn's disease: a systematic review. Inflamm Bowel Dis 2012;18:758-77. [PMID: 21830279 DOI: 10.1002/ibd.21825] [Cited by in Crossref: 122] [Cited by in F6Publishing: 109] [Article Influence: 11.1] [Reference Citation Analysis]
306 Smids C, Horjus Talabur Horje CS, Drylewicz J, Roosenboom B, Groenen MJM, van Koolwijk E, van Lochem EG, Wahab PJ. Intestinal T Cell Profiling in Inflammatory Bowel Disease: Linking T Cell Subsets to Disease Activity and Disease Course. J Crohns Colitis. 2018;12:465-475. [PMID: 29211912 DOI: 10.1093/ecco-jcc/jjx160] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 10.0] [Reference Citation Analysis]
307 Prager M, Durmus T, Büttner J, Molnar T, de Jong DJ, Drenth JP, Baumgart DC, Sturm A, Farkas K, Witt H, Büning C. Myosin IXb variants and their pivotal role in maintaining the intestinal barrier: A study in Crohn’s disease. Scandinavian Journal of Gastroenterology 2014;49:1191-200. [DOI: 10.3109/00365521.2014.928903] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
308 Assa A, Avni I, Ben-bassat O, Niv Y, Shamir R. Practice Variations in the Management of Inflammatory Bowel Disease Between Pediatric and Adult Gastroenterologists. Journal of Pediatric Gastroenterology & Nutrition 2016;62:372-7. [DOI: 10.1097/mpg.0000000000000943] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
309 Wagner SJ, Schmidt A, Effenberger MJP, Gruber L, Danier J, Haller D. Semisynthetic Diet Ameliorates Crohn’s Disease–Like Ileitis in TNFΔARE/WT Mice Through Antigen-Independent Mechanisms of Gluten: . Inflammatory Bowel Diseases 2013;19:1285-94. [DOI: 10.1097/mib.0b013e318281f573] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
310 Prager M, Buettner J, Buening C. Genes involved in the regulation of intestinal permeability and their role in ulcerative colitis. J Dig Dis. 2015;16:713-722. [PMID: 26512799 DOI: 10.1111/1751-2980.12296] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
311 Jung C, Colombel JF, Lemann M, Beaugerie L, Allez M, Cosnes J, Vernier-Massouille G, Gornet JM, Gendre JP, Cezard JP. Genotype/phenotype analyses for 53 Crohn’s disease associated genetic polymorphisms. PLoS One. 2012;7:e52223. [PMID: 23300620 DOI: 10.1371/journal.pone.0052223] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
312 Ghaly S, Murray K, Baird A, Martin K, Prosser R, Mill J, Simms LA, Hart PH, Radford-smith G, Bampton PA, Lawrance IC. High Vitamin D–Binding Protein Concentration, Low Albumin, and Mode of Remission Predict Relapse in Crohnʼs Disease: . Inflammatory Bowel Diseases 2016;22:2456-64. [DOI: 10.1097/mib.0000000000000894] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
313 Kucharzik T, Wittig BM, Helwig U, Börner N, Rössler A, Rath S, Maaser C; TRUST study group. Use of Intestinal Ultrasound to Monitor Crohn's Disease Activity. Clin Gastroenterol Hepatol 2017;15:535-542.e2. [PMID: 27856365 DOI: 10.1016/j.cgh.2016.10.040] [Cited by in Crossref: 79] [Cited by in F6Publishing: 61] [Article Influence: 13.2] [Reference Citation Analysis]
314 Dave M. Crohn's disease with jejunal involvement: predictor of worse outcomes? J Clin Gastroenterol 2013;47:379-80. [PMID: 23426458 DOI: 10.1097/MCG.0b013e3182828dfa] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
315 Kłopocka M, Liebert A, Bielińska J, Manerowski M. Diagnostic Difficulties in Woman with Crohn's Disease, Ascites, and Elevated Value of Serum CA125 Antigen. Case Rep Med 2014;2014:981726. [PMID: 25506366 DOI: 10.1155/2014/981726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
316 Aggarwal SN, Cavanagh Y, Wang L, Akmal A, Grossman MA. Upper Gastrointestinal Crohn's Disease: Literature Review and Case Presentation. Case Rep Gastrointest Med 2019;2019:2708909. [PMID: 31236294 DOI: 10.1155/2019/2708909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
317 Pellino G, Sciaudone G, Selvaggi F, Riegler G. Delayed diagnosis is influenced by the clinical pattern of Crohn’s disease and affects treatment outcomes and quality of life in the long term: a cross-sectional study of 361 patients in Southern Italy. European Journal of Gastroenterology & Hepatology 2015;27:175-81. [DOI: 10.1097/meg.0000000000000244] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 4.9] [Reference Citation Analysis]
318 Ma L, Li W, Zhuang N, Yang H, Liu W, Zhou W, Jiang Y, Li J, Zhu Q, Qian J. Comparison of transmural healing and mucosal healing as predictors of positive long-term outcomes in Crohn's disease. Therap Adv Gastroenterol 2021;14:17562848211016259. [PMID: 34178114 DOI: 10.1177/17562848211016259] [Reference Citation Analysis]
319 Albert JG. Small bowel imaging in managing Crohn’s disease patients. Gastroenterol Res Pract. 2012;2012:502198. [PMID: 22474438 DOI: 10.1155/2012/502198] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
320 Sturm A, Maaser C, Calabrese E, Annese V, Fiorino G, Kucharzik T, Vavricka SR, Verstockt B, van Rheenen P, Tolan D, Taylor SA, Rimola J, Rieder F, Limdi JK, Laghi A, Krustiņš E, Kotze PG, Kopylov U, Katsanos K, Halligan S, Gordon H, González Lama Y, Ellul P, Eliakim R, Castiglione F, Burisch J, Borralho Nunes P, Bettenworth D, Baumgart DC, Stoker J; European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR]. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects. J Crohns Colitis 2019;13:273-84. [PMID: 30137278 DOI: 10.1093/ecco-jcc/jjy114] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 30.7] [Reference Citation Analysis]
321 Uzzan M, Galicier L, Gornet JM, Oksenhendler E, Fieschi C, Allez M, Bouhnik Y, Kirchgesner J, Boutboul D, Treton X, Gérard L, Mahévas M, Cosnes J, Amiot A. Autoimmune cytopenias associated with inflammatory bowel diseases: Insights from a multicenter retrospective cohort. Dig Liver Dis 2017;49:397-404. [PMID: 28063954 DOI: 10.1016/j.dld.2016.12.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
322 Pockley AG, Lindsay JO, Foulds GA, Rutella S, Gribben JG, Alexander T, Snowden JA. Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn's Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation In Refractory CD-Low Intensity Therapy Evaluation Study Investigators. Front Immunol 2018;9:646. [PMID: 29670622 DOI: 10.3389/fimmu.2018.00646] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
323 Kim PH, Park SH, Jin K, Ye BD, Yoon YS, Lee JS, Kim HJ, Kim AY, Yu CS, Yang SK. Supplementary Anal Imaging by Magnetic Resonance Enterography in Patients with Crohn's Disease Not Suspected of Having Perianal Fistulas. Clin Gastroenterol Hepatol 2020;18:415-423.e4. [PMID: 31352093 DOI: 10.1016/j.cgh.2019.07.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
324 Lee MJ, Parker CE, Taylor SR, Guizzetti L, Feagan BG, Lobo AJ, Jairath V. Efficacy of Medical Therapies for Fistulizing Crohn's Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018;16:1879-1892. [PMID: 29374617 DOI: 10.1016/j.cgh.2018.01.030] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
325 Feng R, Chao K, Chen SL, Sun CH, Qiu Y, Chen BL, Mao R, He Y, Cao QH, Xue L, Zeng ZR, Zhang SH, Chen MH. Heat shock protein family A member 6 combined with clinical characteristics for the differential diagnosis of intestinal Behçet's disease. J Dig Dis 2018;19:350-8. [PMID: 29851304 DOI: 10.1111/1751-2980.12613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
326 Preda C, Fulger L, Gheorghe L, Gheorghe C, Goldis A, Trifan A, Tantau M, Tantau A, Negreanu L, Manuc M, Cijevschi-Prelipcean C, Iacob R, Tieranu C, Meianu C, Diculescu M. Adalimumab and Infliximab in Crohn's disease - real life data from a national retrospective cohort study. Curr Health Sci J 2016;42:115-24. [PMID: 30568821 DOI: 10.12865/CHSJ.42.02.01] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
327 Yuksel I, Kilincalp S, Coskun Y, Akinci H, Hamamci M, Alkan A. Diagnostic accuracy of intestinal ultrasound and magnetic resonance enterography for the detection of endoscopy-based disease activity in ileocolonic Crohn’s disease. European Journal of Gastroenterology & Hepatology 2019;31:809-16. [DOI: 10.1097/meg.0000000000001438] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
328 Civitelli F, Casciani E, Maccioni F, Oliva S, Al Ansari N, Bonocore V, Cucchiara S. Use of Imaging Techniques in Inflammatory Bowel Diseases That Minimize Radiation Exposure. Curr Gastroenterol Rep 2015;17. [DOI: 10.1007/s11894-015-0448-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
329 Verdier J, Breunig IR, Ohse MC, Roubrocks S, Kleinfeld S, Roy S, Streetz K, Trautwein C, Roderburg C, Sellge G. Faecal Micro-RNAs in Inflammatory Bowel Diseases.J Crohns Colitis. 2020;14:110-117. [PMID: 31209454 DOI: 10.1093/ecco-jcc/jjz120] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
330 Testa A, Rispo A, Romano M, Riegler G, Selvaggi F, Bottiglieri E, Martorano M, Rea M, Gravina A, Nardone OM. The burden of anaemia in patients with inflammatory bowel diseases. Dig Liver Dis. 2016;48:267-270. [PMID: 26698411 DOI: 10.1016/j.dld.2015.10.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
331 Carpio D, Barreiro-de Acosta M, Echarri A, Pereira S, Castro J, Ferreiro R, Lorenzo A. Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study. European Journal of Gastroenterology & Hepatology 2015;27:1030-7. [DOI: 10.1097/meg.0000000000000395] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
332 Castiglione F, Mainenti P, Testa A, Imperatore N, De Palma GD, Maurea S, Rea M, Nardone OM, Sanges M, Caporaso N, Rispo A. Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents. Dig Liver Dis 2017;49:484-9. [PMID: 28292640 DOI: 10.1016/j.dld.2017.02.014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 10.2] [Reference Citation Analysis]
333 . UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
334 Kim JS, Jang HY, Park SH, Kim KJ, Han K, Yang SK, Ye BD, Park SH, Lee JS, Kim HJ. MR Enterography Assessment of Bowel Inflammation Severity in Crohn Disease Using the MR Index of Activity Score: Modifying Roles of DWI and Effects of Contrast Phases. AJR Am J Roentgenol. 2017;208:1022-1029. [PMID: 28225669 DOI: 10.2214/ajr.16.17324] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 5.4] [Reference Citation Analysis]
335 Halling ML, Nathan T, Kjeldsen J, Jensen MD. High sensitivity of quick view capsule endoscopy for detection of small bowel Crohn's disease. J Gastroenterol Hepatol. 2014;29:992-996. [PMID: 24325204 DOI: 10.1111/jgh.12488] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
336 Won HS, Park DI, Chon CU, Seok HS, Kim TW, Heo WJ, Lee CK, Eun CS, Han DS, Lee S. Comparison of Infliximab and Infliximab/Azathioprine for Maintenance Therapy in Korean Patients with Luminal Crohn's Disease. Intest Res 2011;9:189. [DOI: 10.5217/ir.2011.9.3.189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
337 Wåhlin M, Stjernman H, Munck B. Disease-Related Worries in Persons With Crohn Disease: An Interview Study. Gastroenterol Nurs 2019;42:435-42. [PMID: 31574072 DOI: 10.1097/SGA.0000000000000395] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
338 Kiss LS, Szamosi T, Molnár T, Miheller P, Lakatos L, Vincze A, Palatka K, Bartha Z, Gasztonyi B, Salamon A, Horváth G, Tóth GT, Farkas K, Banai J, Tulassay Z, Nagy F, Szenes M, Veres G, Lovász BD, Végh Z, Golovics PA, Szathmári M, Papp M, Lakatos PL. [Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary]. Orv Hetil 2011;152:1433-42. [PMID: 21865144 DOI: 10.1556/OH.2011.29200] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
339 Chetcuti Zammit S, Sanders DS, McAlindon ME, Sidhu R. Optimising the use of small bowel endoscopy: a practical guide. Frontline Gastroenterol 2019;10:171-6. [PMID: 31205659 DOI: 10.1136/flgastro-2018-101077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
340 Yu XQ, Wang ZJ, Zhao B, Ma HC, Jin ML. Extensively infiltrating colon adenocarcinoma similar to Crohn's disease: a case report. Clin Res Hepatol Gastroenterol 2012;36:e63-8. [PMID: 22326249 DOI: 10.1016/j.clinre.2011.12.013] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
341 Muhvić-Urek M, Tomac-Stojmenović M, Mijandrušić-Sinčić B. Oral pathology in inflammatory bowel disease. World J Gastroenterol 2016; 22(25): 5655-5667 [PMID: 27433081 DOI: 10.3748/wjg.v22.i25.5655] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
342 Zorzi F, Calabrese E, Monteleone I, Fantini M, Onali S, Biancone L, Pallone F, Monteleone G. A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn’s disease. Aliment Pharmacol Ther 2012;36:850-7. [PMID: 22971085 DOI: 10.1111/apt.12051] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
343 Kim AH, Roberts C, Feagan BG, Banerjee R, Bemelman W, Bodger K, Derieppe M, Dignass A, Driscoll R, Fitzpatrick R, Gaarentstroom-Lunt J, Higgins PD, Kotze PG, Meissner J, O'Connor M, Ran ZH, Siegel CA, Terry H, van Deen WK, van der Woude CJ, Weaver A, Yang SK, Sands BE, Vermeire S, Travis SP. Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease-an International, Cross-disciplinary Consensus. J Crohns Colitis 2018;12:408-18. [PMID: 29216349 DOI: 10.1093/ecco-jcc/jjx161] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 14.0] [Reference Citation Analysis]
344 Jensen MD, Nathan T, Rafaelsen SR, Kjeldsen J. Diagnostic Accuracy of Capsule Endoscopy for Small Bowel Crohn's Disease Is Superior to That of MR Enterography or CT Enterography. Clinical Gastroenterology and Hepatology 2011;9:124-129.e1. [DOI: 10.1016/j.cgh.2010.10.019] [Cited by in Crossref: 157] [Cited by in F6Publishing: 144] [Article Influence: 14.3] [Reference Citation Analysis]
345 Nowak JK, Grzybowska-Chlebowczyk U, Landowski P, Szaflarska-Poplawska A, Klincewicz B, Adamczak D, Banasiewicz T, Plawski A, Walkowiak J. Prevalence and correlates of vitamin K deficiency in children with inflammatory bowel disease. Sci Rep. 2014;4:4768. [PMID: 24759680 DOI: 10.1038/srep04768] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
346 Wilenska B, Tymecka D, Włodarczyk M, Sobolewska-włodarczyk A, Wiśniewska-jarosińska M, Dyniewicz J, Somogyi Á, Fichna J, Misicka A. Enkephalin degradation in serum of patients with inflammatory bowel diseases. Pharmacological Reports 2019;71:42-7. [DOI: 10.1016/j.pharep.2018.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
347 Shen EX, Lord A, Doecke JD, Hanigan K, Irwin J, Cheng RK, Radford-smith G. A validated risk stratification tool for detecting high-risk small bowel Crohn's disease. Aliment Pharmacol Ther 2020;51:281-90. [DOI: 10.1111/apt.15550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
348 Manz M, Burri E, Rothen C, Tchanguizi N, Niederberger C, Rossi L, Beglinger C, Lehmann FS. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study. BMC Gastroenterol. 2012;12:5. [PMID: 22233279 DOI: 10.1186/1471-230x-12-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
349 García-Bosch O, Ordás I, Aceituno M, Rodríguez S, Ramírez AM, Gallego M, Ricart E, Rimola J, Panes J. Comparison of Diagnostic Accuracy and Impact of Magnetic Resonance Imaging and Colonoscopy for the Management of Crohn's Disease. J Crohns Colitis 2016;10:663-9. [PMID: 26783346 DOI: 10.1093/ecco-jcc/jjw015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
350 Monteiro S, Dias de Castro F, Boal Carvalho P, Rosa B, Moreira MJ, Pinho R, Saraiva MM, Cotter J. Essential role of small bowel capsule endoscopy in reclassification of colonic inflammatory bowel disease type unclassified. World J Gastrointest Endosc 2017; 9(1): 34-40 [PMID: 28101306 DOI: 10.4253/wjge.v9.i1.34] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
351 Casciani E, Vincentiis CD, Gualdi G. Small bowel imaging of inflammatory bowel disease. World J Radiol 2015; 7(8): 198-201 [PMID: 26339463 DOI: 10.4329/wjr.v7.i8.198] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
352 Kedia S, Kurrey L, Pratap Mouli V, Dhingra R, Srivastava S, Pradhan R, Sharma R, Das P, Tiwari V, Makharia G. Frequency, natural course and clinical significance of symptomatic terminal ileitis. J Dig Dis. 2016;17:36-43. [PMID: 26670338 DOI: 10.1111/1751-2980.12307] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
353 Cassieri C, Brandimarte G, Elisei W, Lecca GP, Goni E, Penna A, Picchio M, Tursi A. How to Differentiate Segmental Colitis Associated With Diverticulosis and Inflammatory Bowel Diseases. J Clin Gastroenterol. 2016;50 Suppl 1:S36-S38. [PMID: 27622359 DOI: 10.1097/mcg.0000000000000630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
354 Freitas M, Cúrdia Gonçalves T, Boal Carvalho P, Dias de Castro F, Rosa B, João Moreira M, Cotter J. From terminal ileitis to Crohn's disease: how capsule endoscopy is crucial to diagnosis. Eur J Gastroenterol Hepatol 2021;33:631-8. [PMID: 32956184 DOI: 10.1097/MEG.0000000000001937] [Reference Citation Analysis]
355 Carvalho AT, Fróes RS, Esberard BC, Santos JC, Rapozo DC, Grinman AB, Simão TA, Nicolau Neto P, Luiz RR, Carneiro AJ, Souza HS, Ribeiro-Pinto LF. Multidrug resistance 1 gene polymorphisms may determine Crohn's disease behavior in patients from Rio de Janeiro. Clinics (Sao Paulo) 2014;69:327-34. [PMID: 24838898 DOI: 10.6061/clinics/2014(05)06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
356 Park Y, Cheon JH, Park YL, Ye BD, Kim YS, Han DS, Kim JS, Hong SN, Kim YH, Jeon SR, Kim WH; IBD Study Group of the Korean Association for the Study of Intestinal Diseases (KASID). Development of a Novel Predictive Model for the Clinical Course of Crohn's Disease: Results from the CONNECT Study. Inflamm Bowel Dis. 2017;23:1071-1079. [PMID: 28410345 DOI: 10.1097/mib.0000000000001106] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
357 Onali S, Calabrese E, Pallone F. Measuring disease activity in Crohn’s disease. Abdom Imaging 2012;37:927-32. [DOI: 10.1007/s00261-012-9877-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
358 Hirayama A, Joshita S, Kitahara K, Mukawa K, Suga T, Umemura T, Tanaka E, Ota M. Lymphocyte Antigen 75 Polymorphisms Are Associated with Disease Susceptibility and Phenotype in Japanese Patients with Inflammatory Bowel Disease. Dis Markers 2016;2016:6485343. [PMID: 27965521 DOI: 10.1155/2016/6485343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
359 Gasparetto M, Guariso G, Pozza LV, Ross A, Heuschkel R, Zilbauer M. Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy. BMC Gastroenterol 2016;16:35. [PMID: 26976427 DOI: 10.1186/s12876-016-0455-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
360 Molendijk I, Duijvestein M, van der Meulen-de Jong AE, van Deen WK, Swets M, Hommes DW, Verspaget HW. Immunomodulatory effects of mesenchymal stromal cells in Crohn's disease. J Allergy (Cairo) 2012;2012:187408. [PMID: 23049573 DOI: 10.1155/2012/187408] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
361 Reinisch W, Mishkin DS, Oh YS, Schreiber S, Hussain F, Jacob R, Hassanali A, Daperno M. Impact of various central endoscopy reading models on treatment outcome in Crohn's disease using data from the randomized, controlled, exploratory cohort arm of the BERGAMOT trial. Gastrointest Endosc 2021;93:174-182.e2. [PMID: 32464142 DOI: 10.1016/j.gie.2020.05.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
362 Schneider A, Hirth M, Weiss C, Weidner P, Antoni C, Thomann A, Reindl W, Ebert MP, Pfützer RH. Prevalence of inflammatory bowel disease in alcoholic, non-alcoholic and autoimmune pancreatitis. Z Gastroenterol 2018;56:469-78. [PMID: 29734447 DOI: 10.1055/s-0043-123881] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
363 Pernat Drobež C, Ferkolj I, Potočnik U, Repnik K. Crohn's Disease Candidate Gene Alleles Predict Time to Progression from Inflammatory B1 to Stricturing B2, or Penetrating B3 Phenotype. Genet Test Mol Biomarkers 2018;22:143-51. [PMID: 29446656 DOI: 10.1089/gtmb.2017.0210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
364 Fiorino G, Bonifacio C, Allocca M, Danese S. Impact of therapies on bowel damage in Crohn's disease. United European Gastroenterol J 2020;8:410-7. [PMID: 32213030 DOI: 10.1177/2050640620908696] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
365 Paul S, Del Tedesco E, Marotte H, Rinaudo-Gaujous M, Moreau A, Phelip JM, Genin C, Peyrin-Biroulet L, Roblin X. Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective study. Inflamm Bowel Dis. 2013;19:2568-2576. [PMID: 24013361 DOI: 10.1097/mib.0b013e3182a77b41] [Cited by in Crossref: 155] [Cited by in F6Publishing: 65] [Article Influence: 19.4] [Reference Citation Analysis]
366 Stawczyk-Eder K, Eder P, Lykowska-Szuber L, Krela-Kazmierczak I, Klimczak K, Szymczak A, Szachta P, Katulska K, Linke K. Is faecal calprotectin equally useful in all Crohn’s disease locations? A prospective, comparative study. Arch Med Sci. 2015;11:353-361. [PMID: 25995752 DOI: 10.5114/aoms.2014.43672] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
367 Lee YJ, Kim KM, Jang JY, Song K. Association of TNFSF15 polymorphisms in Korean children with Crohn's disease. Pediatr Int 2015;57:1149-53. [PMID: 25998826 DOI: 10.1111/ped.12686] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
368 Al-Mofarreh MA, Al-Mofleh IA. Emerging inflammatory bowel disease in saudi outpatients: a report of 693 cases. Saudi J Gastroenterol. 2013;19:16-22. [PMID: 23319033 DOI: 10.4103/1319-3767.105915] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
369 Grover Z, Lewindon P. Two-Year Outcomes After Exclusive Enteral Nutrition Induction Are Superior to Corticosteroids in Pediatric Crohn's Disease Treated Early with Thiopurines. Dig Dis Sci 2015;60:3069-74. [PMID: 26038093 DOI: 10.1007/s10620-015-3722-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
370 Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278:369-395. [PMID: 26212387 DOI: 10.1111/joim.12395] [Cited by in Crossref: 236] [Cited by in F6Publishing: 209] [Article Influence: 33.7] [Reference Citation Analysis]
371 Despott EJ, Fraser C. Small bowel endoscopy in inflammatory bowel disease. Best Practice & Research Clinical Gastroenterology 2012;26:279-91. [DOI: 10.1016/j.bpg.2012.01.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
372 Bessissow T, Van Keerberghen CA, Van Oudenhove L, Ferrante M, Vermeire S, Rutgeerts P, Van Assche G. Anxiety is associated with impaired tolerance of colonoscopy preparation in inflammatory bowel disease and controls. J Crohns Colitis. 2013;7:e580-e587. [PMID: 23664621 DOI: 10.1016/j.crohns.2013.04.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
373 Bojic D, Bodger K, Travis S. Patient Reported Outcome Measures (PROMs) in Inflammatory Bowel Disease: New Data. J Crohns Colitis. 2017;11:S576-S585. [PMID: 27797917 DOI: 10.1093/ecco-jcc/jjw187] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
374 Abbas M, Matta J, Le T, Bensmail H, Obafemi-Ajayi T, Honavar V, El-Manzalawy Y. Biomarker discovery in inflammatory bowel diseases using network-based feature selection. PLoS One. 2019;14:e0225382. [PMID: 31756219 DOI: 10.1371/journal.pone.0225382] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
375 Serafin Z, Białecki M, Białecka A, Sconfienza LM, Kłopocka M. Contrast-enhanced Ultrasound for Detection of Crohn's Disease Activity: Systematic Review and Meta-analysis. J Crohns Colitis 2016;10:354-62. [PMID: 26507861 DOI: 10.1093/ecco-jcc/jjv196] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
376 Petruzziello C, Calabrese E, Onali S, Zuzzi S, Condino G, Ascolani M, Zorzi F, Pallone F, Biancone L. Small bowel capsule endoscopy vs conventional techniques in patients with symptoms highly compatible with Crohn's Disease. Journal of Crohn's and Colitis 2011;5:139-47. [DOI: 10.1016/j.crohns.2010.12.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
377 Argyriou K, Roma E, Kapsoritakis A, Tsakiridou E, Oikonomou K, Manolakis A, Potamianos S. The Rating Form of IBD Patient Concerns: Translation, Validation, and First Implementation of the Greek Version. Gastroenterol Res Pract 2017;2017:6267175. [PMID: 28529522 DOI: 10.1155/2017/6267175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
378 Ponte A, Pinho R, Rodrigues A, Silva J, Rodrigues J, Sousa M, Carvalho J. Evaluation and comparison of capsule endoscopy scores for assessment of inflammatory activity of small-bowel in Crohn's disease. Gastroenterología y Hepatología 2018;41:245-50. [DOI: 10.1016/j.gastrohep.2017.11.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
379 Agarwal A, Kedia S, Jain S, Gupta V, Bopanna S, Yadav DP, Goyal S, Mouli VP, Dhingra R, Makharia G, Ahuja V. High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India. Intest Res 2018;16:588-98. [PMID: 30301331 DOI: 10.5217/ir.2018.00023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
380 Boal Carvalho P, Cotter J. Mucosal Healing in Ulcerative Colitis: A Comprehensive Review. Drugs. 2017;77:159-173. [PMID: 28078646 DOI: 10.1007/s40265-016-0676-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
381 Lovasz BD, Lakatos L, Horvath A, Szita I, Pandur T, Mandel M, Vegh Z, Golovics PA, Mester G, Balogh M, Molnar C, Komaromi E, Kiss LS, Lakatos PL. Evolution of disease phenotype in adult and pediatric onset Crohn’s disease in a population-based cohort. World J Gastroenterol 2013; 19(14): 2217-2226 [PMID: 23599648 DOI: 10.3748/wjg.v19.i14.2217] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
382 Panés J, López-Sanromán A, Bermejo F, García-Sánchez V, Esteve M, Torres Y, Domènech E, Piqueras M, Gomez-García M, Gutiérrez A. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn’s disease. Gastroenterology. 2013;145:766-774.e1. [PMID: 23770132 DOI: 10.1053/j.gastro.2013.06.009] [Cited by in Crossref: 171] [Cited by in F6Publishing: 138] [Article Influence: 19.0] [Reference Citation Analysis]
383 Palone F, Vitali R, Cucchiara S, Pierdomenico M, Negroni A, Aloi M, Nuti F, Felice C, Armuzzi A, Stronati L. Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:1448-1457. [PMID: 24983978 DOI: 10.1097/mib.0000000000000113] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
384 Agraib LM, Yamani MI, Rayyan YM, Abu-Sneineh AT, Tamimi TA, Tayyem RF. The probiotic supplementation role in improving the immune system among people with ulcerative colitis: a narrative review. Drug Metab Pers Ther 2021;37:7-19. [PMID: 35385892 DOI: 10.1515/dmpt-2021-0150] [Reference Citation Analysis]
385 Yamamoto-furusho J, Bosques-padilla F, de-Paula J, Galiano M, Ibañez P, Juliao F, Kotze P, Rocha J, Steinwurz F, Veitia G, Zaltman C. Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn's and Colitis Organisation. Revista de Gastroenterología de México 2017;82:46-84. [DOI: 10.1016/j.rgmx.2016.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
386 Brůhová Michalčíková R, Dryahina K, Španěl P. A detailed study of the ion chemistry of alkenes focusing on heptenes aimed at their SIFT-MS quantification. International Journal of Mass Spectrometry 2018;425:16-21. [DOI: 10.1016/j.ijms.2017.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
387 Barat M, Hoeffel C, Bouquot M, Jannot AS, Dautry R, Boudiaf M, Pautrat K, Kaci R, Camus M, Eveno C, Pocard M, Soyer P, Dohan A. Preoperative evaluation of small bowel complications in Crohn’s disease: comparison of diffusion-weighted and contrast-enhanced MR imaging. Eur Radiol 2019;29:2034-44. [DOI: 10.1007/s00330-018-5734-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
388 Mijac D, Vukovic-Petrovic I, Mijac V, Perovic V, Milic N, Djuranovic S, Bojic D, Popovic D, Culafic D, Krstic M, Jankovic G, Pravica V, Markovic M. MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease. PLoS One 2018;13:e0194536. [PMID: 29543864 DOI: 10.1371/journal.pone.0194536] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
389 Maconi G, Magro F. Comparing techniques to achieve high accuracy and low cost: how should we first diagnose Crohn's disease? Journal of Comparative Effectiveness Research 2015;4:75-8. [DOI: 10.2217/cer.15.2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
390 Moller FT, Knudsen L, Harbord M, Satsangi J, Gordon H, Christiansen L, Christensen K, Jess T, Andersen V. Danish cohort of monozygotic inflammatory bowel disease twins: Clinical characteristics and inflammatory activity. World J Gastroenterol 2016; 22(21): 5050-5059 [PMID: 27275097 DOI: 10.3748/wjg.v22.i21.5050] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
391 Lenti MV, Selinger CP. Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions. Expert Rev Gastroenterol Hepatol 2017;11:215-26. [PMID: 28099821 DOI: 10.1080/17474124.2017.1284587] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
392 Aljebreen AM, Alharbi OR, Azzam NA, Almalki AS, Alswat KA, Almadi MA. Clinical epidemiology and phenotypic characteristics of Crohn's disease in the central region of Saudi Arabia. Saudi J Gastroenterol 2014;20:162-9. [PMID: 24976279 DOI: 10.4103/1319-3767.132993] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
393 González-lama Y, Taxonera C, López-sanromán A, Pérez-calle JL, Bermejo F, Pajares R, Mcnicholl AG, Opio V, Mendoza JL, López P, Algaba A, Estelles J, Barbero A, Mendoza J, Maté J, Gisbert JP. Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience. European Journal of Gastroenterology & Hepatology 2012;24:1086-91. [DOI: 10.1097/meg.0b013e3283556db5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
394 Dryahina K, Španěl P, Pospíšilová V, Sovová K, Hrdlička L, Machková N, Lukáš M, Smith D. Quantification of pentane in exhaled breath, a potential biomarker of bowel disease, using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom 2013;27:1983-92. [PMID: 23939966 DOI: 10.1002/rcm.6660] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
395 Park JJ, Yang SK, Ye BD, Kim JW, Park DI, Yoon H, Im JP, Lee KM, Yoon SN, Lee H; IBD Study Group of the Korean Association for the Study of the Intestinal Diseases. [Second Korean Guidelines for the Management of Crohn's Disease]. Korean J Gastroenterol 2017;69:29-54. [PMID: 28135790 DOI: 10.4166/kjg.2017.69.1.29] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
396 Molina-Infante J, Schoepfer AM, Lucendo AJ, Dellon ES. Eosinophilic esophagitis: What can we learn from Crohn's disease? United European Gastroenterol J 2017;5:762-72. [PMID: 29026590 DOI: 10.1177/2050640616672953] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
397 Haapamäki J, Tanskanen A, Roine RP, Blom M, Turunen U, Mäntylä J, Färkkilä MA, Arkkila PE. Medication use among inflammatory bowel disease patients: excessive consumption of antidepressants and analgesics. Scand J Gastroenterol 2013;48:42-50. [PMID: 23163864 DOI: 10.3109/00365521.2012.743584] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
398 Azzam N, AlRuthia Y, Alharbi O, Aljebreen A, Almadi M, Loftus EV Jr. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease. Hepatol Int 2020;14:1114-24. [PMID: 33369708 DOI: 10.1007/s12072-020-10110-5] [Reference Citation Analysis]
399 Cai C, Shen J, Zhao D, Qiao Y, Xu A, Jin S, Ran Z, Zheng Q. Serological investigation of food specific immunoglobulin G antibodies in patients with inflammatory bowel diseases. PLoS One. 2014;9:e112154. [PMID: 25393003 DOI: 10.1371/journal.pone.0112154] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
400 Bjerrum JT, Steenholdt C, Ainsworth M, Nielsen OH, Reed MA, Atkins K, Günther UL, Hao F, Wang Y. Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease. BMC Med 2017;15:184. [PMID: 29032767 DOI: 10.1186/s12916-017-0949-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
401 Spekhorst LM, Visschedijk MC, Alberts R, Festen EA, van der Wouden EJ, Dijkstra G, (ICC) RKWDIOCAC. Performance of the Montreal classification for inflammatory bowel diseases. World J Gastroenterol 2014; 20(41): 15374-15381 [PMID: 25386087 DOI: 10.3748/wjg.v20.i41.15374] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
402 Sagami S, Ueno Y, Tanaka S, Fujita A, Hayashi R, Oka S, Hyogo H, Chayama K. Significance of non-alcoholic fatty liver disease in Crohn's disease: A retrospective cohort study: NAFLD significance in Crohn's disease. Hepatol Res 2017;47:872-81. [DOI: 10.1111/hepr.12828] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
403 Huoponen S, Blom M. A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel Diseases. PLoS One 2015;10:e0145087. [PMID: 26675292 DOI: 10.1371/journal.pone.0145087] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
404 Hinojosa J, Gisbert JP, Gomollón F, López San Román A. Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on Crohn's disease: a real-life survey in Spain. J Crohns Colitis 2012;6:763-70. [PMID: 22398092 DOI: 10.1016/j.crohns.2011.12.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
405 Chatu S, Poullis A, Holmes R, Greenhalgh R, Pollok RC. Temporal trends in imaging and associated radiation exposure in inflammatory bowel disease. Int J Clin Pract. 2013;67:1057-1065. [PMID: 24073979 DOI: 10.1111/ijcp.12187] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
406 Gücer FI, Senturk S, Özkanli S, Yilmabasar MG, Köroglu GA, Acar M. Evaluation of Crohn’s disease activity by MR enterography: Derivation and histopathological comparison of an MR-based activity index. European Journal of Radiology 2015;84:1829-34. [DOI: 10.1016/j.ejrad.2015.06.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
407 Rieder F, Paul G, Schnoy E, Schleder S, Wolf A, Kamm F, Dirmeier A, Strauch U, Obermeier F, Lopez R, Achkar JP, Rogler G, Klebl F. Hemoglobin and hematocrit levels in the prediction of complicated Crohn's disease behavior--a cohort study. PLoS One 2014;9:e104706. [PMID: 25116048 DOI: 10.1371/journal.pone.0104706] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
408 Carvalho ATP, Esberard BC, Fróes RSB, Rapozo DCM, Grinman AB, Simão TA, Santos JCVC, Carneiro AJV, Ribeiro-Pinto LF, Souza HSP. Thiopurine-methyltransferase variants in inflammatory bowel disease: Prevalence and toxicity in Brazilian patients. World J Gastroenterol 2014; 20(12): 3327-3334 [PMID: 24696613 DOI: 10.3748/wjg.v20.i12.3327] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
409 Lopes S, Andrade P, Conde S, Liberal R, Dias CC, Fernandes S, Pinheiro J, Simões JS, Carneiro F, Magro F, Macedo G. Looking into Enteric Virome in Patients with IBD: Defining Guilty or Innocence? Inflammatory Bowel Diseases 2017;23:1278-84. [DOI: 10.1097/mib.0000000000001167] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
410 Engelmann G. Does Screening for Subclinical PSC Contribute to the Management of IBD? Journal of Pediatric Gastroenterology & Nutrition 2012;55:238. [DOI: 10.1097/mpg.0b013e31825bb350] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
411 Tedjo DI, Smolinska A, Savelkoul PH, Masclee AA, van Schooten FJ, Pierik MJ, Penders J, Jonkers DM. The fecal microbiota as a biomarker for disease activity in Crohn's disease. Sci Rep 2016;6:35216. [PMID: 27734914 DOI: 10.1038/srep35216] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
412 Lin JF, Chen JM, Zuo JH, Yu A, Xiao ZJ, Deng FH, Nie B, Jiang B. Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity. Inflamm Bowel Dis. 2014;20:1407-1415. [PMID: 24983982 DOI: 10.1097/mib.0000000000000057] [Cited by in Crossref: 179] [Cited by in F6Publishing: 84] [Article Influence: 25.6] [Reference Citation Analysis]
413 Chen Y, Salem M, Boyd M, Bornholdt J, Li Y, Coskun M, Seidelin JB, Sandelin A, Nielsen OH. Relation between NOD2 genotype and changes in innate signaling in Crohn's disease on mRNA and miRNA levels. NPJ Genom Med 2017;2:3. [PMID: 29263823 DOI: 10.1038/s41525-016-0001-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
414 Verdier J, Deroche L, Allez M, Loy C, Biet F, Bodier CC, Bay S, Ganneau C, Matysiak-Budnik T, Reyrat JM, Heyman M, Cerf-Bensussan N, Ruemmele FM, Ménard S. Specific IgG response against Mycobacterium avium paratuberculosis in children and adults with Crohn's disease. PLoS One 2013;8:e62780. [PMID: 23658774 DOI: 10.1371/journal.pone.0062780] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
415 Garcia PG, Chebli LA, da Rocha Ribeiro TC, Gaburri PD, de Lima Pace FH, Barbosa KVBD, Costa LA, de Almeida Cruz W, de Assis IC, Moraes BRM, Zanini A, Chebli JMF. Impact of superimposed Clostridium difficile infection in Crohn’s or ulcerative colitis flares in the outpatient setting. Int J Colorectal Dis 2018;33:1285-94. [DOI: 10.1007/s00384-018-3105-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
416 Can G, Poşul E, Yılmaz B, Can H, Korkmaz U, Ermiş F, Kurt M, Dağlı Ü. Epidemiologic features of ınflammatory bowel disease in Western Blacksea region of Turkey for the last 10 years: retrospective cohort study. Korean J Intern Med 2019;34:519-29. [PMID: 29695147 DOI: 10.3904/kjim.2015.310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
417 Li Y, Tian Y, Zhu W, Gong J, Zhang W, Yu C, Gu L, Li N, Li J. Triptolide induces suppressor of cytokine signaling-3 expression and promotes lamina propria mononuclear cells apoptosis in Crohn's colitis. International Immunopharmacology 2013;16:268-74. [DOI: 10.1016/j.intimp.2013.04.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
418 Castiglione F, Diaferia M, Morace F, Labianca O, Meucci C, Cuomo A, Panarese A, Romano M, Sorrentini I, D'Onofrio C, Caporaso N, Rispo A. Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a case-control, multi-centre, prospective study in Southern Italy. J Crohns Colitis 2012;6:324-9. [PMID: 22405169 DOI: 10.1016/j.crohns.2011.09.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
419 Fraga M, Fournier N, Safroneeva E, Pittet V, Godat S, Straumann A, Nydegger A, Vavricka SR, Moradpour D, Schoepfer AM; Swiss IBD Cohort Study Group. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up. Eur J Gastroenterol Hepatol 2017;29:91-7. [PMID: 27622999 DOI: 10.1097/MEG.0000000000000747] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 5.4] [Reference Citation Analysis]
420 Ye Z, Lin Y, Cao Q, He Y, Xue L. Granulomas as the Most Useful Histopathological Feature in Distinguishing between Crohn's Disease and Intestinal Tuberculosis in Endoscopic Biopsy Specimens. Medicine (Baltimore). 2015;94:e2157. [PMID: 26656343 DOI: 10.1097/md.0000000000002157] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
421 Magro F, Santos-Antunes J, Vilas-Boas F, Rodrigues-Pinto E, Coelho R, Ribeiro OS, Lopes S, Macedo G. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience. J Crohns Colitis 2014;8:617-25. [PMID: 24332869 DOI: 10.1016/j.crohns.2013.11.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
422 Parra-Blanco A, Ruiz A, Alvarez-Lobos M, Amorós A, Gana JC, Ibáñez P, Ono A, Fujii T. Achieving the best bowel preparation for colonoscopy. World J Gastroenterol 2014; 20(47): 17709-17726 [PMID: 25548470 DOI: 10.3748/wjg.v20.i47.17709] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
423 Osipenko MF, Livzan MA, Skalinskaya MI, Lyalyukova EA. Fecal calprotectin concentration in the differential diagnosis of bowel diseases. Ter arkh 2015;87:30. [DOI: 10.17116/terarkh201587230-33] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
424 Han M, Jung YS, Cheon JH, Park S. Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases. J Gastroenterol Hepatol 2019;34:1166-74. [PMID: 30672608 DOI: 10.1111/jgh.14609] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
425 Rodrigues C, Oliveira A, Santos L, Pires E, Deus J. Biodegradable stent for the treatment of a colonic stricture in Crohn’s disease. World J Gastrointest Endosc 2013; 5(5): 265-269 [PMID: 23678382 DOI: 10.4253/wjge.v5.i5.265] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
426 Mocciaro F, Di Mitri R, Russo G, Leone S, Quercia V. Motivational interviewing in inflammatory bowel disease patients: A useful tool for outpatient counselling. Digestive and Liver Disease 2014;46:893-7. [DOI: 10.1016/j.dld.2014.07.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
427 Goyal P, Shah J, Gupta S, Gupta P, Sharma V. Imaging in discriminating intestinal tuberculosis and Crohn’s disease: past, present and the future. Expert Review of Gastroenterology & Hepatology 2019;13:995-1007. [DOI: 10.1080/17474124.2019.1673730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
428 Trejo-Vazquez F, Garza-Veloz I, Villela-Ramirez GA, Ortiz-Castro Y, Mauricio-Saucedo P, Cardenas-Vargas E, Diaz-Baez M, Cid-Baez MA, Castañeda-Miranda R, Ortiz-Rodriguez JM, Solis-Sanchez LO, Martinez-Fierro ML. Positive association between leptin serum levels and disease activity on endoscopy in inflammatory bowel disease: A case-control study. Exp Ther Med 2018;15:3336-44. [PMID: 29545852 DOI: 10.3892/etm.2018.5835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
429 Aguas Peris M, Bosó V, Navarro B, Marqués-Miñana MR, Bastida G, Beltrán B, Iborra M, Sáez-González E, Monte-Boquet E, Poveda-Andrés JL, Nos P. Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice. Inflamm Bowel Dis 2017;23:1454-60. [PMID: 28708805 DOI: 10.1097/MIB.0000000000001182] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
430 Rosa I, Silva P, da Mata S, Magro F, Carneiro F, Peixoto A, Silva M, Sousa HT, Roseira J, Parra J, Barosa R, Vieira A, Brito MJ, Lago P, Coelho A, Moleiro J, Pereira da Silva J, Fonseca R, Albuquerque C, Dias Pereira A; Grupo de Estudos em Doença Inflamatória Intestinal – GEDII. Methylation patterns in dysplasia in inflammatory bowel disease patients. Scand J Gastroenterol 2020;55:646-55. [PMID: 32456486 DOI: 10.1080/00365521.2020.1766552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
431 Laass MW, Roggenbuck D, Conrad K. Diagnosis and classification of Crohn’s disease. Autoimmun Rev. 2014;13:467-471. [PMID: 24424189 DOI: 10.1016/j.autrev.2014.01.029] [Cited by in Crossref: 106] [Cited by in F6Publishing: 90] [Article Influence: 13.3] [Reference Citation Analysis]
432 Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol. 2018;113:481-517. [PMID: 29610508 DOI: 10.1038/ajg.2018.27] [Cited by in Crossref: 390] [Cited by in F6Publishing: 311] [Article Influence: 97.5] [Reference Citation Analysis]
433 Af Björkesten CG, Jussila A, Kemppainen H, Hallinen T, Soini E, Mankinen P, Valgarðsson S, Veckman V, Nissinen R, Naessens D, Molander P. Relationship of faecal calprotectin and long-term outcomes in Finnish patients with Crohn's disease: retrospective multi-centre chart review study. Scand J Gastroenterol 2019;54:1226-32. [PMID: 31532265 DOI: 10.1080/00365521.2019.1667426] [Reference Citation Analysis]
434 Qian X, Wang T, Shen J, Ran Z. Low dose of azathioprine is effective to induce and maintain remission in active Crohn disease: A prospective observational study. Medicine (Baltimore) 2018;97:e11814. [PMID: 30142769 DOI: 10.1097/MD.0000000000011814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
435 Pellino G, Sciaudone G, Caserta V, Candilio G, De Fatico GS, Gagliardi S, Landino I, Patturelli M, Riegler G, Di Caprio EL, Canonico S, Gritti P, Selvaggi F. Fatigue in inflammatory bowel diseases: Relationship with age and disease activity. International Journal of Surgery 2014;12:S60-3. [DOI: 10.1016/j.ijsu.2014.08.379] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
436 Jovani M, Fiorino G, Danese S. Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome. Aliment Pharmacol Ther. 2013;37:277-278. [PMID: 23252779 DOI: 10.1111/apt.12136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
437 Sipeki N, Davida L, Palyu E, Altorjay I, Harsfalvi J, Antal Szalmas P, Szabo Z, Veres G, Shums Z, Norman GL, Lakatos PL, Papp M. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn’s disease. World J Gastroenterol 2015; 21(22): 6952-6964 [PMID: 26078573 DOI: 10.3748/wjg.v21.i22.6952] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
438 Tosca Cuquerella J, Bosca-Watts MM, Anton Ausejo R, Tejedor Alonso S, Mora De Miguel F, Minguez Perez M. Amyloidosis in Inflammatory Bowel Disease: A Systematic Review of Epidemiology, Clinical Features, and Treatment. J Crohns Colitis 2016;10:1245-53. [PMID: 27056947 DOI: 10.1093/ecco-jcc/jjw080] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
439 Magarotto A, Orlando S, Coletta M, Conte D, Fraquelli M, Caprioli F. Evolving roles of cross-sectional imaging in Crohn's disease. Digestive and Liver Disease 2016;48:975-83. [DOI: 10.1016/j.dld.2016.05.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
440 Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019;65:100851. [PMID: 30837080 DOI: 10.1016/j.disamonth.2019.02.004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 16.7] [Reference Citation Analysis]
441 So J, Tang W, Leung WK, Li M, Lo FH, Wong MTL, Sze ASF, Leung CM, Tsang SWC, Shan EHS, Chan KH, Lam BCY, Hui AJ, Chow WH, Lam TY, Lam V, Lee TW, Lo HHH, Tang CM, Wong CL, Wu JCY, Chan FKL, Sung JJY, Harbord M, Ng SC. Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study. Inflamm Bowel Dis 2017;23:2061-8. [PMID: 28991855 DOI: 10.1097/MIB.0000000000001240] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
442 So H, Ye BD, Park YS, Kim J, Kim JS, Moon W, Lee KM, Kim YS, Keum B, Kim SE. Gastric lesions in patients with Crohn’s disease in Korea: a multicenter study. Intest Res. 2016;14:60-68. [PMID: 26884736 DOI: 10.5217/ir.2016.14.1.60] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
443 Piotrowicz G, Klufczyńska A, Banaszkiewicz P, Dorosz Ł, Rydzewska G. Assessment of the usefulness of imaging studies and biomarkers in the activity of Crohn's disease. Prz Gastroenterol 2021;16:15-22. [PMID: 33986883 DOI: 10.5114/pg.2020.93539] [Reference Citation Analysis]
444 Magro F, Dias CC, Portela F, Miranda M, Fernandes S, Bernardo S, Ministro P, Lago P, Rosa I, Pita I, Correia L, Rodrigues PP; GEDII [Portuguese IBD Group]. Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network Analysis. J Crohns Colitis 2019;13:401-9. [PMID: 30329032 DOI: 10.1093/ecco-jcc/jjy168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
445 Monteiro S, Barbosa M, Cúrdia Gonçalves T, Boal Carvalho P, Moreira MJ, Rosa B, Cotter J. Fecal Calprotectin as a Selection Tool for Small Bowel Capsule Endoscopy in Suspected Crohn's Disease. Inflamm Bowel Dis 2018;24:2033-8. [PMID: 29722829 DOI: 10.1093/ibd/izy098] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
446 Tasson L, Canova C, Vettorato MG, Savarino E, Zanotti R. Influence of Diet on the Course of Inflammatory Bowel Disease. Dig Dis Sci 2017;62:2087-94. [PMID: 28550491 DOI: 10.1007/s10620-017-4620-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
447 Bar-Gil Shitrit A, Koslowsky B, Livovsky DM, Shitrit D, Paz K, Adar T, Adler SN, Goldin E. A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy. Scand J Gastroenterol 2017;52:328-33. [PMID: 27841040 DOI: 10.1080/00365521.2016.1253769] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
448 Cerrillo E, Moret I, Iborra M, Ramos D, Busó E, Tortosa L, Sáez-González E, Nos P, Beltrán B. Alpha-defensins (α-Defs) in Crohn's disease: decrease of ileal α-Def 5 via permanent methylation and increase in plasma α-Def 1-3 concentrations offering biomarker utility. Clin Exp Immunol 2018;192:120-8. [PMID: 29193023 DOI: 10.1111/cei.13085] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
449 Smids C, Horjus Talabur Horje CS, Nierkens S, Drylewicz J, Groenen MJM, Wahab PJ, van Lochem EG. Candidate Serum Markers in Early Crohn's Disease: Predictors of Disease Course. J Crohns Colitis 2017;11:1090-100. [PMID: 28369318 DOI: 10.1093/ecco-jcc/jjx049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
450 Ingallinella S, Campanelli M, Antonelli A, Arcudi C, Bellato V, Divizia A, Franceschilli M, Petagna L, Sensi B, Sibio S, Siragusa L, Sica GS. The Role of Active Inflammation and Surgical Therapy in Crohn's Disease Recurrence. Gastroenterol Res Pract 2020;2020:2845407. [PMID: 33456458 DOI: 10.1155/2020/2845407] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
451 Vavricka SR, Rogler G, Gantenbein C, Spoerri M, Prinz Vavricka M, Navarini AA, French LE, Safroneeva E, Fournier N, Straumann A, Froehlich F, Fried M, Michetti P, Seibold F, Lakatos PL, Peyrin-Biroulet L, Schoepfer AM. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Inflamm Bowel Dis. 2015;21:1794-1800. [PMID: 26020601 DOI: 10.1097/mib.0000000000000429] [Cited by in Crossref: 92] [Cited by in F6Publishing: 32] [Article Influence: 15.3] [Reference Citation Analysis]
452 Gareb B, Eissens AC, Kosterink JGW, Frijlink HW. Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease. Eur J Pharm Biopharm 2016;103:32-42. [PMID: 27000751 DOI: 10.1016/j.ejpb.2016.03.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
453 Minordi LM, Larosa L, Belmonte G, Scaldaferri F, Poscia A, Gasbarrini A, Manfredi R. Crohn's disease activity before and after medical therapy evaluated by MaRIA score and others parameters in MR Enterography. Clin Imaging 2020;62:1-9. [PMID: 32014620 DOI: 10.1016/j.clinimag.2020.01.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
454 Lucendo AJ, Hervías D, Roncero Ó, Lorente R, Bouhmidi A, Angueira T, Verdejo C, Salueña I, González-Castillo S, Arias Á. Epidemiology and temporal trends (2000-2012) of inflammatory bowel disease in adult patients in a central region of Spain. Eur J Gastroenterol Hepatol 2014;26:1399-407. [PMID: 25341061 DOI: 10.1097/MEG.0000000000000226] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
455 Olivieri I, Cantini F, Castiglione F, Felice C, Gionchetti P, Orlando A, Salvarani C, Scarpa R, Vecchi M, Armuzzi A. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. Autoimmun Rev. 2014;13:822-830. [PMID: 24726868 DOI: 10.1016/j.autrev.2014.04.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 6.9] [Reference Citation Analysis]
456 Moran CP, Neary B, Doherty GA. Endoscopic evaluation in diagnosis and management of inflammatory bowel disease. World J Gastrointest Endosc 2016; 8(20): 723-732 [PMID: 28042386 DOI: 10.4253/wjge.v8.i20.723] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
457 Murphy KP, Healy LJ, Crush L, Twomey M, Moloney F, Sexton S, O’Connor OJ, Maher MM. Effects of oral contrast on dose in abdominopelvic computed tomography with pure iterative reconstruction. World J Radiol 2016; 8(9): 809-815 [PMID: 27721943 DOI: 10.4329/wjr.v8.i9.809] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
458 Cañete F, Mañosa M, Casanova MJ, González-sueyro RC, Barrio J, Bermejo F, Nos P, Iglesias-flores E, García-planella E, Pérez-calle JL, Vicente R, Vera M, Ramos L, Rivero M, De Francisco R, Montserrat A, Benítez O, Navarro P, Taxonera C, Hinojosa E, Márquez-mosquera L, Navarro-llavat M, Ramírez-de la Piscina P, Gomollón F, Rodríguez-alonso L, Núñez-alonso A, Fernández-salazar L, Almela P, Ríos León R, De Castro L, Gisbert JP, Ricart E, Cabré E, Domènech E; ENEIDA registry by GETECCU. Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry. Inflammatory Bowel Diseases 2019;25:1862-70. [DOI: 10.1093/ibd/izz084] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
459 Ye BD, Yang SK, Shin SJ, Lee KM, Jang BI, Cheon JH, Choi CH, Kim YH, Lee H. [Guidelines for the management of Crohn’s disease]. Korean J Gastroenterol. 2012;59:141-179. [PMID: 22387837 DOI: 10.4166/kjg.2012.59.2.141] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
460 Yamamoto T, Watanabe T. Strategies for the prevention of postoperative recurrence of Crohn's disease. Colorectal Dis. 2013;15:1471-1480. [PMID: 23809911 DOI: 10.1111/codi.12326] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
461 La Barbera D, Bonanno B, Rumeo MV, Alabastro V, Frenda M, Massihnia E, Morgante MC, Sideli L, Craxì A, Cappello M, Tumminello M, Miccichè S, Nastri L. Alexithymia and personality traits of patients with inflammatory bowel disease. Sci Rep 2017;7:41786. [PMID: 28150800 DOI: 10.1038/srep41786] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
462 Rao N, Kumar S, Taylor S, Plumb A. Diagnostic pathways in Crohn's disease. Clin Radiol 2019;74:578-91. [PMID: 31005268 DOI: 10.1016/j.crad.2019.03.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
463 Musci JO, Cornish JS, Däbritz J. Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases. J Gastroenterol 2016;51:531-47. [PMID: 26975751 DOI: 10.1007/s00535-016-1191-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
464 Hyun HK, Yu J, Kang EA, Park J, Park SJ, Park JJ, Kim TI, Kim WH, Cheon JH. Radiology plus ileocolonoscopy versus radiology alone in Crohn's disease: prognosis prediction and mutual agreement. Korean J Intern Med 2021. [PMID: 34695881 DOI: 10.3904/kjim.2021.233] [Reference Citation Analysis]
465 Ciccocioppo R, Imbesi V, Betti E, Boccaccio V, Kruzliak P, Gallia A, Cangemi GC, Maffe GC, Vanoli A, Merante S, De Amici M, Falcone C, Klersy C, Corazza GR. The Circulating Level of Soluble Receptor for Advanced Glycation End Products Displays Different Patterns in Ulcerative Colitis and Crohn's Disease: A Cross-Sectional Study. Dig Dis Sci 2015;60:2327-37. [PMID: 25757448 DOI: 10.1007/s10620-015-3619-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
466 Napolitano M, Munari AM, Di Leo G, Panarisi NAR, Zuin G, Fava G, Vecchi M, Sardanelli F, Zuccotti GV. MR enterography grading of pediatric ileocolonic Crohn disease activity based on a single bowel segment. Radiol Med 2021;126:1396-406. [PMID: 34414550 DOI: 10.1007/s11547-021-01409-w] [Reference Citation Analysis]
467 Berrill JW, Sadlier M, Hood K, Green JT. Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels. J Crohns Colitis. 2014;8:945-955. [PMID: 24529603 DOI: 10.1016/j.crohns.2014.01.018] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 7.4] [Reference Citation Analysis]
468 Parisi I, O'Beirne J, Rossi RE, Tsochatzis E, Manousou P, Theocharidou E, Hamilton M, Murray C, Epstein O, Burroughs AK. Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab. Eur J Gastroenterol Hepatol 2016;28:786-91. [PMID: 27015138 DOI: 10.1097/MEG.0000000000000624] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
469 Nomura Y, Moriichi K, Fujiya M, Okumura T. The endoscopic findings of the upper gastrointestinal tract in patients with Crohn's disease. Clin J Gastroenterol 2017;10:289-96. [PMID: 28695451 DOI: 10.1007/s12328-017-0759-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
470 Chao K, Zhang S, Yao J, He Y, Chen B, Zeng Z, Zhong B, Chen M. Imbalances of CD4(+) T-cell subgroups in Crohn's disease and their relationship with disease activity and prognosis. J Gastroenterol Hepatol. 2014;29:1808-1814. [PMID: 24720272 DOI: 10.1111/jgh.12592] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
471 Martínez-Feito A, Bravo-Gallego LY, Hernández-Breijo B, Diez J, García-Ramirez L, Jaquotot M, Plasencia-Rodríguez C, Nozal P, Mezcua A, Martín-Arranz MD, Pascual-Salcedo D. Infliximab concentrations in two non-switching cohorts of patients with inflammatory bowel disease: originator vs. biosimilar. Sci Rep 2020;10:17099. [PMID: 33051546 DOI: 10.1038/s41598-020-74235-1] [Reference Citation Analysis]
472 Lakatos PL, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Kiss LS, Lakatos L. Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: a population-based study from western Hungary 1977-2008. J Crohns Colitis. 2011;5:122-128. [PMID: 21453881 DOI: 10.1016/j.crohns.2010.11.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
473 García-Sanjuán S, Lillo-Crespo M, Richart-Martínez M, Sanjuán Quiles Á. Understanding life experiences of people affected by Crohn's disease in Spain. A phenomenological approach. Scand J Caring Sci 2018;32:354-62. [PMID: 28869658 DOI: 10.1111/scs.12469] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
474 Fujiya M, Sakatani A, Dokoshi T, Tanaka K, Ando K, Ueno N, Gotoh T, Kashima S, Tominaga M, Inaba Y. A Bamboo Joint-Like Appearance is a Characteristic Finding in the Upper Gastrointestinal Tract of Crohn’s Disease Patients: A Case-Control Study. Medicine (Baltimore). 2015;94:e1500. [PMID: 26376393 DOI: 10.1097/md.0000000000001500] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
475 Wilkens R, Novak KL, Lebeuf-Taylor E, Wilson SR. Impact of Intestinal Ultrasound on Classification and Management of Crohn's Disease Patients with Inconclusive Colonoscopy. Can J Gastroenterol Hepatol 2016;2016:8745972. [PMID: 27446873 DOI: 10.1155/2016/8745972] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
476 Borecki K, Zawada I, Pawinska-Matecka A, Salkic NN, Karakiewicz B, Adler G. ABCB1 3435C>T and 2677G>T/A polymorphisms in Polish and Bosnian patients with Crohn's disease - A preliminary report. Bosn J Basic Med Sci 2017;17:323-7. [PMID: 28759738 DOI: 10.17305/bjbms.2017.2172] [Reference Citation Analysis]
477 Włodarczyk M, Sobolewska A, Wójcik B, Loga K, Fichna J, Wiśniewska-Jarosińska M. Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients. World J Gastroenterol 2014; 20(22): 7019-7026 [PMID: 24944497 DOI: 10.3748/wjg.v20.i22.7019] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
478 Onali S, Calabrese E, Petruzziello C, Zorzi F, Sica G, Fiori R, Ascolani M, Lolli E, Condino G, Palmieri G, Simonetti G, Pallone F, Biancone L. Small intestine contrast ultrasonography vs computed tomography enteroclysis for assessing ileal Crohn's disease. World J Gastroenterol 2012; 18(42): 6088-6095 [PMID: 23155337 DOI: 10.3748/wjg.v18.i42.6088] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
479 McLaughlin PD, Murphy KP, Twomey M, OʼNeill SB, Moloney F, OʼConnor OJ, OʼRegan K, McSweeney S, McGarrigle AM, Moore N, Bye J, Shanahan F, Maher MM. Pure Iterative Reconstruction Improves Image Quality in Computed Tomography of the Abdomen and Pelvis Acquired at Substantially Reduced Radiation Doses in Patients With Active Crohn Disease. J Comput Assist Tomogr 2016;40:225-33. [PMID: 26760188 DOI: 10.1097/RCT.0000000000000358] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
480 Atreya R, Neurath MF. From bench to bedside: molecular imaging in inflammatory bowel diseases. Current Opinion in Gastroenterology 2016;32:245-50. [DOI: 10.1097/mog.0000000000000279] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
481 Rispo A, Testa A, De Palma GD, Donetto S, Diaferia M, Musto D, Nardone O, Maione F, Caporaso N, Castiglione F. Different Profile of Efficacy of Thiopurines in Ulcerative Colitis and Crohn’s Disease. Inflamm Bowel Dis. 2015;21:2570-2575. [PMID: 26222340 DOI: 10.1097/mib.0000000000000538] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
482 Lakatos PL, Vegh Z, Lovasz BD, David G, Pandur T, Erdelyi Z, Szita I, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics PA, Mandel M, Horvath A, Szathmari M, Kiss LS, Lakatos L. Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort. Inflamm Bowel Dis 2013;19:1010-7. [PMID: 23399739 DOI: 10.1097/MIB.0b013e3182802b3e] [Cited by in Crossref: 53] [Cited by in F6Publishing: 24] [Article Influence: 5.9] [Reference Citation Analysis]
483 Timerbulatov MV, Grishina EE, Aitova LR, Senderovich EI, Ziganshin TM. [The Capsule Endoscopy Crohn's Disease Activity Index, clinical activity and fecal calprotectin level in patients with isolated small intestine lesions]. Khirurgiia (Mosk) 2021;:63-70. [PMID: 34480457 DOI: 10.17116/hirurgia202109163] [Reference Citation Analysis]
484 Hahnemann ML, Nensa F, Kinner S, Köhler J, Gerken G, Umutlu L, Lauenstein TC. Quantitative assessment of small bowel motility in patients with Crohn‘s disease using dynamic MRI. Neurogastroenterol Motil. 2015;27:841-848. [PMID: 25808321 DOI: 10.1111/nmo.12558] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
485 Cullen G, Donnellan F, Doherty GA, Smith M, Cheifetz AS. Evaluation of the small bowel in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2013;7:239-251. [PMID: 23445233 DOI: 10.1586/egh.13.11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
486 Zhou Y, Chen H, He H, Du Y, Hu J, Li Y, Li Y, Zhou Y, Wang H, Chen Y, Nie Y. Increased Enterococcus faecalis infection is associated with clinically active Crohn disease. Medicine (Baltimore) 2016;95:e5019. [PMID: 27684872 DOI: 10.1097/MD.0000000000005019] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
487 Yadav DP, Kedia S, Madhusudhan KS, Bopanna S, Goyal S, Jain S, Vikram NK, Sharma R, Makharia GK, Ahuja V. Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration.Can J Gastroenterol Hepatol. 2017;2017:1215035. [PMID: 29226115 DOI: 10.1155/2017/1215035] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
488 Andreu-Ballester JC, Catalán-Serra I, Gil-Borrás R, Marqués-García P, García-Ballesteros C, López Chuliá F, Cuéllar C. Gammadelta T cells as a predictor of surgical relapse of Crohn's disease. Clin Res Hepatol Gastroenterol 2020;44:586-97. [PMID: 31864955 DOI: 10.1016/j.clinre.2019.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
489 Park JJ, Yang SK, Ye BD, Kim JW, Park DI, Yoon H, Im JP, Lee KM, Yoon SN, Lee H; IBD Study Group of the Korean Association for the Study of Intestinal Diseases. Second Korean guidelines for the management of Crohn's disease. Intest Res 2017;15:38-67. [PMID: 28239314 DOI: 10.5217/ir.2017.15.1.38] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
490 Jesuratnam-Nielsen K, Løgager VB, Munkholm P, Thomsen HS. Diagnostic accuracy of three different MRI protocols in patients with inflammatory bowel disease. Acta Radiol Open 2015;4:2058460115588099. [PMID: 26097746 DOI: 10.1177/2058460115588099] [Reference Citation Analysis]
491 Altomare A, Putignani L, Del Chierico F, Cocca S, Angeletti S, Ciccozzi M, Tripiciano C, Dalla Piccola B, Cicala M, Guarino MPL. Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota. Digestive and Liver Disease 2019;51:648-56. [DOI: 10.1016/j.dld.2018.11.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
492 Orlando A, Renna S, Mocciaro F, Cappello M, Giunta M, Mendolaro M, Mazza M, Rizzuto G, Orlando E, Affronti M, Dimarco M, Di Mitri R, Craxì A, Cottone M. Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study. Digestive and Liver Disease 2016;48:1314-7. [DOI: 10.1016/j.dld.2016.07.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
493 Gasparetto M, Zilbauer M. Paediatric Inflammatory Bowel Diseases – brief update on current practice and future perspectives. Paediatrics and Child Health 2014;24:501-5. [DOI: 10.1016/j.paed.2014.04.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
494 Sipponen T, Haapamäki J, Savilahti E, Alfthan H, Hämäläinen E, Rautiainen H, Koskenpato J, Nuutinen H, Färkkilä M. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn’s disease detected by wireless capsule endoscopy. Scand J Gastroenterol. 2012;47:778-784. [PMID: 22519419 DOI: 10.3109/00365521.2012.677953] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
495 Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, Kolho KL, Veres G, Russell RK, Paerregaard A, Buderus S, Greer ML, Dias JA, Veereman-Wauters G, Lionetti P, Sladek M, Martin de Carpi J, Staiano A, Ruemmele FM, Wilson DC;  European Society of Pediatric Gastroenterology; Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795-806. [PMID: 24231644 DOI: 10.1097/mpg.0000000000000239] [Cited by in Crossref: 306] [Cited by in F6Publishing: 195] [Article Influence: 43.7] [Reference Citation Analysis]
496 Kim M, Jang HJ. The role of small bowel endoscopy in small bowel Crohn's disease: when and how? Intest Res 2016;14:211-7. [PMID: 27433142 DOI: 10.5217/ir.2016.14.3.211] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
497 Casciani E, Masselli G, Di Nardo G, Polettini E, Bertini L, Oliva S, Floriani I, Cucchiara S, Gualdi G. MR enterography versus capsule endoscopy in paediatric patients with suspected Crohn's disease. Eur Radiol 2011;21:823-31. [PMID: 20922391 DOI: 10.1007/s00330-010-1976-3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
498 Bengi G, Keyvan H, Durmaz SB, Akpınar H. Frequency, types, and treatment of anemia in Turkish patients with inflammatory bowel disease. World J Gastroenterol 2018; 24(36): 4186-4196 [PMID: 30271083 DOI: 10.3748/wjg.v24.i36.4186] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
499 Casciani E, Vincentiis CD, Polettini E, Masselli G, Nardo GD, Civitelli F, Cucchiara S, Gualdi GF. Imaging of the small bowel: Crohn’s disease in paediatric patients. World J Radiol 2014; 6(6): 313-328 [PMID: 24976933 DOI: 10.4329/wjr.v6.i6.313] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
500 Bryant RV, Brain O, Travis SP. Conventional drug therapy for inflammatory bowel disease. Scand J Gastroenterol. 2015;50:90-112. [PMID: 25523560 DOI: 10.3109/00365521.2014.968864] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
501 Ciccacci C, Biancone L, Di Fusco D, Ranieri M, Condino G, Giardina E, Onali S, Lepre T, Pallone F, Novelli G, Borgiani P. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2013;7:44-52. [DOI: 10.1016/j.crohns.2012.02.020] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 4.2] [Reference Citation Analysis]
502 Hashiguchi K, Takeshima F, Akazawa Y, Matsushima K, Minami H, Yamaguchi N, Shiozawa K, Ohnita K, Ichikawa T, Isomoto H. Bamboo joint-like appearance of the stomach: a stable endoscopic landmark for Crohn’s disease regardless of anti-tumor necrosis factor alpha treatment. Med Sci Monit. 2014;20:1918-1924. [PMID: 25308423 DOI: 10.12659/msm.891060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
503 Collins PD. Video capsule endoscopy in inflammatory bowel disease. World J Gastrointest Endosc 2016; 8(14): 477-488 [PMID: 27499830 DOI: 10.4253/wjge.v8.i14.477] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
504 Jess T, Lopez A, Andersson M, Beaugerie L, Peyrin-Biroulet L. Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis. Clin Gastroenterol Hepatol. 2014;12:1793-1800.e1. [PMID: 24907505 DOI: 10.1016/j.cgh.2014.05.019] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
505 Chu Y, Wu S, Qian Y, Wang Q, Li J, Tang Y, Bai T, Wang L. Complimentary Imaging Modalities for Investigating Obscure Gastrointestinal Bleeding: Capsule Endoscopy, Double-Balloon Enteroscopy, and Computed Tomographic Enterography. Gastroenterol Res Pract. 2016;2016:8367519. [PMID: 26858753 DOI: 10.1155/2016/8367519] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
506 Allen JI. Gastroenterologists and the Triple Aim: How to Become Accountable. Gastrointestinal Endoscopy Clinics of North America 2012;22:85-96. [DOI: 10.1016/j.giec.2011.08.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
507 Kovacs M, Papp M, Lakatos PL, Jacobsen S, Nemes E, Polgar M, Solyom E, Bodi P, Horvath A, Molnar K, Szabo D, Cseh A, Muller KE, Dezsofi A, Arato A, Veres G. Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease. J Crohns Colitis 2013;7:134-41. [PMID: 22504031 DOI: 10.1016/j.crohns.2012.03.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
508 Tang MT, Keir ME, Erickson R, Stefanich EG, Fuh FK, Ramirez-Montagut T, McBride JM, Danilenko DM. Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-β7 integrin therapy for inflammatory bowel disease. Aliment Pharmacol Ther 2018;47:1440-52. [PMID: 29601644 DOI: 10.1111/apt.14631] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
509 Dai C, Jiang M, Sun MJ, Cao Q. Fecal Lactoferrin for Assessment of Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2019;. [PMID: 30994521 DOI: 10.1097/mcg.0000000000001212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
510 Lolli E, Saraceno R, Calabrese E, Ascolani M, Scarozza P, Chiricozzi A, Onali S, Petruzziello C, Chimenti S, Pallone F, Biancone L. Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study. J Crohns Colitis 2015;9:699-707. [PMID: 25908719 DOI: 10.1093/ecco-jcc/jjv068] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
511 Lucendo AJ, Roncero Ó, Serrano-duenas MT, Hervías D, Alcázar LM, Miriam-ruiz-ponce, Verdejo C, Laserna-mendieta E, Lorente R, Arias Á. Effects of anti–TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease. Digestive and Liver Disease 2020;52:400-7. [DOI: 10.1016/j.dld.2019.11.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
512 Fiorino G, Bonifacio C, Malesci A, Balzarini L, Danese S. MRI in Crohn’s disease--current and future clinical applications. Nat Rev Gastroenterol Hepatol. 2012;9:23-31. [PMID: 22105109 DOI: 10.1038/nrgastro.2011.2142] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
513 Lucendo AJ, Guagnozzi D. Small bowel video capsule endoscopy in Crohn’s disease: What have we learned in the last ten years? World J Gastrointest Endosc 2011; 3(2): 23-29 [PMID: 21403813 DOI: 10.4253/wjge.v3.i2.23] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
514 Freitas TH, Andreoulakis E, Alves GS, Miranda HL, Braga LL, Hyphantis T, Carvalho AF. Associations of sense of coherence with psychological distress and quality of life in inflammatory bowel disease. World J Gastroenterol 2015; 21(21): 6713-6727 [PMID: 26074710 DOI: 10.3748/wjg.v21.i21.6713] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
515 Sciaudone G, Pellino G, Guadagni I, Somma A, D'armiento FP, Selvaggi F. Disseminated Cryptococcus neoformans infection and Crohn's disease in an immunocompetent patient. Journal of Crohn's and Colitis 2011;5:60-3. [DOI: 10.1016/j.crohns.2010.08.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
516 Kim SY, Mun EC, Chung J, Ha M, Ahn S, Han M, Han S, Yun S, Kim JH, Kim KO, Kim YJ, Kwon KA, Park DK. Increased genomic damage and vitamin B status in inflammatory bowel disease patients: A case-control, prospective, pilot study. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2019;837:42-7. [DOI: 10.1016/j.mrgentox.2018.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
517 Monteleone G, Di Sabatino A, Ardizzone S, Pallone F, Usiskin K, Zhan X, Rossiter G, Neurath MF. Impact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn’s disease. Aliment Pharmacol Ther. 2016;43:717-724. [PMID: 26766141 DOI: 10.1111/apt.13526] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
518 Papadia C, Maffei E, Del Rio P, Taylor S, Caini S, Montana C, Coruzzi A, Franzè A, Cademartiri F, Forbes A. Sensitivity and specificity of magnetic resonance enterography in the clinical management of fistulizing Crohn’s disease. Inflamm Bowel Dis. 2013;19:1896-1903. [PMID: 23759996 DOI: 10.1097/mib.0b013e31828f19a5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
519 Ferrante M, Karmiris K, Newnham E, Siffledeen J, Zelinkova Z, van Assche G, Lakatos PL, Panés J, Sturm A, Travis S, van der Woude CJ, Reinisch W, Colombel J, Panaccione R. Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: Results from an international survey and discussion programme. Journal of Crohn's and Colitis 2012;6:116-31. [DOI: 10.1016/j.crohns.2011.09.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
520 Tontini GE, Pastorelli L, Spina L, Fabris F, Bruni B, Clemente C, de Nucci G, Cavallaro F, Marconi S, Neurath MF. Microscopic colitis and colorectal neoplastic lesion rate in chronic nonbloody diarrhea: a prospective, multicenter study. Inflamm Bowel Dis. 2014;20:882-891. [PMID: 24681653 DOI: 10.1097/mib.0000000000000030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
521 Chen SQ, Song YQ, Wang C, Tao S, Yu FY, Lou HY, Hu FQ, Yuan H. Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis. Carbohydr Polym 2020;230:115613. [PMID: 31887935 DOI: 10.1016/j.carbpol.2019.115613] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
522 Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther. 2012;36:503-516. [PMID: 22827693 DOI: 10.1111/j.1365-2036.2012.05220.x] [Cited by in Crossref: 207] [Cited by in F6Publishing: 191] [Article Influence: 20.7] [Reference Citation Analysis]
523 Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E, Yimam KK, Milkiewicz P, Beuers U, Huynh DK, Pares A, Manser CN, Dalekos GN, Eksteen B, Invernizzi P, Berg CP, Kirchner GI, Sarrazin C, Zimmer V, Fabris L, Braun F, Marzioni M, Juran BD, Said K, Rupp C, Jokelainen K, Benito de Valle M, Saffioti F, Cheung A, Trauner M, Schramm C, Chapman RW, Karlsen TH, Schrumpf E, Strassburg CP, Manns MP, Lindor KD, Hirschfield GM, Hansen BE, Boberg KM; International PSC Study Group. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. Gastroenterology 2017;152:1975-1984.e8. [PMID: 28274849 DOI: 10.1053/j.gastro.2017.02.038] [Cited by in Crossref: 180] [Cited by in F6Publishing: 159] [Article Influence: 36.0] [Reference Citation Analysis]
524 Khoshnevisan R, Vakili F, Klein C, Kotlarz D, Nasirian M, Sherkat R, Rezaei A. An analysis and survey of interleukin-10 receptor mutation in inflammatory bowel disease (IBD) in the first Iranian IBD cohort. Journal of Laboratory Medicine 2019;43:185-9. [DOI: 10.1515/labmed-2019-0005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
525 Alvarez Beltran M, Barber Martinez de la Torre I, Segarra Cantón O, Redecillas Ferreiro S, Castellote Alonso A, Infante Pina D. [MRI enterography in the assessment of paediatric Crohn's disease]. An Pediatr (Barc) 2013;78:314-20. [PMID: 23021590 DOI: 10.1016/j.anpedi.2012.06.008] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
526 Hart AL, Ng SC. Crohn's disease. Medicine 2015;43:282-90. [DOI: 10.1016/j.mpmed.2015.02.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
527 Yamamoto T. Diagnosis and monitoring of postoperative recurrence in Crohn’s disease. Expert Review of Gastroenterology & Hepatology 2014;9:55-66. [DOI: 10.1586/17474124.2014.940318] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
528 Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, Villanacci V, Becheanu G, Borralho Nunes P, Cathomas G, Fries W, Jouret-Mourin A, Mescoli C, de Petris G, Rubio CA, Shepherd NA, Vieth M, Eliakim R; European Society of Pathology (ESP); European Crohn's and Colitis Organisation (ECCO). European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7:827-851. [PMID: 23870728 DOI: 10.1016/j.crohns.2013.06.001] [Cited by in Crossref: 336] [Cited by in F6Publishing: 273] [Article Influence: 37.3] [Reference Citation Analysis]
529 Tharian B, George N, Navaneethan U. Endoscopy in the Diagnosis and Management of Complications of Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2016;22:1184-97. [DOI: 10.1097/mib.0000000000000626] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
530 Amezaga AJ, Van Assche G. Practical Approaches to "Top-Down" Therapies for Crohn's Disease. Curr Gastroenterol Rep 2016;18:35. [PMID: 27184044 DOI: 10.1007/s11894-016-0507-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
531 Aryan A, Azizi Z, Teimouri A, Ebrahimi Daryani N, Aletaha N, Jahanbakhsh A, Nouritaromlou MK, Alborzi F, Mami M, Basirat V, Javid Anbardan S. The Diagnostic Role of Magnetic Resonance Enterography as a Complementary Test to Colonoscopy in Active Crohn's Disease. Middle East J Dig Dis 2016;8:93-101. [PMID: 27252815 DOI: 10.15171/mejdd.2016.13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
532 Balaban DV, Popp A, Lungu AM, Costache RS, Anca IA, Jinga M. Ratio of spleen diameter to red blood cell distribution width: a novel indicator for celiac disease. Medicine (Baltimore) 2015;94:e726. [PMID: 25881851 DOI: 10.1097/MD.0000000000000726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
533 Mhanna M, Gharaibeh MG, Rashid M, Sharab A, Shehab M, Zihlif M. TPMT Genotype and Adverse Effects of Azathioprine among Jordanian Group. Curr Drug Metab 2019;20:889-97. [PMID: 31631819 DOI: 10.2174/1389200220666191021100953] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
534 Sánchez-Montes C, Ortiz V, Bastida G, Rodríguez E, Yago M, Beltrán B, Aguas M, Iborra M, Garrigues V, Ponce J, Nos P. Small intestinal bacterial overgrowth in inactive Crohn’s disease: Influence of thiopurine and biological treatment. World J Gastroenterol 2014; 20(38): 13999-14003 [PMID: 25320539 DOI: 10.3748/wjg.v20.i38.13999] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
535 Hale MF, Drew K, McAlindon ME, Sidhu R. The diagnostic accuracy of faecal calprotectin and small bowel capsule endoscopy and their correlation in suspected isolated small bowel Crohn's disease. Eur J Gastroenterol Hepatol 2016;28:1145-50. [PMID: 27384306 DOI: 10.1097/MEG.0000000000000696] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
536 De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Gibson PR, Sparrow M, Leong RW, Florin TH, Gearry RB, Radford-Smith G, Macrae FA, Debinski H, Selby W, Kronborg I, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Desmond PV. Crohn's disease management after intestinal resection: a randomised trial. Lancet. 2015;385:1406-1417. [PMID: 25542620 DOI: 10.1016/s0140-6736(14)61908-5] [Cited by in Crossref: 306] [Cited by in F6Publishing: 89] [Article Influence: 38.3] [Reference Citation Analysis]
537 Van Gossum A, Ibrahim M. Video capsule endoscopy: what is the future? Gastroenterol Clin North Am. 2010;39:807-826. [PMID: 21093757 DOI: 10.1016/j.gtc.2010.08.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
538 Tharian B, Caddy G, Tham TC. Enteroscopy in small bowel Crohn’s disease: A review. World J Gastrointest Endosc 2013; 5(10): 476-486 [PMID: 24147191 DOI: 10.4253/wjge.v5.i10.476] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
539 Li H, Mo Y, Huang C, Ren Q, Xia X, Nan X, Shuai X, Meng X. An MSCT-based radiomics nomogram combined with clinical factors can identify Crohn's disease and ulcerative colitis. Ann Transl Med 2021;9:572. [PMID: 33987270 DOI: 10.21037/atm-21-1023] [Reference Citation Analysis]
540 Papay P, Primas C, Eser A, Novacek G, Winkler S, Frantal S, Angelberger S, Mikulits A, Dejaco C, Kazemi-shirazi L, Vogelsang H, Reinisch W. Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors. Aliment Pharmacol Ther 2012;36:858-65. [DOI: 10.1111/apt.12037] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
541 Panes J, Jairath V, Levesque BG. Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases. Gastroenterology. 2017;152:362-373.e3. [PMID: 27751880 DOI: 10.1053/j.gastro.2016.10.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
542 Blackwell J, Alexakis C, Saxena S, Creese H, Bottle A, Petersen I, Hotopf M, Pollok RCG. Association between antidepressant medication use and steroid dependency in patients with ulcerative colitis: a population-based study. BMJ Open Gastroenterol 2021;8:e000588. [PMID: 34045238 DOI: 10.1136/bmjgast-2020-000588] [Reference Citation Analysis]
543 Hiroz P, Vavricka SR, Fournier N, Safroneeva E, Pittet V, Rogler G, Schoepfer AM; on behalf of the Swiss Inflammatory Bowel Diseases Cohort Study Group*. Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort. Scandinavian Journal of Gastroenterology 2014;49:1207-18. [DOI: 10.3109/00365521.2014.946082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
544 Fabisiak N, Fabisiak A, Watala C, Fichna J. Fat-soluble Vitamin Deficiencies and Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2017;51:878-889. [PMID: 28858940 DOI: 10.1097/mcg.0000000000000911] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
545 Ognibene NM, Basile M, Di Maurizio M, Petrillo G, De Filippi C. Features and perspectives of MR enterography for pediatric Crohn disease assessment. Radiol Med 2016;121:362-77. [PMID: 26838591 DOI: 10.1007/s11547-015-0613-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
546 M’Koma AE. Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. World J Gastrointest Surg 2014; 6(11): 208-219 [PMID: 25429322 DOI: 10.4240/wjgs.v6.i11.208] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
547 Fernández-clotet A, Castro-poceiro J, Panés J. JAK Inhibition: The Most Promising Agents in the IBD Pipeline? CPD 2019;25:32-40. [DOI: 10.2174/1381612825666190405141410] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
548 Araki T, Okita Y, Kondo S, Hiro J, Toiyama Y, Inoue M, Ohi M, Inoue Y, Uchida K, Mohri Y, Kusunoki M. Risk factors for recurrence of Crohn's disease requiring surgery in patients receiving post-operative anti-tumor necrosis factor maintenance therapy. J Anus Rectum Colon 2017;1:15-21. [PMID: 31583295 DOI: 10.23922/jarc.2016-004] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
549 Latella G, Caprilli R, Travis S. In favour of early surgery in Crohn's disease: a hypothesis to be tested. J Crohns Colitis. 2011;5:1-4. [PMID: 21272796 DOI: 10.1016/j.crohns.2010.11.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
550 Jakobsson GL, Sternegård E, Olén O, Myrelid P, Ljung R, Strid H, Halfvarson J, Ludvigsson JF. Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG). Scand J Gastroenterol 2017;52:216-21. [PMID: 27797278 DOI: 10.1080/00365521.2016.1246605] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 12.7] [Reference Citation Analysis]
551 Larsson G, Shenoy T, Ramasubramanian R, Balakumaran LK, Småstuen MC, Bjune GA, Moum BA. Routine diagnosis of intestinal tuberculosis and Crohn's disease in Southern India. World J Gastroenterol 2014; 20(17): 5017-5024 [PMID: 24803814 DOI: 10.3748/wjg.v20.i17.5017] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
552 Murphy KP, Mclaughlin PD, O’connor OJ, Maher MM. Imaging the small bowel: . Current Opinion in Gastroenterology 2014;30:134-40. [DOI: 10.1097/mog.0000000000000038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 2.1] [Reference Citation Analysis]
553 Coutzac C, Chapuis J, Poullenot F, Chabrun E, Capdepont M, Blanco P, Laharie D. Association Between Infliximab Trough Levels and the Occurrence of Paradoxical Manifestations in Patients with Inflammatory Bowel Disease: a Case-Control Study. J Crohns Colitis 2015;9:982-7. [PMID: 26351388 DOI: 10.1093/ecco-jcc/jjv159] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
554 Guo Z, Wu R, Zhu W, Gong J, Zhang W, Li Y, Gu L, Li N, Li J. Effect of exclusive enteral nutrition on health-related quality of life for adults with active Crohn’s disease. Nutr Clin Pract. 2013;28:499-505. [PMID: 23851180 DOI: 10.1177/0884533613487218] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
555 Ahmed O, Rodrigues DM, Nguyen GC. Magnetic Resonance Imaging of the Small Bowel in Crohn's Disease: A Systematic Review and Meta-Analysis. Can J Gastroenterol Hepatol 2016;2016:7857352. [PMID: 27446869 DOI: 10.1155/2016/7857352] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
556 Kiss LS, Papp M, Lovasz BD, Vegh Z, Golovics PA, Janka E, Varga E, Szathmari M, Lakatos PL. High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: a marker for patient classification? Inflamm Bowel Dis. 2012;18:1647-1654. [PMID: 22081542 DOI: 10.1002/ibd.21933] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 4.9] [Reference Citation Analysis]
557 Walker DG, Williams HR, Kane SP, Mawdsley JE, Arnold J, McNeil I, Thomas HJ, Teare JP, Hart AL, Pitcher MC, Walters JR, Marshall SE, Orchard TR. Differences in inflammatory bowel disease phenotype between South Asians and Northern Europeans living in North West London, UK. Am J Gastroenterol. 2011;106:1281-1289. [PMID: 21577243 DOI: 10.1038/ajg.2011.85] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
558 van Beers JJBC, Vanderlocht J, Roozendaal C, Damoiseaux J. Detection of Anti-neutrophil Cytoplasmic Antibodies (ANCA) by Indirect Immunofluorescence. In: Houen G, editor. Autoantibodies. New York: Springer; 2019. pp. 47-62. [DOI: 10.1007/978-1-4939-8949-2_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
559 Lomer MCE, Gourgey R, Whelan K. Current practice in relation to nutritional assessment and dietary management of enteral nutrition in adults with Crohn's disease. J Hum Nutr Diet 2014;27:28-35. [DOI: 10.1111/jhn.12133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
560 Lovasz BD, Lakatos L, Horvath A, Pandur T, Erdelyi Z, Balogh M, Szipocs I, Vegh Z, Veres G, Müller KE, Golovics PA, Kiss LS, Mandel MD, Lakatos PL. Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011. Dig Liver Dis 2014;46:405-11. [PMID: 24495511 DOI: 10.1016/j.dld.2013.12.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
561 Viganò C, Calzolari R, Marinaccio PM, Bezzio C, Furfaro F, Ba G, Maconi G. Unrevealed Depression Involves Dysfunctional Coping Strategies in Crohn's Disease Patients in Clinical Remission. Gastroenterol Res Pract 2016;2016:7803262. [PMID: 26823663 DOI: 10.1155/2016/7803262] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
562 López-Sanromán A, Vera-Mendoza I, Domènech E, Taxonera C, Vega Ruiz V, Marín-Jiménez I, Guardiola J, Castro L, Esteve M, Iglesias E, Ceballos D, Martínez-Montiel P, Gisbert JP, Mínguez M, Echarri A, Calvet X, Barrio J, Hinojosa J, Martín-Arranz MD, Márquez-Mosquera L, Bermejo F, Rimola J, Pons V, Nos P; Spanish GETECCU group [APPRECIA study]. Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial. J Crohns Colitis 2017;11:1293-301. [PMID: 28402454 DOI: 10.1093/ecco-jcc/jjx051] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]
563 Goran L, Negreanu AM, Stemate A, Negreanu L. Capsule endoscopy: Current status and role in Crohn’s disease. World J Gastrointest Endosc 2018; 10(9): 184-192 [PMID: 30283601 DOI: 10.4253/wjge.v10.i9.184] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
564 Nakase H, Uchino M, Shinzaki S, Matsuura M, Matsuoka K, Kobayashi T, Saruta M, Hirai F, Hata K, Hiraoka S, Esaki M, Sugimoto K, Fuji T, Watanabe K, Nakamura S, Inoue N, Itoh T, Naganuma M, Hisamatsu T, Watanabe M, Miwa H, Enomoto N, Shimosegawa T, Koike K. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol 2021;56:489-526. [PMID: 33885977 DOI: 10.1007/s00535-021-01784-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
565 Tew GA, Leighton D, Carpenter R, Anderson S, Langmead L, Ramage J, Faulkner J, Coleman E, Fairhurst C, Seed M, Bottoms L. High-intensity interval training and moderate-intensity continuous training in adults with Crohn's disease: a pilot randomised controlled trial. BMC Gastroenterol 2019;19:19. [PMID: 30696423 DOI: 10.1186/s12876-019-0936-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
566 Sarid O, Slonim-Nevo V, Pereg A, Friger M, Sergienko R, Schwartz D, Greenberg D, Shahar I, Chernin E, Vardi H, Eidelman L, Segal A, Ben-Yakov G, Gaspar N, Munteanu D, Rozental A, Mushkalo A, Dizengof V, Abu-Freha N, Fich A, Odes S; Israeli IBD Research Nucleus (IIRN). Coping strategies, satisfaction with life, and quality of life in Crohn's disease: A gender perspective using structural equation modeling analysis. PLoS One 2017;12:e0172779. [PMID: 28245260 DOI: 10.1371/journal.pone.0172779] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
567 Burri E, Manz M, Rothen C, Rossi L, Beglinger C, Lehmann FS. Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort. Clin Chim Acta. 2013;416:41-47. [PMID: 23178549 DOI: 10.1016/j.cca.2012.11.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
568 Smids C, Horjus Talabur Horje CS, Groenen MJM, van Koolwijk EHM, Wahab PJ, van Lochem EG. The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient. Scand J Gastroenterol. 2017;52:1104-1112. [PMID: 28661185 DOI: 10.1080/00365521.2017.1344875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
569 O'connor M, Bager P, Duncan J, Gaarenstroom J, Younge L, Détré P, Bredin F, Dibley L, Dignass A, Gallego Barrero M, Greveson K, Hamzawi M, Ipenburg N, Keegan D, Martinato M, Murciano Gonzalo F, Pino Donnay S, Price T, Ramirez Morros A, Verwey M, White L, van de Woude C. N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis. Journal of Crohn's and Colitis 2013;7:744-64. [DOI: 10.1016/j.crohns.2013.06.004] [Cited by in Crossref: 63] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
570 Zhang F, Xu C, Ning L, Hu F, Shan G, Chen H, Yang M, Chen W, Yu J, Xu G. Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis. PLoS One 2016;11:e0167109. [PMID: 27997555 DOI: 10.1371/journal.pone.0167109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
571 Roushan N, Ebrahimi Daryani N, Azizi Z, Pournaghshband H, Niksirat A. Differentiation of Crohn's disease and ulcerative colitis using intestinal wall thickness of the colon: A Diagnostic accuracy study of endoscopic ultrasonography. Med J Islam Repub Iran 2019;33:57. [PMID: 31456981 DOI: 10.34171/mjiri.33.57] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
572 Suzuki S, Takai-Igarashi T, Fukuoka Y, Wall DP, Tanaka H, Tonellato PJ. Systems analysis of inflammatory bowel disease based on comprehensive gene information. BMC Med Genet 2012;13:25. [PMID: 22480395 DOI: 10.1186/1471-2350-13-25] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
573 Ishida N, Miyazu T, Suzuki T, Tamura S, Tani S, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Furuta T, Sugimoto K. Evaluation of the modified Crohn's disease activity index in patients with Crohn disease with enterostomy: A single-center observational study. Medicine (Baltimore) 2021;100:e24717. [PMID: 33578614 DOI: 10.1097/MD.0000000000024717] [Reference Citation Analysis]
574 Park SK, Yang SK, Park SH, Park SH, Kim JW, Yang DH, Jung KW, Kim KJ, Ye BD, Byeon JS. Long-term prognosis of the jejunal involvement of Crohn’s disease. J Clin Gastroenterol. 2013;47:400-408. [PMID: 23269310 DOI: 10.1097/mcg.0b013e3182705f9e] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
575 Rispo A, Imperatore N, Testa A, Mainenti P, De Palma GD, Luglio G, Maurea S, Nardone OM, Caporaso N, Castiglione F. Bowel Damage in Crohnʼs Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index. Inflammatory Bowel Diseases 2017;23:143-51. [DOI: 10.1097/mib.0000000000000980] [Cited by in Crossref: 27] [Cited by in F6Publishing: 5] [Article Influence: 5.4] [Reference Citation Analysis]
576 Fiorino G, Manetti N, Armuzzi A, Orlando A, Variola A, Bonovas S, Bossa F, Maconi G, DʼIncà R, Lionetti P, Cantoro L, Fries W, Annunziata ML, Costa F, Terpin MM, Biancone L, Cortelezzi CC, Amato A, Ardizzone S, Danese S, Guidi L, Rizzuto G, Massella A, Andriulli A, Massari A, Lorenzon G, Ghione S, Kohn A, Ventra A, Annese V; PROSIT-BIO Cohort. The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar. Inflamm Bowel Dis 2017;23:233-43. [PMID: 28092307 DOI: 10.1097/MIB.0000000000000995] [Cited by in Crossref: 96] [Cited by in F6Publishing: 28] [Article Influence: 24.0] [Reference Citation Analysis]
577 Chen XL, Deng J, Chen X, Wan SS, Wang Y, Cao Q. High incidence and morbidity of Clostridium difficile infection among hospitalized patients with inflammatory bowel disease: A prospective observational cohort study. J Dig Dis 2019;20:460-6. [DOI: 10.1111/1751-2980.12798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
578 Roda G, Dal Buono A, Argollo M, Danese S. JAK selectivity: more precision less troubles. Expert Rev Gastroenterol Hepatol 2020;14:789-96. [PMID: 32520647 DOI: 10.1080/17474124.2020.1780120] [Reference Citation Analysis]
579 Sobolewska A, Włodarczyk M, Stec-Michalska K, Fichna J, Wiśniewska-Jarosińska M. Mean Platelet Volume in Crohn's Disease Patients Predicts Sustained Response to a 52-Week Infliximab Therapy: A Pilot Study. Dig Dis Sci. 2016;61:542-549. [PMID: 26441277 DOI: 10.1007/s10620-015-3894-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
580 Tontini GE, Vecchi M, Pastorelli L, Neurath MF, Neumann H. Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives. World J Gastroenterol 2015; 21(1): 21-46 [PMID: 25574078 DOI: 10.3748/wjg.v21.i1.21] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 76] [Article Influence: 13.0] [Reference Citation Analysis]
581 Desmond AN, O'Regan K, Malik N, McWilliams S, O'Neill S, Quigley EM, Shanahan F, Maher MM. Selection of symptomatic patients with Crohn's disease for abdominopelvic computed tomography: role of serum C-reactive protein. Can Assoc Radiol J 2012;63:267-74. [PMID: 22421709 DOI: 10.1016/j.carj.2011.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
582 Flamant M, Roblin X. Inflammatory bowel disease: towards a personalized medicine. Therap Adv Gastroenterol 2018;11:1756283X17745029. [PMID: 29383027 DOI: 10.1177/1756283X17745029] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
583 Lang G, Schmiegel W, Nicolas V, Brechmann T. Impact of Small Bowel MRI in Routine Clinical Practice on Staging of Crohn's Disease. ECCOJC 2015;9:784-94. [DOI: 10.1093/ecco-jcc/jjv106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
584 Kovacs M, Muller KE, Arato A, Lakatos PL, Kovacs JB, Varkonyi A, Solyom E, Polgar M, Nemes E, Guthy I. Diagnostic yield of upper endoscopy in paediatric patients with Crohn’s disease and ulcerative colitis. Subanalysis of the HUPIR registry. J Crohns Colitis. 2012;6:86-94. [PMID: 22261532 DOI: 10.1016/j.crohns.2011.07.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
585 Lomer MC. Dietary and nutritional considerations for inflammatory bowel disease. Proc Nutr Soc. 2011;70:329-335. [PMID: 21450124 DOI: 10.1017/s0029665111000097] [Cited by in Crossref: 48] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
586 Gerçeker E, Yüceyar H, Kasap E, Demirci U, Ekti BC, Aydoğdu İ, Miskioğlu M. Treatment of inflammatory bowel disease by leukocytapheresis. Transfus Apher Sci 2017;56:421-6. [PMID: 28454883 DOI: 10.1016/j.transci.2017.03.016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
587 Prezzi D, Bhatnagar G, Vega R, Makanyanga J, Halligan S, Taylor SA. Monitoring Crohn's disease during anti-TNF-α therapy: validation of the magnetic resonance enterography global score (MEGS) against a combined clinical reference standard. Eur Radiol 2016;26:2107-17. [PMID: 26433956 DOI: 10.1007/s00330-015-4036-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
588 Wenzl HH. Diarrhea in chronic inflammatory bowel diseases. Gastroenterol Clin North Am 2012;41:651-75. [PMID: 22917170 DOI: 10.1016/j.gtc.2012.06.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
589 Saygili F, Saygili SM, Tenlik I, Yuksel M, Kilic ZM, Ozin YO, Kayacetin E. Crohn's disease in the elderly: Clinical presentation and manifestations from a tertiary referral center in Turkey. North Clin Istanb 2016;3:183-6. [PMID: 28275749 DOI: 10.14744/nci.2016.35582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
590 Savić Mlakar A, Hojsak I, Jergović M, Vojvoda Parčina V, Babić Ž, Troskot B, Mihaljević Ž, Bendelja K. Comparison of Cytokine and Efflux Transporter Expression in Pediatric Versus Adult-onset Ulcerative Colitis. J Pediatr Gastroenterol Nutr 2017;64:943-8. [PMID: 27622899 DOI: 10.1097/MPG.0000000000001403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
591 Nijhuis A, Biancheri P, Lewis A, Bishop CL, Giuffrida P, Chan C, Feakins R, Poulsom R, Di Sabatino A, Corazza GR. In Crohn’s disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts. Clin Sci (Lond). 2014;127:341-350. [PMID: 24641356 DOI: 10.1042/cs20140048] [Cited by in Crossref: 54] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
592 Jensen MD, Andersen RF, Christensen H, Nathan T, Kjeldsen J, Madsen JS. Circulating microRNAs as biomarkers of adult Crohn’s disease: . European Journal of Gastroenterology & Hepatology 2015;27:1038-44. [DOI: 10.1097/meg.0000000000000430] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
593 Tillinger W, Jilch R, Waldhoer T, Reinisch W, Junger W. Monocyte human leukocyte antigen-DR expression-a tool to distinguish intestinal bacterial infections from inflammatory bowel disease? Shock 2013;40:89-94. [PMID: 23860582 DOI: 10.1097/SHK.0b013e318299ebdd] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
594 Thörn M, Rorsman F, Rönnblom A, Sangfelt P, Wanders A, Eriksson BM, Bondeson K. Active cytomegalovirus infection diagnosed by real-time PCR in patients with inflammatory bowel disease: a prospective, controlled observational study (.). Scand J Gastroenterol. 2016;51:1075-1080. [PMID: 27142339 DOI: 10.3109/00365521.2016.1156154] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
595 van den Heuvel TRA, Jeuring SFG, Zeegers MP, van Dongen DHE, Wolters A, Masclee AAM, Hameeteman WH, Romberg-camps MJL, Oostenbrug LE, Pierik MJ, Jonkers DM. A 20-Year Temporal Change Analysis in Incidence, Presenting Phenotype and Mortality, in the Dutch IBDSL Cohort—Can Diagnostic Factors Explain the Increase in IBD Incidence? Journal of Crohn's and Colitis 2017;11:1169-79. [DOI: 10.1093/ecco-jcc/jjx055] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
596 Tursi A, Elisei W, Picchio M. Incidence and prevalence of inflammatory bowel diseases in gastroenterology primary care setting. Eur J Intern Med. 2013;24:852-856. [PMID: 23867759 DOI: 10.1016/j.ejim.2013.06.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
597 Baars J, Thijs J, Bac D, ter Borg P, Kuipers E, van der Woude C. Small bowel carcinoma mimicking a relapse of Crohn's disease: A case series. Journal of Crohn's and Colitis 2011;5:152-6. [DOI: 10.1016/j.crohns.2010.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
598 Boal Carvalho P, Rosa B, Dias de Castro F, Moreira MJ, Cotter J. PillCam COLON 2© in Crohn’s disease: A new concept of pan-enteric mucosal healing assessment. World J Gastroenterol 2015; 21(23): 7233-7241 [PMID: 26109810 DOI: 10.3748/wjg.v21.i23.7233] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
599 Gagnière C, Bourrier A, Seksik P, Gornet J, Dewit O, Nancey S, Altwegg R, Abitbol V, Laharie D, Reenaers C, Buisson A, Pariente B, Viennot S, Vuitton L, Stefanescu C, Marteau P, Bouguen G, Cosnes J, Amiot A; the GETAID INFOPRO study group. Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). Aliment Pharmacol Ther 2018;48:713-22. [DOI: 10.1111/apt.14926] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
600 Ampuero J, Rojas-Feria M, Castro-Fernández M, Millán-Lorenzo M, Guerrero-Jiménez P, Romero-Gómez M. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's Disease in clinical practice. J Gastroenterol Hepatol. 2015;Epub ahead of print. [PMID: 26173493 DOI: 10.1111/jgh.13039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
601 Peters V, Dijkstra G, Campmans-Kuijpers MJE. Are all dietary fibers equal for patients with inflammatory bowel disease? A systematic review of randomized controlled trials. Nutr Rev 2021:nuab062. [PMID: 34486663 DOI: 10.1093/nutrit/nuab062] [Reference Citation Analysis]
602 Pous-serrano S, Frasson M, Cerrillo E, Beltrán B, Iborra M, Hervás D, García-granero E, Nos P. Correlation between fecal calprotectin and inflammation in the surgical specimen of Crohn's disease. Journal of Surgical Research 2017;213:290-7. [DOI: 10.1016/j.jss.2017.02.064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
603 Lakatos PL, Sipeki N, Kovacs G, Palyu E, Norman GL, Shums Z, Golovics PA, Lovasz BD, Antal-Szalmas P, Papp M. Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn's Disease. J Crohns Colitis 2015;9:891-8. [PMID: 26188353 DOI: 10.1093/ecco-jcc/jjv127] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
604 Yacoub JH, Obara P, Oto A. Evolving role of MRI in Crohn's disease. J Magn Reson Imaging 2013;37:1277-89. [PMID: 23712842 DOI: 10.1002/jmri.24081] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
605 Carvalho LP, Túlio MA, Rodrigues JP, Bana E Costa T, Chagas C. Miliary Tuberculosis in a Crohn's Disease Patient: The Risk beyond the Screening. GE Port J Gastroenterol 2018;26:64-9. [PMID: 30675506 DOI: 10.1159/000487297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
606 Li Y, Hauenstein K. New Imaging Techniques in the Diagnosis of Inflammatory Bowel Diseases. Viszeralmedizin 2015;31:227-34. [PMID: 26557830 DOI: 10.1159/000435864] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
607 Collins M, Sarter H, Gower-Rousseau C, Koriche D, Libier L, Nachury M, Cortot A, Zerbib P, Blanc P, Desreumaux P, Colombel JF, Peyrin-Biroulet L, Pineton de Chambrun G. Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence. J Crohns Colitis 2017;11:281-8. [PMID: 27578800 DOI: 10.1093/ecco-jcc/jjw151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
608 Santos-Antunes J, Cardoso H, Lopes S, Marques M, Nunes AC, Macedo G. Capsule enteroscopy is useful for the therapeutic management of Crohn’s disease. World J Gastroenterol 2015; 21(44): 12660-12666 [PMID: 26640343 DOI: 10.3748/wjg.v21.i44.12660] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
609 Thomsen KL, Grønbæk H, Dahlerup JF, Aagaard NK, Christensen LA, Agnholt J, Frystyk J, Vilstrup H. Prednisolone but Not Infliximab Aggravates the Upregulated Hepatic Nitrogen Elimination in Patients with Active Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2014;20:7-13. [DOI: 10.1097/01.mib.0000437496.07181.4c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
610 Lee S, Ye BD, Park SH, Lee KJ, Kim AY, Lee JS, Kim HJ, Yang SK. Diagnostic Value of Computed Tomography in Crohn's Disease Patients Presenting with Acute Severe Lower Gastrointestinal Bleeding. Korean J Radiol. 2018;19:1089-1098. [PMID: 30386140 DOI: 10.3348/kjr.2018.19.6.1089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
611 Lv C, Zhao X, Gu H, Huang L, Zhou S, Zhi F. Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms. Med Sci Monit 2016;22:4794-802. [PMID: 27926694 DOI: 10.12659/msm.902274] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
612 Rodriguez-Diaz E, Atkinson C, Jepeal LI, Berg A, Huang CS, Cerda SR, OʼBrien MJ, Bigio IJ, Farraye FA, Singh SK. Elastic scattering spectroscopy as an optical marker of inflammatory bowel disease activity and subtypes. Inflamm Bowel Dis 2014;20:1029-36. [PMID: 24798637 DOI: 10.1097/MIB.0000000000000058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
613 Yamamoto T, Shiraki M, Bamba T, Umegae S, Matsumoto K. Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn’s disease after ileocolonic resection: A prospective pilot study. United European Gastroenterol J. 2013;1:368-374. [PMID: 24917985 DOI: 10.1177/2050640613501818] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
614 Gionchetti P, Rizzello F, Annese V, Armuzzi A, Biancone L, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D'Incà R, Fries W, Kohn A, Orlando A, Papi C, Vecchi M, Ardizzone S; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease.Dig Liver Dis. 2017;49:604-617. [PMID: 28254463 DOI: 10.1016/j.dld.2017.01.161] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
615 Friedman A, Gibson P. Inflammatory Bowel Disease – Crohn's Disease and Ulcerative Colitis. Reference Module in Biomedical Sciences. Elsevier; 2014. [DOI: 10.1016/b978-0-12-801238-3.00052-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
616 Jensen MD, Brodersen JB, Kjeldsen J. Capsule endoscopy for the diagnosis and follow up of Crohn's disease: a comprehensive review of current status. Ann Gastroenterol. 2017;30:168-178. [PMID: 28243037 DOI: 10.20524/aog.2016.0119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
617 Soubières AA, Poullis A. Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2016; 7(1): 41-50 [PMID: 26855811 DOI: 10.4292/wjgpt.v7.i1.41] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
618 Ricci JER Júnior, Chebli LA, Ribeiro TCDR, Castro ACS, Gaburri PD, Pace FHDL, Barbosa KVBD, Ferreira LEVVDC, Passos MDCF, Malaguti C, Delgado ÁHDA, Campos JD, Coelho AR, Chebli JMF. Small-Intestinal Bacterial Overgrowth is Associated With Concurrent Intestinal Inflammation But Not With Systemic Inflammation in Crohn's Disease Patients. J Clin Gastroenterol 2018;52:530-6. [PMID: 28134633 DOI: 10.1097/MCG.0000000000000803] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
619 de Melo SW, Di Palma JA. The Role of Capsule Endoscopy in Evaluating Inflammatory Bowel Disease. Gastroenterology Clinics of North America 2012;41:315-23. [DOI: 10.1016/j.gtc.2012.01.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
620 Zhulina Y, Udumyan R, Henriksson I, Tysk C, Montgomery S, Halfvarson J. Temporal trends in non-stricturing and non-penetrating behaviour at diagnosis of Crohn's disease in Örebro, Sweden: a population-based retrospective study. J Crohns Colitis 2014;8:1653-60. [PMID: 25113899 DOI: 10.1016/j.crohns.2014.07.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
621 Lucendo AJ, Arias Á, Roncero Ó, Hervías D, Verdejo C, Naveas-Polo C, Bouhmidi A, Lorente R, Alcázar LM, Salueña I, García-Quiñones JA, Carrillo-Ramos MJ. Anemia at the time of diagnosis of inflammatory bowel disease: Prevalence and associated factors in adolescent and adult patients. Dig Liver Dis 2017;49:405-11. [PMID: 28096058 DOI: 10.1016/j.dld.2016.12.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
622 Caccaro R, D’incà R, Martinato M, Pont ED, Pathak S, Frigo AC, Sturniolo GC. Fecal lactoferrin and intestinal permeability are effective non-invasive markers in the diagnostic work-up of chronic diarrhea. Biometals 2014;27:1069-76. [DOI: 10.1007/s10534-014-9745-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
623 Atkinson NS, Bryant RV, Dong Y, Maaser C, Kucharzik T, Maconi G, Asthana AK, Blaivas M, Goudie A, Gilja OH. WFUMB Position Paper. Learning Gastrointestinal Ultrasound: Theory and Practice. Ultrasound Med Biol. 2016;42:2732-2742. [PMID: 27742140 DOI: 10.1016/j.ultrasmedbio.2016.08.026] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
624 Berrill JW, Green JT, Hood K, Campbell AK. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. Aliment Pharmacol Ther. 2013;38:44-51. [PMID: 23668698 DOI: 10.1111/apt.12335] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 7.0] [Reference Citation Analysis]
625 Bennett AL, Munkholm P, Andrews JM. Tools for primary care management of inflammatory bowel disease: Do they exist? World J Gastroenterol 2015; 21(15): 4457-4465 [PMID: 25914455 DOI: 10.3748/wjg.v21.i15.4457] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
626 Sahu P, Vuyyuru SK, Kante B, Agarwal A, Sharma R, Das P, Panwar R, Jain S, Bopanna S, Makharia G, Kedia S, Ahuja V. Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India. Indian J Gastroenterol 2020;39:388-97. [PMID: 32880844 DOI: 10.1007/s12664-020-01043-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
627 Ramakrishna BS, Makharia GK, Ahuja V, Ghoshal UC, Jayanthi V, Perakath B, Abraham P, Bhasin DK, Bhatia SJ, Choudhuri G, Dadhich S, Desai D, Goswami BD, Issar SK, Jain AK, Kochhar R, Loganathan G, Misra SP, Ganesh Pai C, Pal S, Philip M, Pulimood A, Puri AS, Ray G, Singh SP, Sood A, Subramanian V; Indian Society of Gastroenterology Task Force on Inflammatory Bowel Diseases. Indian Society of Gastroenterology consensus statements on Crohn's disease in India. Indian J Gastroenterol 2015;34:3-22. [PMID: 25772856 DOI: 10.1007/s12664-015-0539-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
628 Lima Martins A, Volpato RA, Zago-Gomes MDP. The prevalence and phenotype in Brazilian patients with inflammatory bowel disease. BMC Gastroenterol. 2018;18:87. [PMID: 29914399 DOI: 10.1186/s12876-018-0822-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
629 Lazaridis LD, Pistiki A, Giamarellos-Bourboulis EJ, Georgitsi M, Damoraki G, Polymeros D, Dimitriadis GD, Triantafyllou K. Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis. Dig Dis Sci. 2017;62:2348-2356. [PMID: 28523573 DOI: 10.1007/s10620-017-4609-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 9.8] [Reference Citation Analysis]
630 Pieczarkowski S, Kowalska-Duplaga K, Kwinta P, Tomasik P, Wędrychowicz A, Fyderek K. Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain. Gastroenterol Res Pract 2016;2016:8089217. [PMID: 27974886 DOI: 10.1155/2016/8089217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
631 Quénéhervé L, David G, Bourreille A, Hardouin JB, Rahmi G, Neunlist M, Brégeon J, Coron E. Quantitative assessment of mucosal architecture using computer-based analysis of confocal laser endomicroscopy in inflammatory bowel diseases. Gastrointestinal Endoscopy 2019;89:626-36. [DOI: 10.1016/j.gie.2018.08.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
632 Hahnemann ML, Nensa F, Kinner S, Maderwald S, Umutlu L, Gerken G, Lauenstein TC. Improved detection of inflammatory bowel disease by additional automated motility analysis in magnetic resonance imaging. Invest Radiol. 2015;50:67-72. [PMID: 25260093 DOI: 10.1097/rli.0000000000000097] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
633 Czakó L, Szepes Z, Szepes A. [Diagnostic endoscopic ultrasonography in the gastrointestinal tract]. Orv Hetil. 2012;153:93-101. [PMID: 22236415 DOI: 10.1556/OH.2012.29288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
634 Regueiro MD, Greer JB, Hanauer SB. Established Management Paradigms in IBD: Treatment Targets and Therapeutic Tools. Am J Gastroenterol Suppl 2016;3:8-16. [DOI: 10.1038/ajgsup.2016.16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
635 Kim B, Cheon JH, Moon HJ, Park YR, Ye BD, Yang SK, Seo GS, Jang BI, Kim YS, Kim JS, Han DS, Kim YH, Kim WH. Crohn's disease prognosis and early immunomodulator therapy: Results from the CONNECT study. J Gastroenterol Hepatol 2016;31:126-32. [PMID: 26406334 DOI: 10.1111/jgh.13169] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
636 Castiglione F, Mainenti PP, De Palma GD, Testa A, Bucci L, Pesce G, Camera L, Diaferia M, Rea M, Caporaso N, Salvatore M, Rispo A. Noninvasive diagnosis of small bowel Crohn's disease: direct comparison of bowel sonography and magnetic resonance enterography. Inflamm Bowel Dis. 2013;19:991-998. [PMID: 23429465 DOI: 10.1097/mib.0b013e3182802b87] [Cited by in Crossref: 80] [Cited by in F6Publishing: 24] [Article Influence: 8.9] [Reference Citation Analysis]
637 Ikhtaire S, Shajib MS, Reinisch W, Khan WI. Fecal calprotectin: Its scope and utility in the management of inflammatory bowel disease. J Gastroenterol. 2016;51:434-446. [PMID: 26897740 DOI: 10.1007/s00535-016-1182-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
638 Julià A, Domènech E, Chaparro M, García-Sánchez V, Gomollón F, Panés J, Mañosa M, Barreiro-De Acosta M, Gutiérrez A, Garcia-Planella E, Aguas M, Muñoz F, Esteve M, Mendoza JL, Vera M, Márquez L, Tortosa R, López-Lasanta M, Alonso A, Gelpí JL, García-Montero AC, Bertranpetit J, Absher D, Myers RM, Gisbert JP, Marsal S. A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitis. Hum Mol Genet 2014;23:6927-34. [PMID: 25082827 DOI: 10.1093/hmg/ddu398] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
639 Anadol Kelleci U, Calhan T, Sahin A, Kahraman R, Ozdil K, Sokmen HM, Yalcin D. The Prevalence of Headache in Crohn's Disease: Single-Center Experience. Gastroenterol Res Pract 2016;2016:6474651. [PMID: 26904110 DOI: 10.1155/2016/6474651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
640 Griffin N, Grant LA, Anderson S, Irving P, Sanderson J. Small bowel MR enterography: problem solving in Crohn’s disease. Insights Imaging. 2012;3:251-263. [PMID: 22696087 DOI: 10.1007/s13244-012-0154-3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
641 Lopes S, Andrade P, Rodrigues-Pinto E, Afonso J, Macedo G, Magro F. Fecal marker levels as predictors of need for endoscopic balloon dilation in Crohn’s disease patients with anastomotic strictures. World J Gastroenterol 2017; 23(35): 6482-6490 [PMID: 29085198 DOI: 10.3748/wjg.v23.i35.6482] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
642 Shulman S, Kramer M, Amer R, Sorkin N, Schaap-fogler M, Rosenblatt A, Habot-wilner Z. CHARACTERISTICS AND LONG-TERM OUTCOME OF PATIENTS WITH NONINFECTIOUS RETINAL VASCULITIS. Retina 2015;35:2633-40. [DOI: 10.1097/iae.0000000000000623] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 2.1] [Reference Citation Analysis]
643 Sauer CG. Radiation exposure in children with inflammatory bowel disease. Curr Opin Pediatr. 2012;24:621-626. [PMID: 22935753 DOI: 10.1097/mop.0b013e32835742a2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
644 American Society for Gastrointestinal Endoscopy Standards of Practice Committee. , Shergill AK, Lightdale JR, Bruining DH, Acosta RD, Chandrasekhara V, Chathadi KV, Decker GA, Early DS, Evans JA, Fanelli RD, Fisher DA, Fonkalsrud L, Foley K, Hwang JH, Jue TL, Khashab MA, Muthusamy VR, Pasha SF, Saltzman JR, Sharaf R, Cash BD, DeWitt JM. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc 2015; 81: 1101-21. e1-13. [PMID: 25800660 DOI: 10.1016/j.gie.2014.10.030] [Cited by in Crossref: 172] [Cited by in F6Publishing: 152] [Article Influence: 24.6] [Reference Citation Analysis]
645 Keil R, Wasserbauer M, Zádorová Z, Hajer J, Drastich P, Wohl P, Beneš M, Bojková M, Svoboda P, Konečný M, Falt P, Vaňásek T, Pešta M, Pešek F, Bouchner L, Koželuhová J, Novotný A, Bartůsková L, Špičák J. Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis. Scand J Gastroenterol 2016;51:1062-8. [PMID: 27002981 DOI: 10.3109/00365521.2016.1149883] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
646 Agraib LM, Yamani MI, Rayyan YM, Abu-Sneineh AT, Tamimi TA, Tayyem RF. The probiotic supplementation role in improving the immune system among people with ulcerative colitis: a narrative review. Drug Metab Pers Ther 2021. [PMID: 34428363 DOI: 10.1515/dmdi-2021-0150] [Reference Citation Analysis]
647 Schilling J, Loening-baucke V, Dörffel Y. Increased Gardnerella vaginalis urogenital biofilm in inflammatory bowel disease. Journal of Crohn's and Colitis 2014;8:543-9. [DOI: 10.1016/j.crohns.2013.11.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
648 Rodrigues de Carvalho L, de Brito TV, Simião da C Júnior J, José Dias Júnior G, de Aguiar Magalhãres D, Guimarães Sousa S, Oliveira Silva R, Rodolfo Pereira da Silva F, Fernando Pereira Vasconcelos D, Maria Costa Véras L, de Sousa de Almeida Leite JR, Santos Martins D, da Silva Martins C, Soares de Oliveira J, Barbosa ALDR. Epiisopiloturine, an imidazole alkaloid, reverses inflammation and lipid peroxidation parameters in the Crohn disease model induced by trinitrobenzenosulfonic acid in Wistar rats. Biomed Pharmacother 2018;102:278-85. [PMID: 29567541 DOI: 10.1016/j.biopha.2018.03.090] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
649 Dothel G, Vasina V, Barbara G, De Ponti F. Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues. Pharmacology & Therapeutics 2013;139:71-86. [DOI: 10.1016/j.pharmthera.2013.04.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
650 Sasaki T, Kunisaki R, Kinoshita H, Yamamoto H, Kimura H, Hanzawa A, Shibata N, Yonezawa H, Miyajima E, Sakamaki K. Use of color Doppler ultrasonography for evaluating vascularity of small intestinal lesions in Crohn’s disease: correlation with endoscopic and surgical macroscopic findings. Scand J Gastroenterol. 2014;49:295-301. [PMID: 24344807 DOI: 10.3109/00365521.2013.871744] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
651 Ward MG, Kariyawasam VC, Mogan SB, Patel KV, Pantelidou M, Sobczyńska-Malefora A, Porté F, Griffin N, Anderson SH, Sanderson JD, Harrington DJ, Irving PM. Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's Disease. Inflamm Bowel Dis 2015;21:2839-47. [PMID: 26296064 DOI: 10.1097/MIB.0000000000000559] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
652 Oliveira AM, Cardoso FS, Rodrigues CG, Santos L, Martins A, de Deus JR, Reis J. Can Red Cell Distribution Width Be Used as a Marker of Crohn's Disease Activity? GE Port J Gastroenterol 2016;23:6-12. [PMID: 28868424 DOI: 10.1016/j.jpge.2015.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
653 Li Y, Tian Y, Zhu W, Gong J, Guo Z, Guo F, Gu L, Li J. IL-10/microRNA-155/SHIP-1 signaling pathway is crucial for commensal bacteria induced spontaneous colitis. Biochem Pharmacol 2016;116:100-6. [PMID: 27395764 DOI: 10.1016/j.bcp.2016.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
654 Panaccione R, Hibi T, Peyrin-Biroulet L, Schreiber S. Implementing changes in clinical practice to improve the management of Crohn’s disease. J Crohns Colitis. 2012;6 Suppl 2:S235-S242. [PMID: 22463930 DOI: 10.1016/s1873-9946(12)60503-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
655 Gordon H, Harbord M. A patient with severe Crohn's colitis responds to Faecal Microbiota Transplantation. J Crohns Colitis. 2014;8:256-257. [PMID: 24239403 DOI: 10.1016/j.crohns.2013.10.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
656 Azzam NA, Aljebreen A, Almuhareb A, Almadi MA. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients. Saudi J Gastroenterol 2020;26:256-62. [PMID: 32415045 DOI: 10.4103/sjg.SJG_175_20] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
657 Minordi LM, Scaldaferri F, Larosa L, Marra R, Giordano F, Laterza L, Scoleri I, Poscia A, Gerardi V, Bruno G, Gaetani E, Gasbarrini A, Vecchioli A, Bonomo L. Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography. Radiol Med 2015;120:449-57. [PMID: 25450867 DOI: 10.1007/s11547-014-0471-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
658 Holleran G, Valerii G, Tortora A, Scaldaferri F, Conti S, Amato A, Gasbarrini A, Costamagna G, Riccioni ME. The use of single balloon enteroscopy in Crohn's disease and its impact on clinical outcome. Scand J Gastroenterol. 2018;53:925-929. [PMID: 29966446 DOI: 10.1080/00365521.2018.1476914] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
659 Annunziata ML, Caviglia R, Papparella LG, Cicala M. Upper gastrointestinal involvement of Crohn's disease: a prospective study on the role of upper endoscopy in the diagnostic work-up. Dig Dis Sci. 2012;57:1618-1623. [PMID: 22350786 DOI: 10.1007/s10620-012-2072-0] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 7.5] [Reference Citation Analysis]
660 Schulz C, Mönkemüller K, Salheiser M, Bellutti M, Schütte K, Malfertheiner P. Double-balloon enteroscopy in the diagnosis of suspected isolated Crohn’s disease of the small bowel. Dig Endosc. 2014;26:236-242. [PMID: 23855454 DOI: 10.1111/den.12142] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
661 Toyonaga T, Steinbach EC, Keith BP, Barrow JB, Schaner MR, Wolber EA</